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Abstract 
Electrospray ionization mass spectrometry (ESI-MS) is a powerful technique for 
investigating protein structures, conformations, and interactions. Despite its widespread 
use, many fundamental aspects of ESI remain poorly understood. In this thesis, we use a 
combination of molecular dynamics (MD) simulations and experiments to gain insights 
into the hidden complexities of ESI-MS.  
 
Chapter 2 discusses the topic of salt-induced protein signal degradation. Salts 
such as NaCl, CsCl, and tetrabutylammonium chloride (NBu4Cl) interfere with MS data 
acquisition, leading to adduct formation and signal suppression. MD simulations provide 
an explanation for these salt interferences. Signal suppression can be broken down into 
two effects, i.e., i) peak splitting due to adduction, ii) “genuine” signal suppression. The 
results obtained may be helpful to anticipate solution conditions for improved protein 
analyses by ESI-MS. 
The two subsequent Chapters examine the mechanism of native protein 
supercharging, which represents a highly contentious topic. Chapter 3 uses MD 
simulations along with ion mobility mass spectrometry (IMS/MS). Holo-myoglobin 
(hMb) serves as a model protein, along with the two most common supercharging agents 
(SCAs), sulfolane and m-nitrobenzyl alcohol (m-NBA). Our data show that supercharging 
is caused by ‘charge trapping’ that arises from solvent segregation in the droplets, 
resulting in the formation of SCA-enriched surface layer and an aqueous core. The key 
factor to charge trapping is the differential solubility of charge carriers (such as Na+ or 
NH4
+) in water compared to the exterior SCA layer. After complete water evaporation, 
residual SCA molecules impede charge carrier release from the droplet, and any 
remaining charge carriers will bind to the protein. Slow SCA evaporation eventually 
releases a highly charged protein into the gas phase that may undergo Coloumbic 
unfolding. These findings represent the first atomistic view of protein supercharging. 
 ii 
 
In Chapter 4, we explore the mechanism of native protein supercharging from a 
different perspective using a crown ether (18C6). 18C6 selectively binds Na+/NH4
+ and 
enhances their solubility in the SCA layer. This facilitates the release of 18C6-bound 
charge carriers from the droplet. As a result, 18C6 suppressed supercharging effect, as 
confirmed both in MD simulations and experimentally. These data support the proposed 
charge trapping mechanism for both proteins and dendrimers.    
A chain ejection model (CEM) has been proposed to account for the protein ESI 
behavior under such non-native conditions. The CEM envisions that unfolded proteins are 
driven to the droplet surface by hydrophobic and electrostatic factors, followed by 
gradual ejection via intermediates where droplets carry extended protein tails. Thus far it 
has not been possible to support the CEM through MD simulations.  In Chapter 5 we 
overcome these difficulties and use MD simulations along with ion mobility experiments 
to confirm CEM as an ejection mechanism for unfolded proteins. Overall, the modeling 
and experimental work in this thesis provide unprecedented insights into the mechanism 
of protein charging and supercharging during ESI. 
 
Keywords: electrospray ionization mass spectrometry | molecular dynamics (MD) 
simulations | supercharging | charging | protein ion.  
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Chapter 1.  Introduction 
1.1.  Protein Structure-Function Relationship 
Proteins are biological polymers that are involved in all physiological processes. There are 
structural proteins (viral coat proteins, epidermal keratin); catalytic proteins (enzymes); transport 
and storage proteins (hemoglobin, myoglobin, ferritin); regulatory proteins (hormones, 
transcription regulators), and proteins of the immune system. Their size ranges from a few 
thousand Daltons (Da) all the way to the megadalton (MDa) range.1 
Proteins adopt their higher order structure through folding (Figure 1.1). Twenty 
naturally occurring amino acids represent the basic building blocks during protein biosynthesis. 
These amino acids form polypeptide chains via peptide bonds; this is known as the primary 
structure (Figure 1.1a). Secondary structure forms via intramolecular hydrogen bonds that 
organize the backbone into α-helices and β-sheets. The arrangement of secondary motifs results 
in the formation of tertiary structure that is stabilized by non-covalent interactions (hydrogen 
bonds, van der Waals forces, ionic interactions and hydrophobic packing) (Figure 1.1b, c). 
Quaternary structure refers to an assembly of two or more protein chains.2 
 
 
 
 
2 
 
 
 
1.2. Factors that Contribute to the Stability of Native Protein 
Structures in Solution 
In their biologically active (“native”) state, most proteins are folded into highly ordered compact 
structures. There is a delicate balance between the folded native conformation (N) and the 
unfolded state (U). Folding transitions are often discussed in terms of a simple two-state 
equilibrium N⇌U, and the corresponding equilibrium constant K = [U]/[N] can be affected by 
changes in temperature or solvent properties. 
The Gibb’s free energy change ∆𝐺° = −𝑅𝑇𝑙𝑛𝐾 provides a framework for discussing protein 
stability; it includes enthalpic ( ∆𝐻) and entropic ( ∆𝑆) contributions arising from the protein and 
the surrounding solvent according to  
 ∆𝐺°𝑁→𝑈 = ∆𝐻°𝑁→𝑈 − 𝑇∆𝑆°𝑁→𝑈 (1.1) 
Figure 1.1. a) A polypeptide showing a peptide bond in red. b) NMR structure of S100B (PDB: 
1UWO), showing α-helices c) Tertiary structure of outer membrane protein A (PDB: 1QJP), illustrating 
β-sheets.  
 
 
(a)
(b) (c)
C-terminal N-terminal 
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For N to be stable, G° has to be positive. To decipher the basics of protein stability, it is 
essential to identify the types of interactions that affect ∆𝐻 and  ∆𝑆.3 
Hydrogen bonds (H-bonds) are one of the primary stabilizing factors for secondary 
structure (α-helices and β-sheets). H-bonds are non-covalent interactions that occur between a 
hydrogen donor and acceptor e.g., in α-helices the amide hydrogen donor (N-H) is hydrogen 
bonded to the oxygen of the carbonyl group. In addition to these backbone contacts, H-bonds can 
form among side chains, or between side chains and the backbone.4-5 
Van der Waals interactions take place between atoms that are in close contact with one 
another. The protein has favorable internal van der Waals interactions, but there are also 
favorable van der Waals contacts with the solvent.6  
Salt bridges form due to electrostatic interactions between the positively charged side 
chain of lysine (Lys) and arginine (Arg) and the carboxylate group of glutamic acid (Glu) and 
aspartic acid (Asp). Salt bridges are rarely located within the protein as it is energetically 
unfavorable to desolvate two charged groups. Mostly, salt bridges are located on the surface 
where they are solvated by water. Therefore, the contribution of salt bridges to protein stability is 
limited.7 
Disulfide (S-S) bridges are covalent contacts formed between pairs of cysteine (Cys) 
side chains. These bonds are found in many proteins such as lysozyme and insulin. They 
contribute to the stabilization of native state by decreasing the conformational entropy of the 
unfolded state.8 
The hydrophobic effect is the most dominant factor in protein stability. Nonpolar amino 
acids tend to sequester themselves in the protein interior to avoid solvation by water. This 
phenomenon can be explained thermodynamically. The surface of the protein is decorated with 
hydrophilic residues that are solvated by water which is enthalpically favorable. The hydrophobic 
residues that cannot form H-bonds are buried inside which will decrease the entropic penalty as 
described by the “iceberg model”.  In liquid water, the hydrogen bond network is very dynamic 
due to Brownian motions. Placing a non-polar molecule in bulk water will cause the formation of 
immobilized “water cages” around them. This iceberg water has lower entropy than bulk water. 
4 
 
 
To avoid this undesirable effect, water molecules decrease their contact with non-polar 
molecules. This is achieved by the burial of hydrophobic molecules within the protein core.9-10 
The entropy of the polypeptide chain decreases dramatically upon folding. This will 
reduce the entropy of the protein (∆𝑆 < 0) which is thermodynamically unfavorable. At the same 
time, hydrophobic interactions will compensate for this effect by increasing the entropy of the 
surrounding water. When the hydrophobic chains are clustered together, the water molecules 
surrounding these non-polar patches will be released in bulk water and participate into the H-
bond network of the solvent. Overall, the magnitude and the sign of ∆𝐺° in equation 1.1 
represents a delicate balance between numerous competing factors and interactions.  
1.3. Methods for Studying of Protein Structure and Dynamics  
1.3.1. X-ray Crystallography 
X-ray crystallography represents the most important tool for determining high-
resolution 3D protein structures. Thousands of protein structures in the Protein Data Bank (PDB) 
have been obtained via X-ray crystallography. Under optimal conditions, this technique can yield 
structural data with a resolution of about 1 Å which is on the order of atomic bond lengths.11 
The birth of X-ray crystallography started with the work of Nobel prize winner Max von 
Laue, who discovered the interaction of X-ray photons with crystals. In 1915, Nobel Prize 
winners Lawrence Bragg and his father William Bragg developed Bragg’s law that is used to 
analyze the diffraction patterns produced by the crystal lattice upon exposure to X-ray. In X-ray 
crystallography, protein crystals are exposed to an X-ray beam. The X-ray photons are diffracted 
by the electrons in the crystal lattice which constructively or destructively interfere with each 
other. From the resulting diffraction pattern, it is possible to produce a three-dimensional electron 
density map, from which atomic positions and bonds in the crystal can be obtained.12  
Proteins undergo incessant thermal motions and fluctuate between different 
conformations.13 The crystallographic B-factors report on the thermal displacement of atoms 
from their average positions, but they also have contributions from crystal imperfections.14-15 
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Overall, dynamic information obtained from B-factors is limited, calling for the use of 
complementary techniques such as nuclear magnetic resonance spectroscopy.16-17    
1.3.2. Nuclear Magnetic Resonance (NMR) Spectroscopy 
The development of NMR spectroscopy started in the 1940s by the Rabi, Purcell, and Bloch 
groups.18-19 All of them received the Nobel Prize for their achievements. Since then, NMR has 
evolved into a valuable tool that is used for a wide range of applications, from the 
characterization of small molecules to the conformational determination of biomolecules. NMR 
probes nuclei that have a spin such as 1H, 13C, 15N, 17O, 33S. Unlike X-ray crystallography, NMR 
is conducted in aqueous solution and it provides a near physiological environment for protein 
analyses.  
Various NMR techniques are available for probing of protein structures20 and dynamics 
at atomic resolution.21 NMR spectra often suffer from spectral congestion and decreased 
intensity, especially for larger proteins. Replacement of hydrogen with deuterium in conjunction 
with transverse relaxation- optimized spectroscopy (TROSY) experiments is one way to address 
this difficulty, thereby extending the size range accessible by NMR methods.22  
1.3.3. Cryogenic Electron Microscopy (Cryo-EM) 
In recent years, cryo-EM has become a powerful tool in structural biology. In 2017 the Nobel 
Prize in chemistry was granted to Dubochet, Frank, and Henderson for the development of cryo-
EM which helps in obtaining structural information for non-crystallized proteins.23 This 
technique has proved to be an excellent tool in case of multimeric proteins and membrane 
proteins. Cryo-EM uses frozen protein samples.24 The continuous developments of cryo-EM 
made it possible to resolve challenging structures that have been unamenable to X-ray 
crystallography, e.g., the yeast exocyst that is responsible for vesicle transport25 and the structure 
of actin bound to myosin which is important for muscle contraction.26 
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1.3.4. Optical Methods  
Optical methods are easy to use, quick and sensitive, but they do not provide high-resolution 
structural information. Examples include UV-Visible (UV-Vis) absorption, circular dichroism 
(CD) and fluorescence spectroscopy. 
UV-Vis absorption spectroscopy can be used to probe protein conformations as a 
peptide bond absorbs light in the far UV range around 195 nm. A second absorption maximum 
around 280 nm arises from aromatic amino acids such as tyrosine, tryptophan, and 
phenylalanine. Sometimes prosthetic groups have a strong absorption band, e.g., the 
spectroscopic properties of heme groups depend on the oxidation state, the presence of ligands, 
and the surrounding environment.27  In addition, protein concentrations can be calculated using 
the Beer-Lambert law 
 𝐴 = 𝜀𝐶𝑑 (1.2) 
where A is the absorbance,  𝜀 is the molar absorption coefficient as a function of 
wavelength, 𝐶 is the concentration, and 𝑑 is the path length of the cuvette.28 
Circular Dichroism spectroscopy is useful for interrogating chromophores that contain 
chiral centers (such as the alpha carbons along the protein backbone). A CD spectrum represents 
the absorption difference between left and right circularly polarized light. This technique is 
commonly used to probe changes in protein secondary structure. For example, a dominant CD 
band at 222 nm is a hallmark of α-helical structure, while a band around 215 nm corresponds to 
β-sheets. The random coil signal appears at ~ 200 nm.29-30 
Fluorescence spectroscopy is routinely used for protein structural analyses. An excited 
fluorophore emits photons due to relaxation to the ground state. Tryptophan (Trp) is the most 
intense fluorophore in proteins.31 The chromophore environment has a significant effect on 
fluorescence. Förster Resonance Energy Transfer (FRET) is a valuable method for characterizing 
protein conformations. FRET depends on the distance between the excited donor and acceptor. 
One of the consequences of FRET is quenching.  Quenching takes place if a fluorophore is close 
to a non-fluorescent acceptor, such as the heme group in cytochrome c, where the energy 
transfers from Trp59 to heme takes place in native conformation, so Trp59 becomes non-
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fluorescent. In contrast, for unfolded cytochrome c Trp59 is highly fluorescent, thereby providing 
a tool to monitor conformational changes.32 
1.4.  Mass Spectrometry 
Mass spectrometry (MS) has become an indispensable tool in the field of structural biology and 
proteomics. Its applications include measuring mass to charge ratio (m/z), as well as providing 
information on structures, protein-ligand interactions and post-translational modifications. MS 
can be used either as an isolated technique or coupled to liquid chromatography (LC), gas 
chromatography (GC), capillary electrophoresis (CE) or ion mobility spectrometry (IMS).  
1.4.1. Ion Source 
Ionization of analytes takes place in the ion source. There are different methods of ionization in 
MS, such as electron ionization (EI), fast atom bombardment (FAB) and chemical ionization (CI) 
These “traditional” techniques tend to cause fragmentation, particularly for larger analytes.33 The 
analysis of biomolecules such as proteins requires gentle ionization techniques such as 
electrospray ionization (ESI) and matrix-assisted laser absorption/desorption ionization 
(MALDI). In 2002, Fenn 34 and Tanaka won the Chemistry Nobel Prize for developing ESI and 
MALDI, respectively. In the positive ion mode, both ESI and MALDI predominantly form 
protonated analyte ions with m/z that is given by                                                                                         
 𝑚
𝑧
=
[𝑀 + 𝑧 × 1.008]
𝑧
 
(1.3) 
where M is the mass of the neutral analyte and 1.008 represents the proton mass. The mechanism 
of ESI will be discussed in more detail below (section 1.6).  
MALDI is a gentle surface desorption ionization technique that was introduced by 
Hillenkamp and Karas in 1985.35-36 The protein sample is mixed with a matrix, for example, 2,4 
dihydroxybenzoic acid.  The matrix absorbs UV laser energy and then desorbs from the surface 
together with the protein. The charge is transferred from the matrix to the gaseous analyte within 
the MALDI plume.37-38 One of the drawbacks of MALDI is that the extent of charging is limited, 
such that analyte ions tend to appear at very high m/z, beyond the range accessible to some mass 
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analyzers. For this reason, MALDI is often coupled with time of flight mass analyzers (TOF) 
which have a very wide m/z range.  Also, MALDI imaging-MS has become a widely used 
technique for direct, label-free detection of proteins, lipids, and metabolites in tissue sections.39-40 
1.4.2. Mass Analyzers  
A mass analyzer is the part of the mass spectrometer that separates gas phase ions according to 
their m/z. There are several mass analyzers such as quadrupoles, ion traps, TOFs and Fourier-
transform ion cyclotron resonance (FT-ICR) instruments. Only the quadrupole and TOF 
operation will be briefly discussed due to their use in the experiments of the current thesis. 
TOF analyzers have an excellent ion transmission, resolution and an extended mass 
range. The TOF operation is straightforward; ions with different m/z are accelerated by the same 
voltage supplied by an ion pusher. The voltage pulse DELTA 𝑈 supplies all ions with potential 
energy which is then converted into kinetic energy. 
 
𝑧𝑒∆𝑈 =
1
2
𝑚𝑣2 
(1.4) 
 
𝑚, 𝑣, 𝑧𝑒 represent the mass, velocity and ion charge. rearrangement of equation 1.4 yields 
 
𝑣 = √
2𝑧𝑒∆𝑈
𝑚
 
(1.5) 
The time for an ion to reach the detector 𝑡 is given by 
 
𝑡 =
𝑙
𝑣
=
𝑙√𝑚
√2𝑧𝑒∆𝑈
=
𝑙
√2𝑒∆𝑈
√
𝑚
𝑧
 
(1.6) 
 
Equation 1.6 shows that the flight time 𝑡 for an ion depends on m/z.  Therefore, a mass 
spectrum can be recorded as a function of flight time. Ions with different m/z will have variable 
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velocities and different fight times. However, under realistic conditions some ions with the same 
m/z may have slightly different kinetic energy because they do not all experience exactly the 
same acceleration potential ∆𝑈.  These conditions cause peak broadening and decreased 
resolution.41  Reflectrons are used to correct this issue. The reflectron provides an electrostatic 
field to reverse the direction of the ion trajectory.  If two ions have the same m/z but different 
velocities, the faster one penetrates deeper into the reflectron before being directed back toward 
the detector. A reflectron increase the TOF resolution up to 40,000, but at the same time 
sensitivity (ion transmission) is decreased.42-43 TOF mass spectrometers can easily be combined 
with a pulsed ionization technique such as MALDI. However, it is also possible to use 
continuous ionization techniques such as ESI (see below).   
1.4.3. Quadrupole  
One of the most commonly used mass analyzers is the quadrupole. It is composed of four parallel 
cylindrical rods.  Both radiofrequency (RF) and direct current (DC) electric potentials are applied 
to the rods if the quadrupole is used as a ‘mass filter’.  At a constant DC/RF ratio, ions of a 
certain m/z travel through the quadrupole and reach the detector. Any ions with other m/z values 
will have unstable trajectories and hit one of the rods, i.e. they will not be transmitted (Figure 
1.2a). In the absence of DC, all ions will pass through the quadrupole regardless of their m/z. In 
this ‘RF-only’ mode, the quadrupole acts as an ion guide (Figure 1.2b). RF-only quadrupole can 
also be used as collision cell in the presence of a suitable background gas and an accelerating 
bias.44 
Quadrupole mass analyzers have a relatively low resolution (~4000) but offer excellent 
sensitivity. Usually, they are combined with a TOF (Q-TOF) or in a series of three quadrupoles 
known as “triple quads” for tandem MS applications, where the second quadrupole acts as a 
collision cell.43  
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Figure 1.2. Cartoon representation showing quadrupole operation. a) Application of DC voltage 
locks the quadrupole so only specific m/z can pass (blue line). b) RF only where all ions can pass. 
 
1.5. MS Techniques for Studying of Protein Structure and 
Dynamics 
1.5.1. Collision-Induced Dissociation and Tandem MS 
Fragmentation experiments are essential for deciphering the chemical composition of gaseous 
analytes such as peptides and proteins. The bottom-up methodologies are very common, they 
involve enzymatic digestion of the protein prior to gas phase fragmentation and MS analysis.45  
On the other hand, in the top-down approach, intact proteins undergo fragmentation inside the 
mass spectrometer without prior enzymatic digestion.46 
In collision-induced dissociation (CID), protein or peptide ions are accelerated by an 
electric voltage in a region filled with inert gas.  Collisions with this background gas will 
gradually increase the internal energy, ultimately resulting in the rupture of noncovalent contacts 
and covalent bonds. CID can be conducted directly in the ion sampling interface (in-source CID), 
or in an RF-only ion guide after quadrupole-based precursor selection. The latter technique is 
known as tandem MS (MS/MS) which is essential for analyte mixtures.47  
1.5.2. HDX-MS, Covalent Labelling, and Cross-Linking 
Hydrogen/deuterium exchange (HDX) MS is commonly employed to detect protein-
ligand interactions and to explore protein conformational dynamics. HDX uses deuterium (D2O) 
as a labeling reagent.48 HDX exploits the exchange of labile protein hydrogen atoms with 
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deuterium from the solvent. Backbone NH sites and those of side chains tend to exchange 
rapidly. However, hydrogens that are H-bonded (in α-helices and β-sheets) and/or those that are 
buried will exchange much more slowly. Deuteration at these protected sites is mediated by 
thermal opening/closing transitions, i.e. by the conformational dynamics of the protein.49 HDX 
experiments were initially conducted with NMR spectroscopic detection,50  later the use of MS 
for this purpose has become the more widely used approach.48, 51 
The HDX workflow starts with the mixing of the protein solution with D2O based buffer 
for various time intervals (continuous labeling), or just for a fixed labeling period (pulsed HDX). 
This labeling step is followed by quenching at pH ~2.5 and at low temperature, to avoid 
deuterium back exchange. Information about the exchange can be obtained either from intact 
protein mass analyses (global HDX) or after proteolytic digestion and LC-MS of the resulting 
peptides.49, 52-53 
Covalent labeling is a powerful technique that can probe the surface accessibility of 
amino acids in solution via irreversible chemical modifications.54-55 The principle of covalent 
labeling is related to HDX, the main difference is that HDX reports on backbone H-bonds while 
covalent labeling targets protein side chains.  Hydroxyl radical (•OH) is a commonly employed 
highly reactive covalent label that modifies side chains via oxidation. •OH radical can be 
generated by X-ray radiolysis of water or by photolysis of hydrogen peroxide (H2O2) and Fenton 
chemistry. In the last method, a metal is used such as Fe (Ⅱ) to reduce H2O2.56 UV photolysis of 
H2O2 is a method developed by Hambly and Gross, known as fast photochemical oxidation of 
proteins (FPOP).57-58 To determine the location and extent of oxidation, protein digestion is used 
along with MS/MS. Caution must be taken to avoid extensive oxidation, low concentrations of 
H2O2 must be employed and control experiments should be done with no laser treatment to 
evaluate the extent of oxidation. Radical scavengers such as glutamine are used to quench the 
reaction to decrease the •OH lifetime.  A recent study by our group has shown that FPOP can be 
complicated by the presence of secondary radicals that can form during FPOP which extend the 
time of the reaction and give rise to artifacts.59 Despite that, FPOP holds great promise as a 
technique to probe protein-protein or protein-ligand interactions. In studies done by Stocks and 
Konermann, FPOP was used to probe short-lived intermediates in protein folding and 
unfolding.60-62 
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Chemical cross-linking is another widely used approach. The choice of a cross-linking 
reagent relies on the distance between two peptide residues. The crosslinker is a molecule with 
two reactive groups separated by a spacer of a certain length. They can be of different types such 
as homobifuncational molecules that target the same groups on the protein, or heterobifunctional 
molecules that bind different amino acids.63 The main target residues for crosslinking are the 
primary amines and NS carboxyls.64 Cross-linked proteins are analyzed by enzymatic digestion 
followed by LC-MS/MS. The resulting data are used to identify the modified peptide and the 
sites of linkage. Cross-linking provides a distance constraint that limits the number of possible 
structures and helps to draw the topology of subunits in complexes which promotes its use in 
computer modeling.  Interpretation of data is quite challenging as the there may be too many 
cross-links.65-67 This can be resolved by comparing the possible cross-linked peptides against 
database searches.68 
1.5.3. Ion Mobility Spectrometry (IMS) 
IMS is a technique for separating analytes that have different gas-phase structures.15 The history 
of IMS can be traced back to the early 20th century.69 In recent years, the coupling of IMS with 
soft ionization techniques such as ESI and MALDI has opened up new avenues for the analysis 
of biomolecules.70-73 In IMS, protein ion separation depends on size, charge and conformation. 
Drift tubes represent the conceptually most straightforward type of IMS device.  Ions 
move into a background gas (typically helium) under the influence of a weak constant electric 
field 𝐸 in a radial direction towards the mass analyzer. The ions are separated based on their 
mobility K 
 
𝐾 =
𝑣
𝐸
=
𝐿
𝑡𝐷 𝐸
 
(1.7) 
In this equation L refers to the length of the drift tube, 𝑡𝐷 is the drift time and 𝑣 is the 
velocity. The reduced ion mobility 𝐾0 can be calculated according to standard conditions of 
temperature and pressure of the buffer gas to compensate for differences between laboratories 
and instruments. 
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𝐾0 = 𝐾 
𝑇0
𝑇
𝑃
𝑃0
 
(1.8) 
where 𝑇0=273.2 K, and 𝑃0 = 760 Torr. Drift tubes have high-resolving power. Early versions 
suffered from poor ion transmission, but continuous improvements and the use of ion guides 
before the drift cell helps in ion storage and focusing.15 
The collision cross section (CCS) represents a type of projection area that arises from 
the average of all possible orientations involved in the gas phase collisions. The CCS depends on 
the shape of ion and its interaction with the background gas. The dependence between the CCS 
(𝛺) and the measured drift time tD is given by equation 1.9 74 
 
 
𝛺 = 𝑡𝐷𝑧 
𝑒𝐸
16𝑁𝐿
 √
18𝜋
𝜇𝑘𝐵𝑇
 
𝑃0
𝑃
 
𝑇
𝑇0
 
(1.9) 
 
where N is the number density of the gas, µ is the reduced mass of ion and gas. 𝑘𝐵 is the 
Boltzmann constant.74-75  Large ions have a longer drift time due to their more frequent collisions 
with the background gas, while smaller ions will experience a less frictional force. Ions with 
more charges will reach the detector faster, i.e., they will have higher mobilities. 
The introduction of the Synapt platform by Waters in the early 2000s for the first time 
allowed the use of a different type of IM separation. This approach involves the use of traveling 
wave ion guides (TWIGs), and the technique is known as traveling wave ion mobility 
spectrometry (TWIMS). The main difference between drift tube IMS and TWIMS is that drift 
tubes have a static electric field, while TWIMS technology uses “peristaltic” traveling waves. 
More specifically, ions travel through a stack of ring electrodes at which opposite phases of 
radiofrequency (RF) are applied to adjacent electrodes. This creates a radial confining potential 
well. Ions are trapped inside the well. When a transient direct current (DC) voltage that jumps 
from ring to ring is superimposed on the RF voltage ions will travel through the ion guide by 
“surfing” on these waves. Ions with high mobility will tend to be swept along with the wave, 
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while ions of low mobility will occasionally roll over and slip behind the crest of the wave.76-77 
TWIMS generally has a lower resolution than drift tube IMS, but its performance can be 
enhanced by using a He cell prior to the TWIMS device (triwave cell), or by manipulating the 
wave amplitude and velocity .77 
The nature of the TWIMS separation process is not fully understood, so calibration 
methods have been developed to extract numerically accurate CCSs from TWIMS experiments.78  
CCS values can also be predicted on the basis of 3D protein conformations. Different 
algorithms have developed for this purpose. These include the projection approximation (PA) 
which represents the simplest and least accurate of all available methods.79  The exact hard 
sphere (EHSS) is computationally fast and considers the scattering effects of colliding ions, but 
does not include the long-range interactions.80 The later effects are being included in the 
trajectory method (TM ) which by far is the most accurate and expensive method.81 
 
 
Figure 1.3. Schematic layout of a typical “Synapt” Q-TOF mass spectrometer with a quadrupole, 
TOF and ion mobility (TWIMS) separator. The blue line represents the ion trajectory.  
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1.6.  Electrospray Ionization (ESI)  
ESI is the most common atmospheric pressure ionization technique. The idea behind ESI started 
with Malcolm Dole who was the first to exploit the idea of electrostatic spray painting for 
electrospraying kDa polymers. Dole’s results were the starting point for the subsequent “ESI 
revolution”.82 In the 1980s, ESI was further developed by John Fenn. Since then, this ionization 
technique has been proven to be effective for a wide range of analytes including proteins, amino 
acids, DNA, lipids, and sugars.34 
ESI has many advantages such as the possibility for coupling with LC, and the 
production of multiply charged ions which allows the detection of high molecular weight 
biomolecules on analyzers with limited m/z range. ESI cannot tolerate high salt concentrations 
except when the samples are desalted (e.g., by  LC, see Chapter 2).83   
ESI starts with analyte solution that is infused through a metal capillary (typically ~ 0.1 
mm I.D.) held at an electric potential of several kV. The following discussion will be limited to 
positive ion mode as this is most commonly used for a wide range of applications. Charge 
separation takes place by removal of electrons from solution through oxidation (e.g. 2H2O →
O2 + 4H
+ + 4e−). This will induce charge accumulation at the tip of the capillary, forming a 
Taylor cone that emits a mist of µm-sized droplets. The droplets will be charged with excess 
positive ions (such as Na+, K+, H+, NH4
+). Acceleration potentials between the capillary exit and 
orifice will drive the droplets toward the ion sampling interface. During their journey, the 
droplets undergo evaporation assisted by the heating elements in most commercial ion sources. 
Evaporation enhances the charge density on the shrinking droplets until Coulombic repulsive 
forces exceed surface tension; this is known as the Rayleigh limit.84-85 At this point, the 
number 𝑧𝑅 of elementary charges e on the droplet is givent by 
 
𝑧𝑅 =
8𝜋√𝜀0𝛾𝑅3
𝑒
 
(1.10) 
 
where R is the droplet radius, 𝜀0 is the vacuum permittivity, and 𝛾 is the surface tension.  
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At the Rayleigh limit, the droplet becomes unstable and undergoes jet fission, resulting 
in the formation of smaller droplets. Repeated evaporation/fission cycles generate nanodroplets 
from which gas phase analyte ions are released. These ions will travel to the vacuum interface 
where any remaining solvent clusters will be removed by collisional activation.83, 86-88 
 
 
 
 
 
 
 
Figure 1.4. Schematic representation of ESI source operated in positive ion mode.  
1.6.1. Mechanism of Gas Phase Ion Release During ESI 
The ESI mechanism remains controversial; three main models have been suggested to describe 
how protein ion is ejected from the droplet, known as charged residue model (CRM), ion 
evaporation model (IEM) and chain ejection model (CEM). 
In the IEM, successive evaporation and fission events will increase the repulsion of 
charges on the surface of the droplet; this will allow the ejection of small analytes (Figure 1.5a) 
when the electrostatic repulsion allows the ions to overcome the free energy barrier for 
ejection.34, 89-91 The IEM was initially suggested for small inorganic ions such as Na+ and NH4
+. 
However, some authors suggest that the IEM also applies to macromolecules.92 
 𝑁𝑎+(𝑎𝑞) → 𝑁𝑎+(𝐻2𝑂)𝑛(𝑔) (1.11) 
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Ion release in IEM depends mainly on the ability of a solvated ion to cross the free 
energy barrier, so if the ion resides close to the liquid-vacuum surface, then this will enhance its 
ejection probability. De la Mora’s work provided experimental support for the IEM 93-94 while 
MD simulations have shed light on how small solvated ions get released from the surface of the 
droplet.83, 95 
Large globular analytes such as natively folded proteins are believed to follow the CRM, 
where evaporation and Coulombic fission occur until a single analyte molecule remains inside 
the droplet. This molecule gets released into the gas phase upon droplet evaporation to dryness. 
Any remaining charges inside the vanishing droplet transfer to the analyte (Figure 1.5b).96 MD 
simulations and experimental work support the CRM. The CRM/Rayleigh charge model shows 
good agreement between the expected final charge state of protein ions using equation 1.10 and 
the charge produced under experimental conditions.97-98 This charge is exactly what would be 
expected for droplets that dry out until they have reached the same size as the protein. Very 
likely, salt clusters like [ NanCln-1] are also formed by the CRM.
99  
A related framework is known as the combined charged residue-field emission model 
(CCRFEM). It envisions that the number of charges the protein holds is related to the release of 
low molecular weight (MW) charge carriers from the droplet, i.e., any ion that fails to leave the 
droplet will end up on the macromolecule. It can be argued that CCRFEM is very similar to the 
CRM but one difference between both models is that the final analyte charge state does not 
depend on the Rayleigh limit but on the rate of low MW ion departure from the droplet.100-101   
One key factor that determines the mechanism whereby macromolecules are released 
from ESI nanodroplets is their conformation. In native proteins, hydrophobic amino acids are 
buried inside the core while hydrophilic groups are on the surface. These conditions favor the 
CRM. However, under denaturing conditions (i.e. high organic, low pH) the hydrophobic core is 
exposed to solvent. This is energetically unfavorable as described in section 1.2.  To understand 
how disordered protein chains are released from the droplet, it is essential to examine the 
behavior of macromolecules such as polyethylene glycol (PEG) and polypropylene glycol (PPG). 
They are conceptually similar to unfolded proteins in being randomly coiled. Simulations using 
PEG as a model by Consta suggest that PEG travels to the surface of the droplet. One chain 
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terminus then erupts from the droplet and can remain attached until complete dryness of the 
droplet or it can separate from it.102-103 Our laboratory proposed that a similar ESI mechanism 
applies to unfolded proteins named chain ejection model (CEM).83  In the CEM, the protein 
travels to the droplet surface and then undergoes stepwise ejection via hydrated ‘tadpole-like’ 
conformers where the droplet carries an extended protein tail. This chain ejection is enhanced by 
electrostatic repulsion of the charge on the protruding tail and the remaining charges on the 
droplet along with hydrophobicity. CEM is mechanistically similar to CID processes of multi-
subunit systems.104-105 So far it was not feasible to simulate the CEM for unfolded proteins due to 
difficulties associated with the droplet size and charge migration. Details about how we were 
able to deal with those difficulties are discussed in Chapter 5. 
 
Figure 1.5. Cartoon representation of proposed ESI models. a) The ion evaporation model is 
proposed for small ions, b) The charged residue model is suggested for globular folded proteins, 
c) The chain ejection model is envisioned for polymers and unfolded proteins.  
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 1.6.2. Nanoelectrospray Ionization (NanoESI) 
NanoESI is a variation of ESI that was developed in the mid-1990s by Wilm and Mann.106 Both 
nanoESI and conventional ESI follow the same fundamental steps. NanoESI uses a lower flow 
rate, typically less than 100 nL min-1, while conventional ESI operates in the µL min-1 range. The 
emitter tip diameter in nanoESI is typically on the order of 1 µm. The analyte can be in contact 
with high voltage at the tip of the emitter, or with a metal (Pt) wire that is placed inside the 
needle. The need to initiate and maintain a constant flow rate can be achieved by using gentle N2 
back-pressure. The low flow rate is responsible for the high ionization efficiency. One of the 
advantages of nanoESI is its higher salt tolerance. Because the initial droplets formed in nano 
ESI are smaller, the salt concentration after evaporative droplet shrinkage tends to be lower. 
NanoESI is also beneficial because of its much lower sample consumption.107-108 It has been 
proposed that nanoESI is even more gentle than regular ESI for the preservation of non-covalent 
complexes109 but these claims are not universally accepted.110-112 In recent years, nanoESI with 
very small emitter diameters have been used to increase charge states,113 to observe membrane 
proteins, 114 and to study proteins in physiological buffers by direct infusion nanoESI-MS.115 
1.7.  Protein ESI under Native and Denaturing Conditions 
Electrosprayed proteins are always multiply charged. The number of charges can be described by 
charge state (z), and the protein charge state distribution (CSD) depends critically on the protein 
conformation in solution.  
Globular proteins are characterized by a hydrophobic core and a hydrophilic surface. 
Their tightly folded structure gives rise to CSDs centered at low charged states. Direct analysis of 
these globular folded proteins by MS was developed in the 1990s by Katta 116 and Ganem,117  
this was later known as ‘native ESI-MS’. The name originates from the ability of the technique to 
preserve protein-ligand and protein-protein interactions in the gas phase.118-120 Both Robinson121 
and Heck122 have contributed to the development of native ESI-MS in investigating mega Dalton 
proteins, viruses or their capsid shells.123-128 This field has benefited greatly from the 
development of nanoESI, the inception of novel mass analyzers, and the development of 
commercially available IMS devices.129-131  
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Controlling the instrumental parameters along with using suitable buffers helps in the 
analysis of protein and protein complexes under native ESI-MS. Typically, ammonium acetate is 
used as a buffer in native ESI-MS to mimic the cellular environment and decrease the probability 
of structural changes. However, ammonium acetate is not an actual ‘buffer’ at pH 7 because it is 
not composed of a weak acid and its conjugate base. Ammonium acetate is nonetheless used due 
to its volatile character which facilitates the formation of adduct-free protein ions. Conventional 
pH 7 buffers (e.g. phosphate buffer) cannot be used for direct infusion experiments because they 
would trigger extensive adduct formation.132 Ammonium carbonate is a volatile pH 7 buffer, but 
it can destabilize proteins under ESI conditions.133-134 Substantial evidence has been accumulated 
that globular proteins generated by native ESI are formed via the CRM. As outlined above, the 
low charge states of these ions are close to the Rayleigh charge of a protein-sized water droplet. 
The ESI behavior of unfolded proteins is completely different, these species show wide 
CSDs that are shifted to much higher z values than in native ESI. Any non-covalent interactions 
are disrupted.  This effect can be triggered by solution unfolding after exposure to acid,135-136 
base,137 heat,138 or reduction of disulfide bonds.139 Instrumental parameters such as increasing the 
temperature inside the ion source can also induce unfolding.140 As noted above, unfolded proteins 
are likely transferred into the gas phase via the CEM, but this concept remains controversial (see 
Chapter 5). 
High protein charge states can also be achieved by supercharging agents (SCA) in both 
native and denatured protein solutions.141-143 SCAs are added to the sample at low concentration 
that do not affect protein structure.144 Nonetheless, SCAs increase protein charging during ESI. 
SCAs have a high dipole moment and low volatility.145 They concentrate inside the ESI droplet, 
therefore the final nanodroplets contain significantly enhanced SCA concentrations compared to 
the initial bulk solution. The mechanism of supercharging is highly controversial.146 (see 
Chapters 3 and 4). High protein charge states formed after unfolding and/or in the presence of 
SCAs enhance fragmentation in top-down experiments.147 Also, increased charges are beneficial 
for mass analyzers that have limited m/z, or that have m/z-dependent performance characteristics 
(resolution and sensitivity) such as FT-ICR or orbitrap mass analyzers.  
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1.8.  Proteins in the Gas Phase vs. in Solution 
It is common to think of proteins as biomolecules that are surrounded by a buffered aqueous 
environment. Water is essential for proteins to function and to maintain the native conformation. 
The presence of salts along with water dipoles screens electrostatic interactions and decreases the 
magnitude of Coulombic interactions. In addition, water plays a role in protein folding by 
enhancing hydrophobic collapse. Ideally, experiments should be done under native conditions to 
avoid any structural changes. However, MS experiments involve desolvated proteins ions in a 
vacuum, usually in charge states that are very different from those in solution. The absence of 
water will decrease hydrophobic interactions and electrostatic interactions (both attractive and 
repulsive) will be enhanced.148-149  
Electrostatic interactions between two charges 𝑞𝑖  and 𝑞𝑗  that are separated by distance 𝑟 
having a potential 𝑉𝑖𝑗  are described by Coulomb’s law: 
 𝑉𝑖𝑗 =
𝑞𝑖𝑞𝑗
4𝜋𝜀0𝑘𝑒𝑟
 
(1.12) 
 
 
ε0 is the vacuum permittivity and 𝑘𝑒 is the dielectric constant of the medium. Water has 𝑘𝑒 ≈ 80 
. Water dipoles arrange themselves around charges inside the medium. Therefore, interactions 
between   q1and q2 tend to be quite weak. In contrast, vacuum has 𝑘𝑒 = 1 so interactions 
between charges are much more pronounced.  
In solution, pKa values of the main amino acids such as Lys (K), Arg (R), His (H), Glu 
(E), Asp (D), added to N-terminus and C-terminus govern the titration behavior and the net 
charge of the protein.150 Generally, pKa characterizes the protonation status in solution which is 
affected by pH changes and the surrounding environment.  At pH 7 Asp (pKa~ 4), Glu (pKa~4.4) 
and C-terminal carboxylic acids  (pKa ~3.9)  are expected to be negatively charged while Lys, 
Arg, and N-terminus are protonated.151  In the gas phase, proton affinity or gas phase basicity 
controls the protonation of amino acids. Gas phase basicity indicates the transfer of H+ from 
gaseous biomolecular ions to another gas phase species and vice versa. For electrosprayed ions of 
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the same charge states, unfolded proteins tend to have a higher gas phase basicity than folded 
ones due to electrostatic interactions in globular proteins.152  
Some studies have attempted to explain the factors that affect the charging of protein in 
solution150 or the gas phase. Suggestions include increase in the accessibility of possible charge 
sites,116, 153 decreased of Coulombic repulsion between charges, disruption of interactions 
between COO- and positive sites 154 and formation of salt bridges.155 Besides, ESI process plays 
a role in determining the charge state of native protein according to CRM, where the droplet 
transfers its remaining charges to contained macromolecules just at complete evaporation.  
Despite the vastly different environment experienced by proteins in solution and in the 
gas phase, it is well documented that protein ions produced by “native ESI” generally retain 
solution-like properties. In other words, gas phase conformers appear to be kinetically trapped in 
conformations that resemble those in bulk solution. Evidence to support this view includes the 
observation of CCSs that are consistent with crystal structures 15, 110, 127, 156-157 , as well as the 
survival of intricate multi-component protein complexes in the gas phase.126, 158-160 
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1.9. Computer Simulations 
Computational simulations enable us to study system properties and model phenomena that are 
difficult to observe experimentally. Simulations can act as a link between theory and experiment. 
To perform simulations, we need to use algorithms that provide numerical solutions for some of 
the fundamentals of physical laws. Recent advances related to software development and the 
ever-increasing speed of computers continue to push this entire field forward.  
Exact solutions of the Schrödinger equation exist only for a small number of systems 
such as the particle in a box, harmonic oscillator, and hydrogen atom. Because of that, 
approximative ab initio methods have been developed to give the closest solution to the 
Schrödinger equation. These methods do not rely on experimental parameters, but they are 
extremely computationally expensive and can only be applied to small systems.  
Molecular mechanics (MM) is a modeling tool that is used for simulating large 
molecules. MM is not based on quantum mechanics calculations. Instead, it uses classical 
methods to calculate the potential energy of the system. These methods are known as force field 
methods which contain a set of parameters that are derived from experimental data or ab initio 
methods.161 
Monte Carlo methods generate different configurations for the system randomly, with 
relative occupancies that are governed by free energies. Monte Carlo methods can provide a good 
conformational sampling of proteins and other large systems, but they cannot study the system in 
a time-dependent fashion.161 
1.10. Molecular Dynamics (MD) Simulations 
The development of MD simulations started in the 50s with work by Alder, Wainwright, and 
Rahmann.162-163 Ever since the field has advanced rapidly. Today, MD simulations are being 
applied in many fields such as modeling of biomolecules, drug discovery and materials science. 
164 MD simulations model the motion of atoms by solving the classical (Newtonian) laws of 
motion. Many MD methods employ the fact that the statistical ensemble average is equal to the 
time average of a single system according to the ergodic principle. The ensemble average 
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corresponds to a series of microstates of the system under study. The macroscopic properties of 
the system under equilibrium can be predicted from these microstates. There are different 
ensembles that can be modeled based on the experimental conditions. They are named according 
to what is kept constant for example, the microcanonical ensemble (NVE) can be used for 
isolated system simulations in which the number of particles, volume, and energy is kept 
constant; in isobaric-isothermal ensemble (NPT), the temperature and pressure are constant; the 
canonical ensemble (NVT) with constant number of particles, volume and temperature.165 
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A typical MD simulation has the following scheme: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At zero time( 𝑡0),  , 
choose the positions( 𝑟𝑖 ), 
velocities (𝑣𝑖) and the 
time step (∆𝑡) 
Calculate forces on all 
particles using potential 
energy (𝑉) due to 
interaction between 
atoms (force fields) 
Integration of Newton’s law 
of motion using the suitable 
integration scheme, update 
positions and velocities at 
(𝑡 + ∆𝑡) 
System is sampled to 
calculate physical 
properties 
Repeat 
Temperature and pressure 
control using thermostat and 
barostat 
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1.10.1. Initial Coordinates and Velocities 
As outlined in the above scheme, the first step in MD simulations is to find the starting 
positions and velocities. Three-dimensional X-ray structures are used to obtain the primary 
coordinates. Initial velocities can be assigned randomly from Maxwell-Boltzmann distribution at 
a specific temperature.166 
 
𝑝(𝑣) = √
𝑚𝑖
2𝜋𝑘𝐵𝑇
exp [−
𝑚𝑖𝑣
2
2𝑘𝐵𝑇
] 
 
(1.13) 
Where 𝑝(𝑣) is the probability distribution of atoms having velocities between 𝑣 and 𝑣 + ∆𝑣, 𝑣 
represents velocity in three directions, 𝑘𝐵 is the Boltzmann constant, 𝑇 is the temperature and 𝑚 
is the mass. The temperature of the system during simulation will not be constant due to 
randomization of velocity but this can be adjusted using thermostats (section 1.10.6) 
1.10.2. Force Fields  
The idea behind the use of forcefields for macromolecules is based on the work of Warshel, 
Levitt, and Karplus who shared the 2013 Chemistry Nobel Prize.167 Force fields consist of 
parameters that are obtained from ab-initio methods or DFT. These calculations are quite 
expensive for large molecules such as proteins. Therefore, the interactions between atoms are 
modeled semi-empirically using MM force field. Force fields include terms that are derived from 
interactions between atoms in the microscopic system to form molecules. These interactions 
contribute to the total potential of the system. The total potential energy is derived from N 
interacting atoms as a function of their position  𝑉 (𝑟𝑖 ⃗ … 𝑟𝑁⃗⃗⃗⃗ ). From this 𝑉 term the force acting on 
each atom i can be calculated as the gradient with respect to the atom’s position 
 
 𝐹 𝑖 = − ∇ 𝑉(𝑟𝑖 ⃗ … 𝑟𝑁⃗⃗⃗⃗ ) 
 
(1.14) 
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𝑉 (𝑟𝑖 ⃗ … 𝑟𝑁⃗⃗⃗⃗ )is the sum of bonded and non-bonded interactions at any point in time. 
 𝑉𝑡𝑜𝑡𝑎𝑙 = 𝑉𝑏𝑜𝑛𝑑𝑒𝑑 + 𝑉𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑 
 
(1.15) 
Bonded interactions (𝑉𝑏𝑜𝑛𝑑𝑒𝑑) arise from covalent bonds. They consist of a sum of terms related 
to bond stretching, change in angles, and torsion terms. 
 
𝑉𝑏𝑜𝑛𝑑𝑒𝑑 = ∑
1
2
𝑏𝑜𝑛𝑑𝑠
𝑘𝑏(𝑏 − 𝑏0)
2 + ∑
1
2
𝑎𝑛𝑔𝑙𝑒𝑠
 𝑘𝜃(𝜃 − 𝜃0)
2
+ ∑
1
2
 𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠
 𝑘𝑛 [1 + cos(𝑛∅ − 𝛿)] + ∑ 𝑘𝜓 (𝜓 − 𝜓0)
2
𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠
 
(1.16) 
In equation 1.16 the first term involves changes in the bond energy that is taken to have 
harmonic form, 𝑘𝑏 is the force constant of the bond, 𝑏 is current bond length, 𝑏0 is the 
equilibrium bond length. The second term represents energies associated with changes in bond 
angles. It is also using harmonic potentials, where 𝑘𝜃 is the force constant of angle, 𝜃 is the 
distorted angle, 𝜃0 is the equilibrium value.  
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Figure 1.6. Interactions in a typical forcefield between atoms a) Bond stretch, b) Angle rotation, 
c) Dihedral angle rotation, or torsion angle applies where two pairs of covalently bonded atoms 
are joined by another covalent bond. It is the angle between the planes formed by two atom pairs. 
d) Improper dihedral angle is the angle between the planes formed by atoms i, j, l and j, k, l. 
Non-bonded interactions (𝑉𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑) refer to contacts between atoms or molecules 
that are not directly bonded. These interactions are very essential for the stability of biological 
macromolecules. From a computational point of view, the most important ones are the short-
range interactions which are described by Lennard Jones (LJ) potentials (𝑉𝐿𝐽) and electrostatic 
interactions represented by Coulomb potential. 
Lennard Jones (LJ) potentials are weak and proportional to a distance of  
1
𝑑6
 , where A is 
the repulsion component which falls off with 𝑑−12 and B is the attractive component due to 
dipole-interactions that also degenerates after 𝑑−6.   
 
            𝑉𝐿𝐽 = 4𝜀 (
𝐴
𝑑12
−
𝐵
𝑑6
) 
(1.17) 
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In Coulomb potentials, the electrostatic energy is a function of charges on non-bonded 
atoms along with the distance separating them. Dielectric constant accounts for increasing or 
decreasing the strength of interactions (section 1.8). 
Some of the most commonly used force fields are  Optimized Potential for Liquid Simulations-
All Atoms (OPLS/AA) 168, Assisted Model Building with Energy Refinement (AMBER), and 
The Chemistry at Harvard Molecular Mechanics (CHARMM). 169 
1.10.3. Integration Algorithms 
MD simulations study the time-dependent behavior of a microscopic system using classical laws 
of motion. This is achieved by integration of Newton’s second law of motion.  
 
𝐹 𝑖 = 𝑚𝑖𝑎𝑖 = 𝑚𝑖 
𝑑2𝑟𝑖 ⃗
𝑑𝑡2
= −
 𝜕 𝑉(𝑟𝑖 ⃗ … 𝑟𝑁⃗⃗⃗⃗ )
𝜕𝑟𝑖
 
(1.18) 
Where, 𝐹 𝑖 is the net force acting on atom i, ai is the corresponding acceleration, mi is the mass, 𝑟𝑖 ⃗ 
is the position, and V  is the potential energy. 
V is a function of the 3N atomic positions (x, y, z) of all N atoms in the simulation. 
Because of that there is no explicit solution to the equation of motion, and numerical algorithms 
must be used. These algorithms should allow for a long integration time step (∆𝑡), and to achieve 
that bond constraints such as SHAKE, LINCS and SETTLE are commonly used to eliminate fast 
vibrational bond motions.161 The positions, velocities and accelerations of atoms at points in (t +
∆t) or (t − ∆t) can be approximated by a Taylor series expansion. After calculating the 
acceleration for each atom, coordinates are updated, and the process is repeated. 
 
𝑟𝑖 ⃗(𝑡 + ∆𝑡) = 𝑟𝑖 ⃗(𝑡) + ∆𝑣𝑖  (𝑡). ∆𝑡 +
∆𝑡2
2
𝑎𝑖(𝑡) + 𝑂 (∆𝑡
3) 
(1.19) 
 
𝑟𝑖 ⃗(𝑡 − ∆𝑡) = 𝑟𝑖 ⃗(𝑡) − ∆𝑣𝑖(𝑡). ∆𝑡 +
∆𝑡2
2
 𝑎𝑖(𝑡) + 𝑂 (∆𝑡
3) 
(1.20) 
The 𝑂 indicates higher order terms that decays to zero and can be neglected  
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Adding and rearranging equations 1.19 and 1.20 gives the Verlet algorithm, 
 
 𝑟𝑖 ⃗(𝑡 + ∆𝑡) ≃ 2𝑟𝑖 ⃗(𝑡) − 𝑟𝑖 ⃗(𝑡 − ∆𝑡) + ∆𝑡
2  𝑎𝑖(𝑡) 
 
(1.21) 
The Verlet algorithm is easy to apply and efficient, but an explicit velocity term is 
missing. A modification of the Verlet algorithm can solve the velocity problem; this is known as 
velocity Verlet algorithm. 
 
𝑟𝑖 ⃗(𝑡 + ∆𝑡) = 𝑟𝑖 ⃗(𝑡) + ∆𝑡𝑣𝑖(𝑡) +
∆𝑡2
2
  𝑎𝑖(𝑡) 
(1.22) 
 
𝑣𝑖(𝑡 + ∆𝑡) = 𝑣𝑖(𝑡) +
∆𝑡
2
 (𝑎𝑖(𝑡) + 𝑎𝑖(𝑡 + ∆𝑡)) 
(1.23) 
The velocity Verlet algorithm calculates the position and velocity at the same time. 
Another important tool is the leapfrog algorithm that is commonly used in MD simulations due to 
simplicity. Velocity calculations are done at halftime step interval while the positions are 
calculated at full-time step. Within the leapfrog scheme, both positions and velocities leap over 
each other. 
 
𝑣𝑖 (𝑡 +
∆𝑡
2
) = 𝑣𝑖 (𝑡 −
∆𝑡
2
) + ∆𝑡  𝑎𝑖(𝑡) 
(1.24) 
Velocities at time 𝑡 +
∆𝑡
2
 are calculated from velocities at time(𝑡 −
∆𝑡
2
)  and accelerations at the 
time(𝑡). 
The position is calculated in full-time step 
 
𝑟𝑖 ⃗(𝑡 + ∆𝑡) = 𝑟𝑖 ⃗(𝑡) + ∆𝑡𝑣𝑖 (𝑡 +
∆𝑡
2
) 
(1.25) 
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1.10.4. Energy Minimization 
At the beginning of each simulation, the internal configuration (usually obtained from X-ray or 
NMR structures) may involve unfavorable local contacts between atoms of the system. The 
purpose of energy minimization is to perform a simple MM relaxation procedure that will 
eliminate direct clashes and moves the system into a local energy minimum. The most common 
method for this purpose is the steepest descent algorithm, which is an iterative method to obtain 
an approximate solution. 
 𝑟 𝑛+1 = 𝑟 𝑛 − 𝐾𝑛𝛻𝑉(𝑟(𝑛)) (1.26) 
𝑟 𝑛 is a vector representing the position of all particles in the system, 𝐾𝑛 is the step size towards 
the lowest energy minima and ∇𝑉 is the gradient of potential energy.161, 165 
1.10.5. Water Models 
Water is very important as most chemical reactions take place in aqueous media. The quality of 
macromolecular simulations depends on the choice of water model. Although water molecules 
are very small there are different models to describe it.  
Water models can be classified into rigid models where only non-bonded interactions 
considered and the bonded interactions are restrained. Polarizable models include explicit 
parameters for polarization. Rigid models are usually preferred for MD simulations of large 
systems because of their low computational cost. Rigid models differ in their interaction sites, 
e.g. the SPC (simple point charge model) and TIP3P (transferable intermolecular 3-point 
potential) where point charges are placed on each of the three H2O atoms. Both are 
computationally cheap and perform well in bulk solution. However, their surface tension 
properties are poor compared to experimentally measured values.170 The TIP4P and TIP4P/2005 
models have four interaction sites; the negative charge of the oxygen is moved slightly and is 
placed on a virtual point on the bisector of the HOH angle which improves electrostatic 
properties.170 TIP4P/2005 is mostly used in the work described in the thesis as it gives the best 
representation of surface tension compared to all other commonly used models. 171-172  
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1.10.6. Thermostats  
Thermostat algorithms are indispensable in MD simulations to keep the temperature of the 
system close to the desired one for sampling in NVT or NPT ensemble 
Temperature is related to the average kinetic energy or velocity (equation 1.27).161, 173 
 
 
𝐾𝑎𝑣𝑔 = ∑
𝑚𝑖𝑣
2
2
=
1
2
𝑁
𝑖=1
𝑘𝐵𝑇𝑁𝑓 
(1.27) 
Where 𝐾𝑎𝑣𝑔 is the average kinetic energy, 𝑁𝑓 is the number of degrees of freedom in 3-
dimensional space, 𝑘𝐵 is the Boltzmann constant, 𝑇 is the temperature. 
One of the ways to adjust temperature is to rescale velocity known as the velocity-
rescaling temperature coupling. In this algorithm, the velocity is rescaled by multiplying the 
velocity of each particle with rescaling factor 𝜆. 
 
 
 
𝜆 = √
𝑇𝑡𝑎𝑟𝑔𝑒𝑡
𝑇𝑐𝑢𝑟𝑟𝑒𝑛𝑡
 
(1.28) 
This is an easy and straightforward method but temperature fluctuations are expected. 
Another way to control the temperature is to couple the system to heat bath at a fixed temperature 
where the velocity is rescaled at each step by supplying or removing heat from the system like in 
the Berendsen thermostat.174 The rate of temperature change is kept proportional to the 
temperature difference between the bath and system. However, the Berendsen thermostat 
represents a weak coupling of the system with a heat bath so the system will spend a long time to 
reach the desired temperature. 
The Nosé-Hoover thermostat is an extended method algorithm which provides a 
rigorous way of a system and heat bath coupling. Both the system and the heat bath exchange 
kinetic energy. The average kinetic energy of the particles in the system does not change at each 
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time step while the temperature is kept constant by scaling of velocity. This can be represented 
by introducing an additional parameter (𝜉) to the equation of motion. This introduced parameter 
(𝜉)  reflects the frictional or drag force which can slow down or accelerates the particles in the 
system until the desired temperature is reached. The Nosé-Hoover equations of motion showing 
an additional frictional term (𝜉)  : 
 
𝜉 =
∑ 𝑃𝑖 𝑚𝑖⁄ − 3𝑁𝑘𝐵𝑇𝑖
𝑄
 
(1.29) 
Equation 1.29 shows 𝑄 which determines the strength of coupling between the heat bath and the 
system,  𝑇 is the desired temperature and 𝑃𝑖 is the momentum. This thermostat reproduces the 
NVT ensemble, time-reversible but computationally expensive.161 
1.10.7. Periodic Boundary Conditions (PBC)  
Modeling the bulk properties and the behavior of massive systems such as proteins or DNA is 
done in an explicit solvent which increases their modeling complexity. Periodic boundary 
conditions can be used to avoid the finite-size problem and to eliminate surface artifacts.175 
PBC use a simulation box that contains the system under study, and this box is repeated 
on all sides such that the simulated system is surrounded by identical copies of itself. Any 
particle that leaves the box from one side, will re-enter the box from the opposite side. In this 
way, the number of particles in the simulation box remains the same, and there are no physical 
boundaries or surface molecules. In protein simulations, ions such as Na+ or Cl- are used to 
compensate the intrinsic charge of protein and neutralize the box. Different box shapes can be 
used, such as cubic, hexagonal, etc.176 It is necessary to choose a suitable box shape that is 
compatible with the geometry of the system and also minimize the number of solvent molecules 
to save the computer time.  
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.  
Figure 1.7. Periodic boundary conditions in two dimensions. The shaded middle cell represents 
the simulation cell, where the filled blue atom moves out of the box and all images move in the 
same manner.  
1.10.8. Treatment of Non-Bonded Interactions  
Non-bonded interactions are the most time-consuming part of MD simulations. To reduce 
computational cost, cut-offs are used. This means that the interaction between two atoms 
separated by more than the cut-off distance is ignored. For short range (LJ) interactions, the cut-
off is simply introduced to potential (𝑉𝐿𝐽) and any interactions beyond this cut-off are set to zero 
without causing noticeable perturbations. A different approach is needed for the Coulomb 
potential which represents a long-range interaction. In PBC simulations this problem is solved by 
using Particle Mesh Ewald (PME) summation. This method is based on fast Fourier transform 
algorithms that calculate the potential for charges beyond a certain cutoff and maps them on a 
mesh.177 A disadvantages of using PBCs with PME is that the approach is only suitable for 
neutral systems as applying it to the charged system causes artifacts.178-180 
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Using PBC/PME with cutoffs is not suitable for gas phase simulations due to the 
strength of electrostatic interactions in the vacuum, plus the fact that the vacuum ions (or 
droplets) considered below carry a net charge. Also, periodic images would feel each other due to 
Coulomb interactions. Nowadays, the speed of the modeling is controlled by graphics processing 
units (GPU). Unfortunately, widely used  MD packages such as Gromacs that run with GPU 
acceleration were designed for use with PBC/PME and cutoffs. This problem can be 
circumvented by using a ‘pseudo-PBC’ method that allows gas phase simulations using GPU-
acceleration without PBC/PME artifacts. Generally, the simulation system under study is placed 
in the center of the PBC box with large dimensions (999.9nm3), PME is switched off, cutoffs are 
set less than the dimensions of the box. The atoms contained inside the box will then interact 
among themselves, while interactions with periodic images are absent.181 Effectively, this 
method provides an environment that is indistinguishable from a genuine vacuum environment 
without cutoffs. 
1.10.9. Neighbor Lists  
The use of cutoff may not reduce the time spent to calculate non-bonded interactions because the 
distance between every pair of atoms must be computed to decide whether they are close enough 
to calculate their interaction energy. This pair distance calculations can be time-consuming, but 
the problem can be addressed by using a Verlet neighbor list. This list sorts all atoms that are 
potential partners and lie within the cutoff distance or slightly further from the cutoff distance. 
Initially, the neighbor list is constructed for each pair of particles. Only the pairs in the list are 
checked for force calculations for some integration steps, if the particle moves by more than the 
cutoff distance then an algorithm automatically update the neighbor list in a way that it is not too 
fast or too slow.161, 175 
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1.11. Scope of the Thesis 
In this dissertation, we use ESI-MS experiments and MD simulations to answer several 
controversial questions related to protein ESI. 
 Sample preparation is one of the most challenging aspects of protein ESI-MS. The 
presence of salts like NaCl can severely degrade the quality of the data obtained. Even after 
sample cleanup using different desalting techniques, the presence of residual salt can still be 
problematic. The mechanism of salt interferences in protein ESI-MS is not fully understood. 
Previous work relied on equilibrium-partitioning and charge competition to explain the behavior 
of mono-cations.86, 182 In Chapter 2, we investigate the concept of charge competition between 
proteins and cations like tetrabutylammonium chloride and CsCl and we clarify that the concept 
of salt-induced signal suppression has different facets that have been under-appreciated in the 
previous literature.  
Supercharging agents offer an attractive approach for increasing the protein charge 
under “native” ESI conditions, where SCAs are added to the bulk solution in low concentration 
where they do not affect protein structure or stability. Several proposals exist in the literature that 
aim to explain how SCAs work. These include surface tension effects and protein unfolding 
within droplets, but none of these explanation attempts offers a consistent picture. Chapters 3 and 
4 scrutinize the native ESI supercharging mechanism from a new perspective. In Chapter 3, we 
uncover the first atomistic view of the supercharging mechanism. Our findings indicate that 
protein supercharging takes place due to “charge trapping” afforded by a SCA peripheral layer. 
This mechanism is further tested and confirmed in Chapter 4, where we use crown ether (18C6) 
to test the charge trapping hypothesis on both proteins and dendrimers. 
Chapter 5  provides a detailed study about the behavior of unfolded proteins in ESI 
nanodropets. For the first time, we apply a combination of MD simulations and ESI-MS/IMS to 
address this topic. We show unequivocally that the CEM is the actual ESI mechanism for acid-
unfolded proteins in high charge states.  
Finally, Chapter 6 highlights possible future research directions, outlining how the 
combination of MD simulations and ESI-IM/MS will continue to advance the field. 
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Chapter 2. Exploring the Mechanism of Salt-Induced Signal 
Suppression in Protein Electrospray Mass Spectrometry 
Using Experiments and Molecular Dynamics Simulations 
2.1.  Introduction 
Electrospray ionization (ESI) mass spectrometry (MS)1 has become an indispensable tool for a 
wide range of bioanalytical applications. The impact of ESI-MS has been particularly 
pronounced for research in the areas of protein structure, dynamics, and interactions.2-5 The ESI 
process commences when analyte solution is passed through a capillary that is held at a high 
electric potential. Charged droplets are emitted from a Taylor cone at the capillary outlet. These 
droplets undergo several rounds of solvent evaporation and jet fission,6 ultimately generating 
nanodroplets that are close to the Rayleigh limit and from which analyte ions are released into 
the gas phase.7  
The mechanism of the final ESI steps remains a matter of debate,8-11 although recent studies 
seem to converge towards a consensus view.7, 12 Accordingly, low molecular weight gaseous ions 
are produced by field emission from the nanodroplet surface, as envisioned by the ion 
evaporation model (IEM).13 Globular proteins are released via nanodroplet evaporation to 
dryness, in line with the charged residue model (CRM).14 A third mechanism, the chain ejection 
model (CEM), has been proposed for unfolded proteins12 and other disordered polymers.15 The 
CEM posits that macromolecular chains get expelled from aqueous droplets by electrostatic and 
hydrophobic effects.12, 16 ESI can be conducted under positive and under negative polarity 
conditions. We will restrict our considerations to positive ion mode, as it is more widely used for 
protein analyses. 
A well-known problem in ESI-MS is the fact that non-volatile salts in the analyte 
solution can cause a significant degradation of the spectral S/N ratio.17-24 The presence of Na+ is 
particularly problematic, as it represents a ubiquitous contaminant. Also, NaCl is used in many 
biochemical experiments for ensuring a physiological ionic strength of ~150 mM.25 Direct 
infusion of such samples into an ESI source is not a viable option. Numerous desalting 
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approaches have been devised to address this issue.17-24 Even with these treated samples, 
however, the presence of residual salt contaminants often remains problematic. 
 
 
Figure 2.1. Schematic protein ESI mass spectra (only the 10+ region is shown), illustrating two 
different types of salt effects. (a) Protonated ion signal generated from salt-free solution. (b) Peak 
splitting due to adduct formation. The integrated signal intensity in panels a and b is identical. (c) 
Protein ion suppression. 
 
The mechanistic basis of salt interferences in protein ESI-MS continues to be a matter of 
debate. One fairly trivial aspect is the fact that species such as NanClm
(n-m)+ can obscure protein 
signals due to spectral crowding.26-28 Clusters of this type are formed via the CRM as salt-
containing nanodroplets evaporate to dryness.29-31 Of greater concern are issues that are 
commonly treated under the umbrella of salt-induced “signal suppression”.17, 23, 32-38 In the 
literature this term may carry different connotations, a fact that can complicate discussions of the 
topic. Here, we propose that signal suppression can be conceptually dissected into (i) peak 
splitting due to adduct formation and (ii) ion suppression. Both effects will degrade the spectral 
S/N ratio, as briefly outlined in the following sections. 
(1) While salt-free solutions generate clean [M + zH]z+ species, protein ions formed in 
the presence of nonvolatile salts tend to have a heterogeneous composition such as [M + zH + 
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n(Na - H) + m(Cl + H)]z+ where both n and m can cover a wide range.39-40 This adduct formation 
is particularly pronounced for native proteins that follow the CRM, because the salt 
concentration in vanishing droplets increases dramatically during solvent evaporation to 
dryness.39, 41 Under these conditions the total ion count of each charge state z is split into a 
multitude of peaks, thus reducing the [M + zH]z+ intensity.39, 42 We hypothesize that peak 
splitting does not represent a genuine signal suppression effect, as it may occur without reducing 
the total protein signal intensity. In other words, the sum of the mixed adduct signals for all 
values of z, n, and m may still add up to the same intensity as for [M + zH]z+ species produced in 
the absence of salt (Figure 2.1a, b).  
(2) Ion suppression occurs under conditions where the presence of salt reduces the total 
analyte signal (Figure 2.1c). This effect was first examined for singly charged small analytes, 
assuming that different species compete with each other for excess charge.32 This framework was 
subsequently extended into an equilibrium-partitioning model17 which envisions that ESI 
droplets consist of an electrically neutral core, and a charged surface layer. Analytes that become 
part of the surface charge layer are thought to be more easily ejected under IEM conditions. The 
development of this model was spurred by the observation that surface-active species generally 
exhibit high ESI-MS signal intensities. Related charge competition models were also proposed to 
account for the effects of salts on the ESI-MS signals of proteins.33, 36 
Despite the substantial body of work in this area, the mechanism of salt interferences in 
protein ESI-MS is still not fully understood. Recent work has put into question the tenet that 
excess charge carriers always reside on the droplet surface,12 an assumption that is central to the 
equilibrium-partitioning model.17 The purported link between charge competition and ion 
suppression17, 32-33, 36 is readily understood for mono-cationic species, but for multiply charged 
analytes the situation is less clear. For example, charge competition may reduce ESI charge 
states,43 but this does not necessarily imply the occurrence of ion suppression because proteins 
will remain observable as long as z > 0.44 Finally, the relationship between adduct formation and 
ion suppression remains to be elucidated. It is unclear if the phenomena indicated in Figure 2.1b, 
c can actually occur independently of one another, or if they are always coupled. 
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This work explores the ESI-MS behavior of cytochrome c (Cyt c), ubiquitin (Ubq), and 
lysozyme (Lyz) under native and denaturing solvent conditions. To investigate the effects of salts 
with different physicochemical properties we tested NaCl, CsCl, and tetra-butyl ammonium 
chloride (NBu4Cl). The three cations cover a wide range of hydration free energies, from highly 
favorable for Na+ (hydG = -365 kJ mol-1) to unfavorable for NBu4+ (hydG  0). The properties 
of Cs+ lie in between these two extremes (hydG = -250 kJ mol-1).45 It is found that the effects of 
NaCl are largely consistent with the “pure” adduction scenario of Figure 2.1b, whereas NBu4Cl 
displays “pure” ion suppression (Figure 2.1c). MD simulations on salt-containing droplets 
suggest that NBu4
+ induces ion suppression primarily by interfering with the formation of 
progeny droplets within the ESI plume. 
2.2.  Materials and Methods  
2.2.1. Protein Solutions 
Horse heart Cyt c, hen egg white Lyz, bovine Ubq, 1,4-dithiothreitol (DTT), NBu4Cl, 
ammonium acetate, CsCl, and formic acid were purchased from Sigma (St. Louis, MO). For 
native ESI-MS, proteins were infused in aqueous solution at pH 7. Denatured (unfolded) samples 
were prepared by dissolving proteins in water/methanol (50:50 v/v) in the presence of formic acid 
(pH 2.0). Lysozyme unfolding was further promoted by disulfide reduction .46 For this purpose, 
100 M Lyz was incubated in 10 mM DTT at 75 ℃ for 1 h. The reduced protein is referred to as 
“rLyz”. Protein samples for ESI-MS had a concentration of 5 μM and contained 10 mM 
ammonium acetate. This volatile electrolyte represents a standard additive in ESI-MS.7 The 
solutions were supplemented with NaCl, CsCl, or NBu4Cl at concentrations up to 10 mM. 
2.2.2.  Mass Spectrometry (ESI-MS) 
ESI mass spectra were acquired in sensitivity mode on a Synapt G2 time-of-flight 
instrument (Waters, Milford, MA) equipped with a dual ESI source. The ESI capillary was held 
at +3 kV. Protein solutions were infused using a syringe pump at a flow rate of 5 L min-1. Cone 
and desolvation gas flow rates were 50 and 600 L h-1, respectively. The desolvation temperature 
was 200 °C, and the source was kept at 80 C. For native solutions the cone voltage was set to a 
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relatively high value of 75 V which promotes the conversion of mixed cation/chloride adducts to 
[M + zH + n(cation - H)]z+ species via HCl loss.39, 41 These settings considerably improve the 
spectral S/N ratio (Figure 2.2a-f). High charge states formed under denaturing conditions would 
suffer from rupture of covalent bonds under these conditions. For those measurements the cone 
voltage was reduced to 40 V (Figure 2.2d-f). Except for the cone voltage, all data were acquired 
under identical instrument settings as the sum of 500 one-second scans. Intensity units refer to 
analog-to-digital converter (ADC) count. 
Figure 2.2.  Cone voltage effects on ESI mass spectra of cyt c. Panels a-c refer to data acquired 
at pH 7 in aqueous solution, spectra in panels d-f were recorded at pH 2 in 50:50 (v/v) 
water/methanol. (a) Complete spectrum of native Cyt c electrosprayed in the absence of NaCl. 
(b) Close-up view of the 8+ charge state in the presence of 1 mM NaCl at a cone voltage of 5 V. 
(c) Same as in panel b, but for a cone voltage of 75 V. Note that the m/z axes were converted to 
Mass in panels b, c, e, and f. The “cleaner” appearance of the spectrum in panel c is due to the 
collisional loss of chloride adducts (as HCl). (d) Complete spectrum of denatured Cyt c 
electrosprayed in the absence of NaCl. (e) Close-up view of the 14+ charge state in the presence 
of 1 mM NaCl at a cone voltage of 5 V. (f) Same as in panel e, but for a cone voltage of 40 V. 
Numbers 0, 1, 2, … indicate how many adducted sodium ions can be resolved in the spectra. 
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2.2.3.  Experimental Design and Data Analysis 
A potential problem with measurements on salt-contaminated samples is a drift in 
sensitivity, caused by the deposition of non-volatile material on the ion optics during a series of 
measurements. An internal standardization procedure was devised to compensate for such drifts, 
taking advantage of the dual ESI source on the Synapt instrument. The regular (analyte) source 
was used to deliver actual protein samples at salt concentrations C between zero and 10 mM. The 
integrated signal intensity for each of these spectra is referred to as I(C). Integration was 
performed using Microsoft Excel over the spectral range that was deemed to contain adducted 
protein ions, as identified via comparisons with low salt spectra, up to m/z ~3000. Signals 
corresponding to protein-free cluster ions (recognizable by their characteristic isotope 
distributions and low charge states29, 31) were eliminated manually prior to integration. After 
recording each of these spectra, the second (lock spray) source was used to deliver an internal 
standard comprising the same protein and solvent, but without salt. Salt-containing samples and 
reference solutions were infused in an alternating fashion, using a mechanical baffle to switch 
between both sprayers. The flow for the non-operating sprayer was turned off to eliminate any 
cross-contamination. In each case, it was ensured that the ESI-MS signals had stabilized before 
data acquisition commenced. From these pairwise measurements a normalized intensity N(C) can 
be calculated as N(C) = I(C) / Iref, where Iref is the integrated signal intensity of the reference 
sample. As a final step, these data were normalized according to R(C) = N(C) / N(C = 0). These 
R(C) values will be referred to as “integrated ion intensity”, and they directly reflect the extent of 
salt-induced signal attenuation relative to a salt-free sample. To reiterate, R(C) comprises the 
contributions of all protein signals regardless of their salt adduction state. All measurements were 
conducted in triplicate. Error bars represent standard deviations. 
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2.2.4.  Molecular Dynamics Simulations 
All atom MD simulations  of salt-containing droplets were carried out using Gromacs 
4.6.5 with CHARMM36 force field 47 and TIP3P water model.48 Production runs employed 
trajectory stitching as described previously31 with Nosé-Hoover temperature coupling. The 
structure of NBu4
+ was obtained from the ZINC database,49 and it was parameterized using the 
ParamChem server.50  All bonds were constrained, thereby allowing for a 2fs integration time 
step. To take advantage of GPU acceleration the simulations were carried out in a 1 μm box 
using a potential-shift non-bonded interaction cut-off of 333.3 nm without relying on particle-
mesh Ewald summation. Initial system configurations consisted of spherical water droplets with 
radius 3 nm containing 10 Na/Cl pairs. Each droplet also contained a 12+ excess charge 
consisting of either 12 Na+ or 12 NBu4
+. These systems were subjected to energy minimization 
followed by 10ps of equilibration at 330 K using a modified Berendsen thermostat.51 Individual 
MD segments consisted of 500 ps windows at 330 K, between which any molecules that had 
drifted more than 10 nm from the droplet center were removed from the system. The simulated 
droplets are highly dynamic and undergo occasional distortions into non-spherical shapes. For 
reporting the droplet size we report an “effective” radius r corresponding to that of a sphere with 
the equivalent number of molecules. Calculations involving the surface tension of water 
employed the experimental value of  = 0.06624 Nm-1 at 330 K,52 although standard MD water 
models yield values that are somewhat lower.53-54  Similar to earlier droplet simulations 12, 15, 31, 
54-58 the current work uses a non-polarizable force field. It has been noted 59-60 that such an 
approach may not adequately describe the behavior of “soft” ions such as Cs+ which possess a 
high polarizability (~tenfold higher than that of Na+).61 To circumvent polarizability issues, the 
simulations of this study were therefore limited to droplets containing NaCl and/or NBu4Cl. The 
NBu4
+ behavior is largely invariant when using polarizable or non-polarizable force fields.62 All 
simulations were carried out in triplicate with different starting configurations and random seeds 
for initial velocity assignments. 
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2.3. Results and Discussion 
2.3.1. NaCl Effects on Protein Mass Spectra 
In an initial set of experiments we explored the effects of NaCl on the ESI-MS behavior 
of native Cyt c. When electrosprayed in NaCl-free solution the protein displays a charge state 
distribution that is dominated by [M + 7H]7+ and [M + 8H]8+ ions (Figure 2.3a).63-64 Increasing 
the NaCl concentration from zero to 10 mM dramatically reduces the base peak intensity. Protein 
signals become almost unobservable for 1 mM NaCl when displaying the data using constant y-
axis scaling (Figure 2.3a-d). These observations illustrate the well-known perils of conducting 
protein ESI-MS in the presence of non-volatile salts.  
 
Figure 2.3e-h provides a closer look at the same Cyt c data, using a y-axis range that 
scales with base peak intensity. The spectrum acquired in 10 mM NaCl (Figure 2.3h) is of 
particular interest. When considered in isolation, these data would be difficult to interpret. 
However, comparison with the spectra acquired at lower salt concentrations (Figure 2.3e-g) 
leaves no doubt that the humps marked 8+ and 7+ in Figure 2.3h represent heavily adducted 
protein signals with unresolved tails that extend to m/z ~3000. The range of m/z < 1500 in Figure 
2.3h is dominated by NanClm
(n-m)+ clusters.29 When integrating the protein ion intensity for the 
spectra in Figure 2.3 it is seen that R(C) of native Cyt c is not very strongly affected by NaCl; no 
intensity loss is evident up to a salt concentration of 1 mM. Even at 10 mM R(C) remains above 
0.6 (Figure 2.4a). 
Observations similar to those described above were made when studying NaCl effects 
for native Ubq and Lyz (Figure 2.5). Those data show a precipitous drop in base peak intensity, 
whereas the integrated ion intensity R(C) remains constant up to 1 mM NaCl. At a salt 
concentration of 10 mM the R(C) values of Ubq and Lyz exhibit a decrease down to 0.4 and 0.25, 
respectively (Figure 2.4a). 
ESI-MS experiments on the three proteins were also conducted under denaturing 
conditions. The resulting spectra are shifted to higher charge states 63-64 that show less salt 
adduction (Figure 2.6). Previous work 41 suggests that adduction is reduced for unfolded proteins 
55 
 
 
because the chains are ejected from droplets that experienced a relatively low degree of NaCl 
enrichment. Salt interferences in Figure 2.6 only become prevalent at 10 mM NaCl, at which 
point the base peak intensity has dropped by one order of magnitude. The integrated ion intensity 
of the three denatured proteins decreases down to R(C)  0.5 in 10 mM NaCl (Figure 2.4b). 
  
 
Figure 2.3. ESI mass spectra of cyt c acquired at pH 7 in the presence of various NaCl 
concentrations. Panels a/e, b/f, c/g, and d/h display the same data, but with different y (intensity) 
axis scaling. Panels a-d shares the same y-axis range, whereas panels e-h were scaled according 
to base peak intensity. 
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Figure 2.4. Salt dependence of the integrated ion intensity R(C) relative to NaCl-free samples. 
Data are depicted for three proteins (a) Under native conditions, and (b) In a denaturing 
environment. 
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Figure 2.5. ESI mass spectra of Ubq (a-d) and Lyz (e-h) acquired at pH 7 in the presence of 
different NaCl concentrations (zero to 10 mM NaCl, as indicated in the individual panels). 
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Figure 2.6. ESI mass spectra of Cyt c (a-d), Ubq (e-h) and rLyz (i-l) acquired under denaturing 
solvent conditions (pH 2 in water/methanol) in the presence of different NaCl concentrations 
(zero to 10 mM NaCl, as indicated in the individual panels). 
 
In summary, NaCl induces a dramatic reduction in the S/N ratio of protein ESI mass 
spectra by lowering the intensity of [M + zH]z+ ions. However, R(C) remains surprisingly 
insensitive to the presence of NaCl. The sum of all adducted protein signals stays relatively close 
to that of [M + zH]z+ ions observed for NaCl-free samples. Even the R(C) drop seen for 10 mM 
NaCl is quite moderate, considering that cursory analysis suggests the near-complete loss of 
signal (Figure 2.3d). We conclude that NaCl degrades ESI mass spectra primarily via adduct-
mediated peak splitting (Figure 2.1b) rather than ion suppression (Figure 2.1c). 
 
1e+6
3e+6
1e+6
2e+6
5e+5
2e+6
m/z
700 1400 2100
1e+5
3e+5
7+
7+
7+
7+
14+
14+
14+
1e+6
4e+6
1e+6
3e+6
1e+6
3e+6
700 1400 2100
1e+5
3e+5
6+
10+
6+10+
6+
11+
6+
Na
14
Cl
13
+
3e+5
6e+5
1e+5
3e+5
5e+5
1e+6
700 1400 2100
2e+5
5e+5
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)
(l)
8+
8+
8+
17+
16+
16+
15+
E
S
I-
M
S
 I
n
te
n
s
it
y
 (
a
.u
.)
A to D (cytoC)
E to H (ubq)
I to L (r lys)
no NaCl
0.1 mM
1 mM
10 mM
m/z
Cyt c Ubq rLyz
Na
14
Cl
13
+
Na
14
Cl
13
+
59 
 
 
2.3.2. Comparison with Other Salts  
Although Na+ represents the most commonly encountered interfering cation in ESI-MS, 
additional insights into the mechanism of signal degradation can be obtained by examining the 
properties of other additives.33, 36, 65 We chose to study Cyt c in the presence of CsCl and 
NBu4Cl. The consistent use of chloride salts ensures that any of the observed effects are 
attributable solely to differences in cation behavior. 
Addition of CsCl to Cyt c at pH 7 reduces the base peak intensity and causes extensive adduct 
formation (Figure 2.7a-c). At a concentration of 10 mM the spectrum is crowded by Cs(n+1)Cln
+ 
clusters, but close examination still reveals residual protein signals (Figure 2.8). Experiments 
conducted with NBu4Cl reveal a very different behavior, resulting in protein ions that are 
virtually free of adducts. However, a dramatic signal deterioration is seen for this salt, where 
protein signals become almost undetectable in 10 mM NBu4Cl (Figure 2.7d-f). Spectra at this 
high salt concentration are dominated by a NBu4
+ peak that dwarfs all other signals by a factor of 
several thousand (Figure 2.9). Observations similar to those described here for pH 7 were also 
made in Cyt c measurements under denaturing conditions (Figure 2.10). 
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Figure 2.7.  ESI mass spectra of Cyt c acquired at pH 7 in the presence of different CsCl (a-c) 
and NBu4Cl concentrations (d-f). Protein charge states as well as the composition of selected salt 
cluster signals are indicated.  
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Figure 2.8.  Close-up views of the Cyt c the 7+ charge state acquired at pH 7 in the presence of 
(a) 1 mM CsCl and (b) 10 mM CsCl. Numbers n = 0, 1, 2, … in panel A denote how many Cs+ 
ions are bound to the [M + 7H + n(Cs - H)]7+ ions. Dashed arrows in panel (b) emphasize that 
protein signals are still observable in 10 mM CsCl, despite the dominance of salt cluster signals. 
Protein signals in panel (b) are further highlighted by filled circles. 
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Figure 2.9. ESI mass spectrum of Cyt c acquired at pH 7 in the presence of 10 mM NBu4Cl. 
Protein signals are almost completely suppressed; instead the spectrum is dominated by NBu4
+. 
Note that the signal intensity has been magnified by a factor of 3000 for m/z > 600. 
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Figure 2.10. ESI mass spectra of Cyt c acquired at pH 2 in water/methanol and in the presence of 
different concentrations of CsCl (a-c) and NBu4Cl (d-f). Protein charge states as well as the 
composition of selected salt cluster signals are indicated. 
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notable R(C) reduction, down to around 0.1 and 0.2 for native and unfolded Cyt c, respectively. 
A much more significant drop in R(C) is seen for NBu4Cl. This salt begins to lower R(C) already 
at a concentration of 1 mM. For 10 mM NBu4Cl the integrated ion intensity is reduced by two 
orders of magnitude (Figure 2.11). 
 
Figure 2.11. Salt dependence of the integrated ion intensity R(C) for Cyt c under (a) Native 
solvent conditions and (b) In denaturing solution in the presence of NaCl, CsCl, and NBu4Cl. 
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The data presented above reveal that the detrimental effects associated with the three 
salts are quite different. As noted above, NaCl does not cause a dramatic R(C) decrease. Instead, 
the degradation of the spectral S/N ratio is primarily due to adduct formation which leads to 
extensive peak splitting. The effects of NaCl can therefore be approximated by the scenario 
depicted in Figure 2.1b. The opposite applies to NBu4Cl, i.e., a pronounced reduction in R(C) 
without adduct formation. The effects of NBu4Cl are thus consistent with the ion suppression 
scenario of Figure 2.1c. CsCl shows a behavior in-between these two extremes; it promotes the 
formation of adducts while at the same time reducing R(C). It is clear from Figure 2.11, however, 
that ion suppression by CsCl is less pronounced than for NBu4Cl. In summary, the tendency to 
form protein/salt adducts follows the sequence NaCl > CsCl > NBu4Cl. Conversely, the potential 
of these species to cause protein ion suppression exhibits the reverse order, NBu4Cl > CsCl > 
NaCl. 
2.3.3. MD Simulations of Salt-Containing Droplets.  
To better understand the observed salt effects, we turned to MD simulations. 
Considerable recent progress has been made in the application of MD techniques to MS-related 
phenomena,12, 15, 31, 54-58 although realistic simulations of the complete ESI process (from 
micrometer-sized early droplets to bare protein ions) still remain out of reach. The simulations of 
the current work will be limited to protein-free nanodroplets, comparable in size to “late” 
droplets in the ESI plume.7, 32 It will be seen that even this simplified approach provides 
important insights. We focus on aqueous systems for two reasons. (i) Native ESI-MS studies 
generally use water-based solvents.2, 66-67 (ii) ESI of water/organic mixtures induces H2O 
enrichment because the organic component usually has a higher evaporation rate.68-69  Thus, late 
ESI droplets tend to be predominantly aqueous, regardless of the initial solvent composition. For 
reasons outlined in the Methods section we will focus on the behavior of Na+ and NBu4
+, i.e., the 
types of ions that epitomize the two scenarios of adduction vs. ion suppression in Figure 2.1. 
The theoretical number of maximum excess charges zR that can be accommodated on a droplet is 
usually estimated by the Rayleigh equation7, 70 which states that 
3
0
8
r
e
zR 

=      (2.1) 
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where e is the elementary charge, r is the radius, 0 is the vacuum permittivity, and  is the 
surface tension. For the droplets considered here with an initial radius of 3 nm Equation 2.1 
yields zR  20. The droplet charge at the onset of our simulations was chosen to be z = 12, well 
below the Rayleigh limit. Two droplet types were examined, where this charge was implemented 
via incorporation of either 12 Na+ or 12 NBu4
+. In addition, all droplets contained 10 Na+ / Cl- 
pairs, keeping in mind that realistic simulations have to include some counter ions.31 
MD snapshots for a Na+ charged droplet are depicted in Figure 2.12a. As reported 
earlier,15, 31, 54-55 droplet shrinkage due to water evaporation is accompanied by the IEM ejection 
of solvated Na+. Prior to being ejected, Na+ ions tend to reside at intermediate radial positions 
rather than at the surface.12 NBu4
+ containing droplets show a different behavior. NBu4
+ ions 
rapidly move to the surface, with protrusion of alkyl chains into the vacuum environment (Figure 
2.12b). As the droplets shrink, NBu4
+ ions detach from the surface. Both the low surface affinity 
of Na+ and the high surface affinity of NBu4
+ seen here are consistent with previous reports,12, 17, 
33, 36, 59-60, 71 reflecting the fact that Na+ interacts very favorably with water, with a hydration free 
energy hydG = -365 kJ mol-1. In contrast, NBu4+ hydration is unfavorable (hydG  0).45 
Figure 2.12c displays changes in droplet radius throughout the 35 ns simulation 
window. When plotting the relative droplet charge z/zR on the same time axis it is seen that IEM 
events give rise to saw tooth patterns (Figure 2.12d) that are reminiscent of experimental Doppler 
interferometry data.72 Notably, the relative droplet charge remains much lower for the NBu4
+ 
systems (z/zR = 0.59  0.05) than for the Na+ charged droplets (z/zR = 0.74  0.05). These 
averages and standard deviations are based on three independent runs for each set of conditions. 
Readers are reminded that both types of droplets contain NaCl as background electrolyte. In 
principle, therefore, NBu4
+ droplets should also be able to undergo Na+ ejection. However, we 
did not observe a single Na+ ejection event as long as there was any NBu4
+ present. In other 
words, the ejection of NBu4
+ is much more facile than that of Na+. This difference is due to the 
tendency of Na+ to stay inside the droplet where it is tightly solvated. In contrast, the 
hydrophobic alkyl chains of NBu4
+ drive this ion to the surface, thereby facilitating its ejection at 
much lower z/zR values. 
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Figure 2.12. MD simulation results for the evaporation of ESI droplets carrying an initial 12+ 
charge caused by excess Na+ or NBu4
+. All droplets contained an additional 10 Na+/Cl- pairs as 
background electrolyte. (a) Na+ charged droplet at t = 0, 2.5 ns, and 21.5 ns, top to bottom. (b) 
NBu4
+ charged droplet at the same time points as in panel (a). Element coloring: Na+ blue, Cl- 
green, C black, O red. (c) Droplet size as a function of time. Also indicated is the number of 
water molecules in the droplet at the beginning and at the end of the simulation window. (d) 
Droplet charge z relative to the Rayleigh charge zR. Solid circles indicate ion ejection events. 
 
Another interesting observation is that solvent evaporation proceeds faster for the Na+ 
charged droplets than for the NBu4
+ containing systems (Figure 2.12c). The former shrink from 
an initial value close to 4000 H2O down to less than 100 H2O in 35 ns. In the presence of NBu4
+ 
the number of water molecules remaining after the same time period is roughly ten times greater. 
(a) (b) (c)
(d)
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The different evaporation rates likely reflect a destabilization of the hydrogen bonding network 
within the electrostatically stressed (high z/zR) Na
+ containing droplets. Another contributing 
factor could be the presence of NBu4
+ ions at the surface which keep the droplet partially 
wrapped in an organic layer, thereby inhibiting water evaporation due to steric effects. 
2.3.4. Mechanism of Protein Ion Suppression  
On the basis of the data described above one can propose a mechanistic framework to account for 
the interfering effects that are associated with different salts. Shrinking droplets that approach the 
Rayleigh limit have two options for relieving electrostatic stress. The first possibility is the 
emission of small progeny droplets via jet fission.6 Alternatively, the droplet may eject ions via 
the IEM.13 The two pathways are in kinetic competition with each other, governed by the 
corresponding activation barriers.13 Under typical conditions fission is the preferred option for 
larger droplets, whereas for radii below ~10 nm the high surface electric field favors ion 
ejection.7, 13 Importantly, it is the small progeny droplets that ultimately produce gaseous protein 
ions.7, 12, 32 Hence, the analyte ion yield is directly related to the number of nanodroplets 
generated in the ESI plume.7 
Protein ESI in the Absence of Salt Contaminants: Under favorable conditions the 
evolution of ESI droplets proceeds as outlined in Figure 2.13.7, 32 Early droplets with z/zR  0.5 
undergo solvent evaporation until they approach z/zR  0.8 (indicated by hatch markings in 
Figure 2.13a).6, 32 At this point jet fission produces a litter of progeny droplets (indicated in solid 
red).6 The charge-depleted parents undergo further evaporation until another round of jet fission 
produces additional progeny droplets. These evaporation/fission events repeat themselves 
through several generations. The prevalence of H+ or NH4
+ as excess charge carriers under 
typical conditions12, 73 favors the formation of clean [M + zH]z+ ions from the nanodroplets, 
keeping in mind that NH4
+ adducts will be lost as NH3 during ion sampling.
7 
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Figure 2.13. Schematic of droplet evolution within the ESI plume. Time increases from left to 
right. Droplet shrinkage due to solvent evaporation is indicated by horizontal arrows, fission 
events that produce progeny droplets (solid red) are represented by vertical arrows. The progeny 
droplets will subsequently produce gaseous protein ions. Parent droplets close to the Rayleigh 
limit carry a red hatch pattern. (a) Shrinkage/fission scenario for droplets charged with H+, NH4
+, 
or Na+.7, 32 (b) Scenario encountered in the presence of NBu4
+, where shrinking droplets remain 
far below zR due to the facile loss of NBu4
+. Droplet fission only takes place after ejection of all 
NBu4
+. Key features to note in panel (b): (i) the low number of progeny droplets implies a low 
protein ion yield; and (ii) droplet evaporation is slowed down compared to panel (a). 
 
 
 
+
+
+
NBu4
+ NBu4
+
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+
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ESI in NaCl Solutions: Our data demonstrate that the main problem encountered in the 
presence of NaCl is extensive adduction that spreads the total ion count over numerous [M + zH 
+ n(Na - H) + m(Cl + H)]z+ species. Adducts are particularly prevalent under CRM conditions.41 
Figure 2.4 reveals that R(C) is not strongly affected by the presence of NaCl. In addition, the 
protein charge state distributions with and without NaCl remain almost unchanged (Figures 2.3, 
2.5, 2.6). Taken together, this implies that (i) NaCl does not cause major interferences with the 
droplet evaporation/fission events outlined in Figure 2.13, and (ii) NaCl does not strongly 
interfere with release of protein ions from nanodroplets. The cartoon representation of Figure 
2.13a therefore applies to both salt-free and NaCl contaminated protein solutions. 
Effects of NBu4
+: A key feature observed in our simulations is the facile IEM ejection of 
NBu4
+ which keeps the corresponding droplets far below the Rayleigh limit (Figure 2.12d). 
Emission of NBu4
+ will take place already for droplets much larger than those in Figure 2.12. 
NBu4
+ emission thus prevents these “would-be parents” from reaching the threshold of z/zR  0.8 
which is required for progeny droplet formation via jet fission.6, 32 Since progeny droplets are the 
precursors of gaseous analyte ions,7 the reduced value of z/zR represents a key reason why the 
protein ion yield  is lowered by NBu4
+. Analogous considerations likely apply to other ionic 
additives with high surface affinity. Jet fission will take place only after all NBu4
+ have drained 
from the droplet, because it is only then that droplets can reach the critical range of z/zR  0.8 
(Figure 2.13b). The absence of NBu4
+ from the final nanodroplets is evident from the fact that 
charge states formed in NBu4Cl are similar to those observed for salt-free solution (Figure 2.7, 
2.10). The presence of residual NBu4
+ at the point of protein release would manifest itself as a 
shift to lower charge states,7, 12, 14 because the corresponding nanodroplets would be far below the 
Rayleigh limit (Figure 2.12d). Overall, a key factor responsible for protein ion suppression by 
NBu4
+ appears to be a shift in the kinetic competition from jet fission towards charge carrier 
ejection (Figure 2.13b). 
An additional aspect to consider is that solvent evaporation in the presence of NBu4
+ is 
quite slow (Figure 2.12c). The prolonged droplet lifetime increases the likelihood of droplet 
collisions with metal components of the ion sampling interface, thereby further lowering the 
yield of gaseous protein ions. The cartoon in Figure 2.13b indicates both the lower progeny 
droplet yield and the longer droplet lifetime in the presence of NBu4
+. 
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Interferences Caused by Cs+: The propensity of Cs+ to suppress the protein ion intensity 
is lower than that of NBu4
+ (Figure 2.11). This suggests that the ability of Cs+ to interfere with 
the ESI process via charge loss from early droplets is less pronounced. Consistent with this 
interpretation, the hydration free energy of Cs+ (hydG = -250 kJ mol-1) is intermediate between 
those of Na+ and NBu4
+ .45  From an experimental point of view the main problem encountered in 
the presence of Cs+ is the formation of adducts (Figures 2.7, 2.10). 
2.4. Conclusions 
The starting point for the current investigation was the hypothesis that salt interferences 
in protein ESI-MS can be dissected into two unrelated effects, i.e., adduct formation and ion 
suppression (Figure 2.1). The findings discussed above strongly support the validity of this idea. 
NaCl induces major adduction, while not strongly interfering with the total ion intensity. 
Conversely, NBu4Cl leads to the near-complete breakdown of protein ion formation, while not 
causing any adduction. Other additives may show hybrid scenarios, exemplified by CsCl in this 
work. The key factor that governs the nature of the interfering effects appears to be the surface 
affinity of the cation. Species with high surface affinity (hydG  0) tend to cause ion 
suppression, whereas those with low surface affinity (hydG << 0) tend to cause adduction. It is 
possible that the extent of adduction can be modulated somewhat by factors such as protein size 
and amino acid composition. 
Equation 2.1 plays a key role in mechanistic discussions of the ESI process. 
Specifically, Rayleigh’s theory is commonly used for estimating the amount of charge that can be 
accommodated on a stable droplet.7, 32 However, Equation 2.1 was derived on the basis of a 
continuum model, without any atomistic details.70 Recent work11, 74 has already suggested that 
shrinking droplets may lose charge due to IEM events far below the Rayleigh limit. The 
feasibility of these premature ion ejection events depends on the nature of the charge carrier, as 
well as the electric field at the droplet surface. Consistent with those proposals11, 74 the current 
work demonstrates that ions with high surface affinity (such as NBu4
+) get ejected from ESI 
droplets at z/zR << 1. We propose that this phenomenon represents the root cause for the 
occurrence of protein ion suppression in the presence of low MW ions that possess high surface 
affinity. Specifically, we propose that the hemorrhaging of charge at z/zR << 1 prevents shrinking 
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ESI droplets from undergoing jet fission. Reduced jet fission implies that a lower number of 
progeny droplets will be formed which are the precursors of gaseous protein ions.7 In addition, 
the reduced droplet evaporation rate in the presence of NBu4
+ may lower the yield of gaseous 
protein ions as well. 
Finally, we return to the concept of charge competition that is frequently mentioned in 
the context of ESI-MS signal suppression.17, 32-33, 36 The framework proposed here (Figure 2.13) 
is consistent with a competition mechanism in the ESI plume, where kinetic partitioning favors 
either the IEM emission of small ions or the production of progeny droplets. The emission of 
small ions drains the parent droplet charge in an unproductive fashion, whereas the formation of 
nanodroplets will ultimately lead to production of gaseous protein ions. The competing nature of 
these two processes becomes clear when realizing that the total amount of excess charge on the 
initial ESI droplets is limited; hence, any charge that is lost via ejection of small ions will not be 
available for the production of protein ions. This competition framework is suitable for 
understanding the effects of species such as NBu4
+ that reduce the total protein ion signal (Figure 
2.1c). On the other hand, the behavior of salts such as NaCl is primarily based on the rather 
trivial spreading of the ion count over a wide m/z range via adduct formation (Figure 2.1b). It is 
hoped that the ideas put forward here will improve the general understanding of salt interferences 
in ESI-MS, paving the way towards strategies to better cope with contaminants in biological 
samples. 
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Chapter 3. Mechanism of Protein Supercharging by Sulfolane 
and m-NBA: Molecular Dynamics Simulations of the 
Electrospray Process 
3.1. Introduction 
The capability to transfer intact proteins and protein complexes from solution into the gas phase 
by electrospray ionization (ESI)1 has revolutionized the area of mass spectrometry (MS).2-5 
During the ESI process analyte solution is dispersed into charged droplets. These droplets 
undergo evaporation and jet fission close to the Rayleigh limit,6-7 ultimately producing 
nanodroplets from which gaseous protein ions are released.8-9 These ions are then analyzed 
according to their mass-to-charge ratio. Additional information is obtainable by applying various 
excitation and fragmentation techniques,10-14 as well as ion mobility spectrometry (IMS).15-18 
Early ESI experiments mostly employed denaturing solvents. Recent years have witnessed the 
rise of “native” ESI, which uses aqueous solutions at neutral pH. Protein ions generated by native 
ESI can retain solution-like structures, provided that collisional activation is minimized.2, 5, 15, 19  
A key factor that governs the behavior of gaseous proteins is their charge state z. Low z 
values are usually associated with compact conformations, while proteins with elevated charge 
states tend to adopt extended structures.15-16, 20 High z values are beneficial for fragmentation 
experiments,11, 21 and they increase the performance characteristics of Fourier transform mass 
analyzers.14, 22 The following discussion is restricted to the widely used positive ESI mode, where 
analytes carry excess protons and/or metal cations.8 
Not surprisingly, there is tremendous interest in methods for manipulating the charge 
states of gaseous proteins. Native ESI usually results in low z values, whereas denaturing 
conditions produce ions that are highly charged.23-25 This effect has been linked to the 
mechanisms by which different conformers emerge from aqueous ESI nanodroplets.9 While 
several aspects of the ESI process remain contentious,26-27 there is considerable support for the 
view that compact structures are released upon solvent evaporation to dryness28-29 as described 
by the charged residue mechanism (CRM).30 The CRM produces ions that have z values close to 
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the Rayleigh charge of protein-sized water droplets.8-9, 31 For unfolded proteins a chain ejection 
model (CEM)2, 9 has been proposed that envisions the extrusion of polymer chains from the 
nanodroplet surface.32 The CEM attributes the high z values of unfolded proteins to H+ migration 
from the droplet to the protruding chain.9 Shifts in charge states may also originate from protein 
structural changes within the droplet.33-34 For example, exposure of a native ESI plume to heat35 
or acidic vapors36 can induce unfolding, resulting in elevated z values. Proton transfer reactions16, 
37-38 and electron capture39-40 allow modifying charge states after protein release from the droplet. 
Supercharging agents (SCAs) offer an alternative way to modulate protein z values 
during ESI.41 SCAs are added to the bulk solution in low concentration where they do not affect 
protein structure or stability.42 Yet, ESI of these samples produces greatly elevated charge 
states.41, 43 Supercharging can increase z values for native42, 44-49 and for denaturing solutions.50-53 
SCAs have large dipole moments.42-43, 51 Their surface tension values are in-between those of 
methanol and water.51 In addition to one or more polar groups, most SCAs possess an aliphatic 
moiety.43, 51 The low volatility of SCAs (bp > 180 C)42-43, 51 causes differential evaporation. 
Hence, ESI nanodroplets have a SCA content that is significantly elevated relative to the bulk 
solution.27, 51 Two widely used SCAs that embody all these characteristics are sulfolane 
(C4H8SO2) and m-NBA (m-nitrobenzyl alcohol, HO-CH2-C6H4-NO2, see Figure 3.1 insets).
43, 45-
46, 48, 51-52 
The mechanism of supercharging has yet to be elucidated.27, 51 Despite the common 
features noted above, there is no clear correlation between the effectiveness of SCAs and their 
physicochemical properties.51 Initial work focused on the surface tension  .41 The charge of a 
droplet with radius r at the Rayleigh limit8 is zR = 8(0  r3)1/2/e, where 0 is the vacuum 
permittivity and e = 1.602  10-19 C. If SCA enrichment were to increase surface tension, the 
droplet should support more charge and produce protein ions with higher z.9, 41 Unfortunately, 
this idea is inconsistent with experimental data.54 For example, m-NBA enrichment in aqueous 
droplets lowers the surface tension (m-NBA < water), but m-NBA increases protein charging in 
native ESI.43 Other proposals envision that SCA-enriched droplets trigger chemical42 or thermal55 
denaturation. Unfolding within the droplet would then produce high charge states, analogous to 
conditions where proteins are electrosprayed in denaturing bulk solutions.23-25 This unfolding 
mechanism is at odds with reports that some supercharged proteins retain a compact fold.44, 56 
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Other investigations considered direct SCA-protein interactions,47, 52 as well as the SCA Brønsted 
acid/base chemistry.27 None of those earlier studies has yielded compelling evidence for any 
particular mechanism. 
Molecular dynamics (MD) simulations can provide detailed insights into the ESI 
process. 7, 9, 32, 57-63 Several studies demonstrated the field emission of small charge carriers from 
the droplet surface.7, 9, 32, 58, 63 These events are consistent with the ion evaporation model 
(IEM).64-65 MD work from our laboratory resulted in the an atomistic view of CRM protein 
release from aqueous nanodroplets.57 The IEM ejection of small ions (such as Na+) plays an 
ancillary role during the CRM 57 by keeping the shrinking water droplets close to zR.
28-29 
Surprisingly, there appear to be no previous MD studies on protein supercharging. 
Here we use a combination of experiments and MD techniques to elucidate the 
supercharging mechanism for two archetypical SCAs, sulfolane and m-NBA. Our simulations 
focus on late generation nanodroplets within the ESI plume from which protein ions are released 
into the gas phase.8 Holo-myoglobin (hMb) was chosen as model system, reflecting the use of 
this heme-protein complex in numerous earlier supercharging experiments.27, 42-43, 46-47 Also, hMb 
represents a minimalist example of a biologically relevant complex, keeping in mind the steadily 
increasing use of SCAs for investigations on noncovalent assemblies.42-43, 48-49, 56 We specifically 
focus on the role of SCAs in neutral aqueous solution, where proteins adopt their biologically 
active conformations as they enter the ESI process.2, 5, 15, 19 Our data reveal that supercharging 
proceeds via a previously unrecognized mechanism, where solvent segregation induces charge 
trapping in the droplet and on the protein.  
3.2. Materials and Methods 
3.2.1. Electrospray Ionization Mass Spectrometry and Ion Mobility 
Spectrometry 
Equine hMb, sulfolane, m-NBA and ammonium acetate were purchased from Sigma (St. 
Louis, MO). Protein samples were centrifuged to remove small amounts of insoluble debris, 
followed by dialysis against 10 mM aqueous ammonium acetate. All solutions had a protein 
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concentration of 10 μM and contained 10 mM ammonium acetate. For supercharging 
experiments the samples were supplemented with 1% (v/v) sulfolane or m-NBA. 
Mass spectra were acquired on a Synapt HDMS instrument (Waters, Milford, MA). The 
Z-spray ESI source was operated at 2.8 kV. The desolvation and source temperatures were 
200 °C and 80 C, respectively, and the cone was at 20 V. Average charge states were calculated 
as zav = (zi Ii)/Ii, where Ii is the signal intensity of charge state i. IMS data were recorded using 
the instrument’s travelling-wave cell. Potential gradients were tuned to be as gentle as possible to 
minimize collisional activation. This includes lowering the cone to 5 V.66 Drift times were 
converted to collision cross sections (). Instrument settings and  calibration procedure have 
been summarized elsewhere.66 
3.2.2. MD Simulations  
All-atom MD simulations were conducted using the CHARMM36 force field 67 in 
Gromacs 5.0 with GPU acceleration.68 Our choice of CHARMM is based on its excellent 
performance for proteins in solution69 as well as for droplet systems.57 All bonds were 
constrained, using LINCS70 for protein and SCAs, and SETTLE71 for water, thereby allowing for 
a 2 fs integration time step. The hMb X-ray coordinates 1WLA72 served as starting structure. 
Side chains and termini were set to their default pH 7 protonation states; this includes 
deprotonation of both heme propionates. TIP4P/2005 water73 was chosen because it reproduces 
the experimental surface tension better than other models.74 The topology and structure files for 
sulfolane were taken from the GROMACS Molecule & Liquid Database.75 Parameters for m-
NBA were obtained using the ParamChem Server76 and the ZINC database.77 Initial ESI droplets 
were generated by surrounding the protein with pre-equilibrated water. For SCA simulations 315 
sulfolane or m-NBA were inserted at random positions, while eliminating any water molecules 
that would result in steric clashes. In-house Perl software was used to carve the systems into 
spherical droplets. The initial radius was r0 = 3.5 nm, corresponding to 5400 water molecules for 
purely aqueous droplets, with the protein at its center. 26 random water molecules were replaced 
with Na+. Together with the hMb 2- net charge the resulting net droplet charge was 24+, 
corresponding to zR for a 3.5 nm aqueous droplet at 370 K.
8  This charge regime is well within 
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the range of experimentally measured values.6 A few short runs were also conducted on larger 
droplets (5.5 nm radius). 
Simulations were run by placing the droplets in a vacuum environment, effectively 
without cutoffs for van der Waals or electrostatic interactions.57 The droplets were initially 
subjected to steepest descent energy minimization. Subsequent production runs followed a 
recently developed trajectory stitching approach.57  This method breaks up simulations into 250 
ps segment during which the temperature was controlled by a Nosé-Hoover78 thermostat with a 
coupling constant of 0.5 ps. After each segment the system was run through an in-house Fortran 
program to remove any evaporated moieties (H2O, sulfolane, m-NBA, or Na
+) that had moved 
more than 7 nm from the center of mass. New velocities were then assigned from a 
Maxwell-Boltzmann distribution prior to beginning of the next simulation window. This 
trajectory stitching dramatically reduces wall clock time by gradually decreasing the number of 
atoms in the simulation.57 Unless noted otherwise, the simulations were initially run at 370 K for 
75 ns. Subsequently the temperature was elevated to 450 K for facilitating the evaporation of any 
remaining solvent molecules. This temperature profile reflects progressive heating of protein ions 
as they traverse the ion optics of the mass spectrometer.79 The temperatures used are in line with 
experimental studies.80-81 The overall simulation window was 350 ns. All ESI simulations were 
repeated five times with different initial atom positions and velocities. 
Early tests revealed that the slow SCA evaporation precluded formation of desolvated 
hMb within reasonable wall clock time. Starting at t = 150 ns, SCA molecules were therefore 
subjected to “forced evaporation”. Under this scheme the SCA molecule farthest from the droplet 
center was eliminated after each 250 ps run segment, corresponding to an SCA evaporation rate 
of 4 ns-1. This strategy is reminiscent of biased82 or steered83 MD techniques used by others. 
Forced evaporation reduces the wall clock time from months to roughly one week for each 
droplet run. It could be argued that this forced evaporation scheme biases the temporal evolution 
of the system towards a CRM scenario. However, the approach chosen here seems well justified, 
considering that previous studies strongly argue against IEM or CEM-type behavior under native 
ESI conditions. 
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3.3.  Results and Discussion 
3.3.1. Supercharging of Holo-Myoglobin  
Before discussing MD simulations, it is beneficial to examine the effects of SCAs 
experimentally. The hMb mass spectrum acquired in neutral aqueous solution (without SCA) is 
dominated by 9+ ions of the intact heme-protein complex (Figure 3.1a). Addition of 1% 
sulfolane shifts the spectrum to higher charge states, with hMb17+ as the most intense ion. In 
addition, the spectrum shows minor apo-myoglobin (aMb) signals (Figure 3.1b). Similar 
supercharging effects are seen in the presence of 1% m-NBA, albeit with an elevated aMb 
abundance (Figure 3.1c).  
The structures of the gaseous hMb were probed by IMS (Figure 3.1d-h). Regardless of 
solvent conditions, hMb9+ displays a collision cross section around 1740 Å2. This value coincides 
with literature data, matching the calculated  of the crystal structure to within 2%.84 Elevated 
charge states show larger  values, e.g., 3260 Å2 for hMb17+. Clearly, these highly charged ions 
are extensively unfolded.42 Some of the  distributions in Figure 3.1 are multimodal, reflecting 
the presence of co-existing conformers.15-18 The data in Figure 3.1 are consistent with earlier 
reports,24, 27, 42-43, 46-47 illustrating the dramatic effects of SCAs on protein charge states.42-43, 48-49, 
56  
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Figure 3.1. ESI mass spectra of hMb in aqueous solution at pH 7. (a) Control without SCA. (b) 
Supercharged, 1% sulfolane, and (c) Supercharged, 1% m-NBA. (d) – (h) IMS data for selected 
charge states. Coloring: Red, purely aqueous; green, 1% sulfolane; orange, 1% m-NBA. The 
heme peak in b, c was scaled by 1/3. Insets in b, c show the structures of sulfolane and m-NBA. 
The signal at m/z 754 in Figure 1c corresponds to a singly charged contaminant ion. 
3.3.2. Choice of Charge Carrier for Simulations  
Electrosprayed proteins usually appear as [M + zH]z+ ions, i.e., they are charged by 
excess protons (exemplified in Figure 3.1). The inclusion of H+ in standard MD force fields is 
problematic.85 Realistic proton simulations call for QM/MM86, ab initio 60, 87, or DFT/MD 
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methods 85 that are out of reach for the size and time regime considered here. Luckily, there is a 
way to sidestep this issue.57 Proteins electrosprayed in the presence of Na+ salts are charged by a 
combination of protonation and sodiation, all the way to fully sodiated [M + zNa]z+8. Figure 3.2 
demonstrates that this also applies to supercharged hMb. Similar to our earlier ESI simulations,57 
the present study thus uses Na+ as charge carrier, thereby simulating the formation of [M + 
zNa]z+ ions. The inclusion of Na+ in MD force fields is straightforward.67 In neutral solution (and 
in the initial droplets used here) hMb has a net charge of 2-. Thus, the charge state of hMb ions 
carrying n Na+ in our simulations is z = (n – 2). 
3.3.3. Charge Carrier Behavior in Different Solvents  
As a final step before conducting ESI simulations we examine the behavior of water, sulfolane, 
and m-NBA droplets under quasi-equilibrium conditions. Pure solvents (not mixtures) were used 
to generate protein-containing droplets with radius r0  5.5 nm. The temperature was kept low to 
ensure minimum evaporation (see Figure 3.3 for details). 20 Na+ were included as excess charge 
carriers. For these tests we chose a starting configuration where all Na+ were initially placed in 
contact with carboxylates and/or carbonyl groups on the protein surface.  
The three droplet types exhibit very different behavior. In water each of the Na+ 
immediately separates from the protein and diffuses throughout the droplet (Figure 3.3a, b). In 
sulfolane all Na+ remain associated with hMb (Figure 3.3c, d). Similarly, in m-NBA most of the 
Na+ remain attached; only a few charge carriers venture slightly away from the protein (Figure 
3.3 e, f). 
The unconventional starting configuration used for the simulations of Figure 3.3 (with 
all Na+ located at the protein surface for t = 0) helps illustrate an important point. Water is an 
excellent solvent for Na+; its favorable hydration88 readily outcompetes Na+ interactions with the 
protein. Na+ solvation by sulfolane and m-NBA is much less favorable, as reported for other 
solvents that carry aliphatic moieties.89 In conclusion, small charge carriers such as Na+ exhibit 
high affinity for water, lower affinity for the protein surface, and very low affinity for SCA 
environments. It will be seen that these trends cause partitioning effects that are responsible for 
ESI supercharging. 
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Figure 3.2. (a) ESI mass spectrum obtained after infusion of holo-myogobin  (hMb) in aqueous 
solution containing 0.1 mM sodium acetate and 1% m-NBA. Some of the hMb undergoes heme 
loss, generating apo-myoglobin (aMb). Selected charge states are denoted using “h” and “a” for 
hMb and aMb, respectively. (b) Expanded view of hMb14+ supercharged ions. Numbers 1, 2, 3, ... 
indicate how many Na+ ions are bound to the protein ions as charged adducts. The sodiation 
progression extends all the way to [M + 14Na]14+. 
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Figure 3.3. Quasi-equilibrium MD data for ESI droplets containing hMb (radius ~5.5 nm) and 20 
Na+. Simulation snapshots on the left were taken after 2 ns. Plots show the distance of individual 
Na+ from the closest protein heavy atom. (a, b) Water at 330 K; (c, d) Sulfolane at 370 K; (e, f) 
m-NBA at 370 K. At the onset of the simulations all Na+ were placed in direct contact with the 
protein. The net droplet charge corresponds to 0.42 zR (for water with  = 0.066 N m-1 at 330 K). 
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3.3.4. ESI Simulations  
We modeled the release of proteins from nanodroplets consisting of water, water/sulfolane, and 
water/m-NBA. The extended time frame of these runs necessitated the use of slightly smaller 
droplets than in Figure 3.3 (r0  3.5 nm instead of 5.5 nm). Na+ and SCA molecules were inserted 
in random locations, thereby ensuring unbiased starting configurations. 
Purely aqueous droplets underwent rapid shrinkage due to water evaporation, 
accompanied by ejection of solvated Na+. Any remaining Na+ associate with the protein (Figure 
3.4a).57 MD data for water/sulfolane are exemplified in Figure 3.4b. Rapid water evaporation 
results in sulfolane enrichment. Figure 3.4b/panel 2 reveals partial solvent segregation, where an 
aqueous droplet core harbors the protein, while the outer shell primarily consists of sulfolane. 
The sulfolane shell is dynamic enough to permit water evaporation, as well as the occasional 
ejection of small clusters comprising one Na+ and a few water and sulfolane molecules (Figure 
3.4b/panel 2). After ~40 ns most of the water has vanished, leaving behind the protein 
surrounded by sulfolane (Figure 3.4b/panel 3). Complete sulfolane evaporation eventually 
releases the protein into the gas phase (Figure 3.4b/panel 4). A very similar progression was seen 
for water/m-NBA droplets (Figure 3.4c). 
The three ESI scenarios in Figure 3.4 share several features. Droplet shrinkage is 
accompanied by the field emission of Na+, in line with IEM events previously described for other 
systems.9, 28-29, 64-65 The droplets produce gaseous proteins via solvent evaporation to dryness. 
This morphological characteristic implies that ESI is a CRM process for the conditions studied 
here,30, 57 regardless whether SCAs are present or not. 
Protein charge states predicted by simulations with and without SCAs are summarized 
in Figure 3.6. Water droplets produce z values around 9+. This is identical to the result of our 
earlier simulations,57 despite the use of larger droplets in the present work. This consistency is 
reassuring, as it confirms that the MD results are not affected by droplet size. Strikingly, 
simulations of both water/sulfolane and water/m-NBA droplets produce charge states around 
15+, i.e., significantly higher than for the purely aqueous systems. The simulated z values show 
remarkable agreement with the experimental average charge states for all three solvent systems 
(Figure 3.6). 
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Experimental mass spectra acquired in the presence of SCAs cover a range of charge 
states, whereas the water/SCA simulations produce z values that are quite well defined (see 
Figure 3.6 caption). Charge heterogeneity in the experimental data likely reflects the fact that 
individual ESI droplets contain different SCA concentrations, with higher concentrations 
favoring formation of higher z values.42 Capturing this heterogeneity in our simulations is 
difficult, as it would require knowledge of the exact ESI plume composition. Nonetheless, the 
agreement between experimental and simulated z values in Figure 3.6 implies that our MD 
approach successfully captures the key aspects of SCA behavior during protein ESI. 
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Figure 3.4. MD snapshots illustrating the temporal evolution of hMb-containing nanodroplets. 
(a) Water, (b) Water/sulfolane, and (c) Water/m-NBA. Time points are indicated along the top. 
Blue arrows indicate various stages of Na+ IEM ejection. Coloring: Protein, pink; heme, black; 
Na+, blue; water oxygen, red; sulfolane, dark green; m-NBA, orange. All Na+ in the final frames 
are bound to hMb, connecting side chains are not shown to prevent clutter (see also fig. 3.5). 
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Figure 3.5. Details of hMb interactions with selected Na+ ions after release from a water/m-NBA 
droplet (t = 225 ns of Figure 3.4 c). Side chain contacts are indicated using regular labels, main 
chain contacts are highlighted in bold. 
 
 
 
Figure 3.6. ESI charge states of hMb predicted by MD simulations compared to experimental 
average charge states. MD results are the average of five independent runs, resulting in z values 
8/9/9/9/10 (water), 14/14/15/15/15 (water/sulfolane), and 14/14/14/15/15 (water/m-NBA). 
Experimental values are averaged over all peaks in the spectra from three measurements. Error 
bars represent standard deviations. 
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3.3.5. Anatomy of the ESI Process  
After confirming that the MD results are consistent with experiments, we now dissect the 
simulation trajectories to scrutinize the ESI events with and without SCAs. Most Na+ ejection 
events take place within the first ~25 ns. More Na+ are retained in water/SCA than in purely 
aqueous droplets (Figure 3.7a, e, i). Any retained Na+ will eventually contribute to the protein 
charge. Understanding why aqueous droplets shed Na+ with higher efficiency thus holds the key 
to deciphering the supercharging mechanism. We will discuss this central point in more detail 
below. 
Na+ attachment provides the protein with its net charge. Early on, Na+ ions show noisy 
trajectories, arising from diffusive movement in the space between the protein and the droplet 
surface. Within ~50 ns the profiles settle down at 0.22 nm, reflecting Na+ binding to carboxylate 
and carbonyl oxygens on the protein (Figure 3.7c, g, k, see Figure 3.5 for interaction details). 
There is a striking correlation between Na+ attachment (Figure 3.7c, g, k) and water evaporation 
(Figure 3.7b, f, j): Na+ ions can roam the droplet interior only as long as there is water. Once the 
water vanishes all remaining Na+ attach to the protein. The pure SCA environments encountered 
for t > 50 ns cannot prevent Na+ attachment to the protein (see Figures 3.7g, k, t = 50 - 150 ns, 
where all remaining Na+ are bound to hMb while most SCA molecules are still present). This 
behavior arises from the Na+ affinity trends discussed earlier (Figure 3.3): Na+ prefers to be 
solvated in water. In the absence of water, Na+ binding to the protein is preferred. Being 
dissolved in an SCA environment is least favored. 
Radial distributions report on the internal droplet structure (Figure 3.7, bottom row, t = 
3-5 ns). In all three cases the protein resides close to the droplet center. It is surrounded by water 
containing the Na+ ions. Note that the Na+ and water distributions closely coincide. Water-SCA 
segregation causes sulfolane and m-NBA to accumulate in the outermost droplet layers (Figures 
3.7h, l). This segregation is consistent with nanoscale de-mixing of other binary systems such as 
water/methanol.9, 90 Formation of an aqueous droplet core maximizes enthalpically favorable 
water-water hydrogen bonding as well as water-protein contacts.91 
The number of solvent molecules in the droplet is tallied in Figure 3.7b, f, j. Most of the 
water has evaporated after ~50 ns, while only a handful of SCA molecules have left at this point. 
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This enrichment reflects the low volatility of SCAs, in line with experiments.27, 51 As noted in the 
Materials and Methods section, starting at t = 150 ns a “forced evaporation” scheme was applied 
for speeding up the temporal evolution of SCA-containing droplets (arrows in Figures 3.7f, j). 
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Figure 3.7. MD data, illustrating the evaporation of hMb-containing ESI droplets: (a-d) Water, 
(e-h) Water/sulfolane, (i-l) Water/m-NBA. Top row: Na+ ejection from the droplet. Second row: 
Solvent evaporation (vertical arrows in f, j indicate the onset of forced evaporation). Third row: 
Average distance of Na+ in the droplet from the closest protein heavy atom. Bottom row: Radial 
distributions, averaged over 3 - 5 ns and five MD runs. These P(r) data were generated by 
tallying heavy atoms for each component with 4r2 normalization. Protein P(r) data are scaled by 
 0.33. 
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3.3.6. Electrospray Ionization Supercharging via Charge Trapping  
For understanding the supercharging mechanism, it is necessary to recall three basic facts. (1) 
Charge accumulation on the protein competes with IEM ejection of small ions (such as Na+) 
from the droplet.28-29, 57 (2) Strong electrostatic interactions (e.g., R-COO- Na+) prevent the 
protein from ejecting charge once the solvent has left.92 Thus, any charge carriers that did not 
leave the droplet during solvent evaporation will contribute to the z value of the protein.28-29, 57 
(3) Charge carriers can undergo IEM ejection only after coming close to the droplet surface.64 
Hence, any factors that restrict charge carrier access to the droplet surface will reduce the IEM 
ejection rate, thereby boosting the protein charge. 
In purely aqueous systems, favorable solvation allows charge carriers to roam the entire 
liquid space within the droplet, including positions close to the droplet surface (Figures 3.3a, 
3.7d). The IEM ejection of charge carriers from aqueous droplets is therefore a facile process, 
provided that the system net charge is sufficiently high.64-65 This facile charge loss causes protein 
ions generated from water droplets via the CRM to have low z values.8-9, 31 
Water/SCA droplets undergo solvent segregation. SCA molecules are enriched in the 
outermost layers, while protein and water reside close to the center. Charge carrier partitioning 
proceeds according to solvation preferences, i.e., small ions reside in the aqueous core (Figures 
3.7h, l). The resulting charge carrier depletion at the droplet surface disfavors IEM ejection,64 a 
view that is supported by experiments on m-NBA droplets.6 As the final water molecules escape 
(leaving the SCA behind), all remaining charge carriers bind to the protein. Being a poor solvent 
for small ions, the SCA is incapable of dissolving charge carriers away from the protein (Figure 
3.3b, c), such that IEM ejection is shut down. Charge carriers remain associated with the protein, 
causing it to emerge as highly charged CRM product once the SCA has evaporated. 
In summary, protein supercharging is based on charge trapping within ESI nanodroplets. 
This trapping results from two effects that are related to one another. (i) Early during nanodroplet 
evaporation, SCA accumulation in the outermost layers restricts charge carrier access to the 
droplet surface. (ii) After all the water has evaporated, charge carriers are bound to the protein 
deep within the droplet. Unfavorable solvation characteristics prevent these charge carriers from 
venturing into the surrounding SCA. Both (i) and (ii) interfere with the capability of the 
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nanodroplets to shed charge via the IEM. As a result, more charge is imparted to the protein than 
in the absence of SCAs. 
3.3.7. Surface Charge of ESI Droplets  
The trapping mechanism outlined above involves the binding of numerous charge carriers to the 
protein, surrounded by an SCA shell, after all water has left. One might argue that such a charge 
carrier accumulation should be electrostatically disfavored. This apparent conundrum is resolved 
when solvation effects are taken into account. 
We previously noted that water droplets containing excess Na+ undergo dipole 
ordering.9 As a result, the droplets carry their entire net charge on the surface (as widely assumed 
in the ESI literature8) while excess charge carriers (e.g., Na+) are located in the interior where 
solvation is more favorable.88 This surface charge is a consequence of Gauss’ Law,93 which 
states that a conducting sphere with radius r0 will carry its entire charge at r = r0. In MD units
68 
the electrostatic potential under such “ideal” condition is V(r) = z/r for r > r0, and V(r) = z/r0 = 
const for r  r0.93 The V(r) profile predicted by Gauss’ Law is shown in Figure 3.8 (dotted lines 
in each panel). 
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Figure 3.8. Electrostatic potential V(r) of nanodroplets containing hMb and 20 Na+, generated 
from the trajectories of Figure 3.3. (a) Water, (b) Pure sulfolane, (c) Pure m-NBA. Each panel 
contains three data sets. 1. Gauss’ Law for an ideal conductor (black dotted lines). 2. Whole 
droplet with hMb, 20 Na+, and solvent (solid lines). 3. hMb / 20 Na+ without solvent 
contributions (dash-dotted lines). Each curve represents the average of 140 scans between 2 ns 
and 3 ns. 
 
It is has never been confirmed that the surface charge projection seen for water/Na+ 
droplets9 also applies in the presence of proteins and/or other solvents. We examined this aspect 
by mapping V(r) for the three droplets depicted in Figure 3.3. a virtual test particle was scanned 
from the droplet midpoint in radial direction. For each position r the electrostatic potential was 
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calculated as V(r) = (qi/di) where the sum includes all atoms i, qi is the atom charge i defined in 
the force field,67 and di is the distance between the test particle and atom i. 
Droplet profiles were first generated by only scanning protein and Na+, omitting the 
solvent. V(r) profiles generated under these conditions show dramatic deviations from Gauss’ 
Law (dash-dotted lines, Figure 3.8a-c). The mismatch is most pronounced for sulfolane and m-
NBA, reflecting Na+ accumulation close to the center (cf. Figure 3.3). In contrast, V(r) scans of 
the whole droplets (protein, Na+, and solvent) agree closely with the ideal profiles (solid lines, 
Figure 3.8a-c). 
The data of Figure 3.8 confirm the expectation9 that ESI droplets containing a dipolar 
solvent will project their net charge to the surface. The droplet interior is free of static fields 
because V(r)  const for r  r0. As a result, large-scale electrostatic repulsion among charges 
within the droplet is absent. This effect greatly reduces the energetic penalty associated with 
charge carrier accumulation on the protein close to the center. Also, bound charge carriers will 
not trigger electrostatic protein unfolding while the polypeptide chain is surrounded by a solvent 
shell, because the charge is projected away from the protein. Instead, the net charge destabilizes 
the whole droplet by forcing surface solvent molecules into orientations that satisfy Gauss’ Law93 
at the expense of intermolecular contacts.9 The net charge of SCA droplets under these 
conditions may exceed zR, in line with experiments on various non-aqueous systems.
6 
3.3.8. Supercharging and Protein Unfolding 
 Highly charged hMb ions generated in the presence of SCAs are unfolded (Figure 3.1f-h). 
Similar observations prompted Williams et al. to propose that chemical42 or thermal55 unfolding 
within ESI droplets is the primary origin of supercharging. Bulk solution studies confirmed that 
high SCA percentages can reduce protein stability.34, 42 However, it is unclear if this effect can 
trigger unfolding on the very short time scale of the final ESI steps,34 keeping in mind that 
protein/SCA contact is limited by segregation (Figure 3.7h, l). These questions necessitate a 
closer look at the relationship between supercharging and unfolding. 
Figure 3.9 tracks the hMb radius of gyration (Rg) over 350 ns. For purely aqueous ESI 
the protein retains a native-like compactness with Rg  1.5 nm throughout the entire time window 
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(Figure 3.9a). For water/sulfolane and water/m-NBA compact conformations are retained only 
for ca. 180 ns (Figure 3.9b, c). The final protein z values are determined after the last Na+ 
ejection event (blue vertical lines at ~70 ns, Figure 3.9). The Rg profiles therefore imply that hMb 
supercharging is complete prior to unfolding. Significant conformational changes start to occur 
later, during evaporation of the final solvent molecules (Figure 3.9b, c).  
In summary, our data imply that unfolding within ESI droplets is not the origin of 
supercharging by sulfolane or m-NBA. Electrostatically driven unfolding15-16, 20 takes place after 
protein charging is complete. Major structural changes start during the final stages of 
desolvation, and they likely continue for the bare proteins beyond the 350 ns window of Figure 
3.9. Unfolding under these conditions is facilitated by electrostatic repulsion once the stabilizing 
effects caused by solvent-mediated charge projection have disappeared (cf. Figure 3.8). 
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Figure 3.9. Radius of gyration (Rg) as a function of time for ESI droplets consisting of water (a), 
Water/sulfolane (b) Water/m-NBA (c) Averaged over five MD runs. Blue vertical lines denote 
ejection of the last Na+ from the droplet. Also indicated are the time points where 80% of water 
(a), sulfolane (b), and m-NBA (c) have evaporated. Representative structures populated at the 
end of the simulation window (t = 350 ns) are shown along the right. 
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3.4. Conclusions 
The ESI charge states predicted by our MD simulations are in remarkable agreement with 
experimental data (Figure 3.6). This high level of consistency suggests that the MD trajectories 
describe the physics of the ESI process quite well, despite the limitations of classical force fields. 
We focused on the fate of native hMb in charged nanodroplets consisting of water, 
water/sulfolane, and water/m-NBA. In all cases the protein is released via solvent evaporation to 
dryness, as envisioned by the CRM.30 ESI charge states generated in water are close to the 
Rayleigh charge of protein-sized aqueous droplets.31, 57 In contrast, the elevated z values formed 
in the presence of SCAs are inconsistent with the predicted zR() trend. This behavior implies that 
supercharging is not a simple surface tension effect.43, 54 Our results also indicate that neither 
unfolding within ESI droplets,42, 55 nor the Brønsted acid/base properties of SCAs27 represent key 
components of the supercharging mechanism. 
Figure 3.10 summarizes the ESI process for water and water/SCA droplets. Without 
SCAs, highly charged aqueous droplets generated by native ESI undergo rapid evaporation. The 
aqueous environment favors relatively unrestricted movement of charge carriers, allowing them 
to approach the droplet surface where IEM ejection takes place with high efficiency (Figure 3.10 
a, b). The few remaining charge carriers bind to the protein as the final water layers evaporate 
(Figure 3.10c). The low z values render proteins electrosprayed in water quite resistant to gas 
phase unfolding, favoring the retention of solution-like conformations (Figure 3.10d).2, 5, 15, 19 
Supercharging is caused by a charge trapping mechanism. Mixed water/SCA 
nanodroplets undergo solvent segregation, resulting in an aqueous core that contains the protein 
and an outer shell of SCA molecules. Charge carriers partition into the aqueous core where 
solvation is more favorable than in the outer SCA layers. As a consequence, the IEM ejection of 
charge carriers from the droplet surface proceeds at a lower rate (Figure 3.10e). Poor solvation 
afforded by the SCA causes binding of all remaining charge carriers to the protein once the water 
has evaporated. IEM ejection is no longer feasible after this point because charge carrier affinity 
to the protein exceeds their affinity for the SCA environment; the charge carriers are trapped 
(Figure 3.10f). SCA evaporation releases the protein into the gas phase without any additional 
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charge loss (Figure 3.10g). As a result of their high z values, supercharged protein ions are prone 
to electrostatically driven unfolding in the gas phase (Figure 3.10h). 
 
 
 
Figure 3.10.  ESI in water without (a-d) and with supercharging (e-h). (a, b) Water droplet 
undergoing solvent evaporation. Charge carriers (Na+ or H+, blue) can move to the surface and 
undergo IEM ejection. (c) Native-like nascent gas phase protein. (d) Low charge favors retention 
of compact structures. (e) Water/SCA droplet after solvent segregation. Na+ or H+ accumulate in 
the aqueous core, reducing IEM ejection. (f) Na+ or H+ are trapped on the protein after water 
evaporation. (g) Supercharged nascent gas phase protein. (h) High charge states favor unfolding. 
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The supercharging mechanism outlined in Figure 3.10e-h suggest that an “ideal” SCA will be 
dipolar and moderately miscible with water, while its evaporation rate will be much lower than 
that of water. In addition, interactions of the SCA with the protein surface and with excess charge 
carriers have to be less favorable than in the case of water. These features are consistent with 
typical SCA characteristics previously noted in the literature.43, 51 
The supercharging mechanism outlined in Figure 3.10 applies to proteins that are 
electrosprayed from non-denaturing bulk solution in positive ions mode. Supercharging also 
takes place for proteins that enter the ESI process as unfolded conformers, e.g. in the presence of 
acids.50-53  Meaningful MD simulations under those conditions will require the use of mobile 
proton methods, as the process likely involves protein release via the CEM 9, It will also be of 
interest to examine the effects of SCAs in negative ion mode,47 and for analytes such as nucleic 
acids. 94-95 Work in this direction is currently ongoing in our laboratory, and the results of those 
endeavors will be reported elsewhere. 
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Chapter 4. Crown Ethers Modulate the Location of Charge 
Carriers in Electrospray Droplets: Implications for the 
Mechanism of Protein Charging and Supercharging 
4.1. Introduction 
Electrospray ionization (ESI)1 transforms solution phase proteins into multiply charged gaseous 
ions for analysis by mass spectrometry (MS). Of particular interest are “native” ESI-MS 
experiments2-4 that aim to preserve solution structures and interactions in the gas phase. These 
studies employ non-denaturing aqueous solutions and gentle ion sampling conditions. Native 
ESI-MS reports on protein binding stoichiometries.2-5 Complementary information is obtainable 
from dissociation experiments2, 6-7 and ion mobility spectrometry.8-10  
In positive ESI the protein solution is dispersed into droplets that carry excess H+, NH4
+, 
or Na+.11-12 Evaporation and fission events close to the Rayleigh limit produce progressively 
smaller droplets.11, 13 The mechanisms of analyte ion release from these nanodroplets were 
shrouded in controversy for many years.1, 11-12, 14-17 Recent molecular dynamics (MD) simulations 
helped address some of the questions in this area.18-24 For example, it is now widely accepted that 
globular proteins are released via droplet evaporation to dryness during native ESI,20-24 as 
envisioned by the charged residue model (CRM).11, 25 Charge carriers bind to the protein during 
the final stages of evaporation, generating ions such as [M + zH]z+ or [M + zNa]z+ .11 
The dissociation behavior26-32 and conformations of gaseous proteins33-35 are governed 
by their charge state z. As a result, there is considerable interest in ways to manipulate these 
charge states.33-34, 36-39 Native ESI generates low z values close to the Rayleigh charge of protein-
sized water droplets,11, 25 in accordance with the CRM.20-24 Much higher charge states are 
generated from proteins that are unfolded in bulk solution.40-41 According to the chain ejection 
model (CEM) these highly charged ions form during protein expulsion from the droplet 
surface.42-44 
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A common strategy for modulating protein charge states is the use of supercharging 
agents (SCAs).45-46 SCAs are added to the sample at low concentrations that do not significantly 
affect the protein structure in bulk solution.44, 47 Yet, SCAs significantly enhance charging during 
ESI. Typical SCAs (such as sulfolane, C4H8SO2) possess a nonpolar hydrocarbon moiety and one 
or more polar groups.32, 45, 47 Their low volatility makes them evaporate more slowly than water, 
such that late ESI nanodroplets are SCA-enriched.32, 45, 47-48 Supercharging takes place for 
native30, 38, 45, 47, 49-53 and for denaturing solutions.32, 44, 54 Here, we focus on the role of SCAs in 
native ESI, i.e., the conversion of folded solution phase proteins to highly charged gaseous 
ions.30, 38, 45, 47, 49-52, 55 
The mechanism of native ESI supercharging remains controversial.45-46, 48, 50, 54, 56 
According to one proposal supercharging is caused by thermal or chemical unfolding in SCA-
enriched droplets.47 Within this model, SCAs cause proteins to switch from the CRM to the 
CEM. 44 Although this “unfolding model” offers an intuitive explanation for supercharging, its 
validity is under dispute.30, 45, 55, 57-59 The elevated CCSs observed for some supercharged 
proteins44, 47, 58 do not prove that unfolding takes place within the droplet; alternatively, unfolding 
could be caused by Coulombic repulsion after release into the gas phase.58, 60 A number of 
supercharged proteins retain a native-like compactness,30, 60 making it unlikely that unfolding 
constitutes the root cause of supercharging. Also, weakly bound complexes can be supercharged 
without undergoing dissociation,30, 45, 55 prompting, Robinson et al.59 to conclude that 
“supercharging does not appear to perturb the structure in that unfolding is not detected”. 
Our group recently addressed this issue by applying MD simulations in which Na+ 
served as excess charge carrier for probing the supercharging mechanism, focusing on the SCAs 
sulfolane and m-nitrobenzyl alcohol (m-NBA).58 The MD-generated [M + zNa]z+ ions closely 
matched the z values of experimentally observed sodiated and protonated protein ions, both with 
and without SCAs. In the simulations proteins were released via droplet evaporation to dryness. 
Droplet shrinkage was accompanied by charge carrier ejection. The remaining charge carriers 
underwent binding to the protein during the final stage of evaporation. The simulations indicated 
(i) SCA enrichment at the droplet surface, followed by (ii) formation of an SCA layer around the 
protein after complete water evaporation. Both factors inhibited charge carrier ejection from the 
droplet because SCAs are ionophobic58 (e.g., the NaCl solubility in sulfolane is four orders of 
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magnitude lower than in water61). We thus proposed58 that supercharging is caused by charge 
trapping, not by unfolding. This “charge trapping model”58 and the aforementioned unfolding 
model44, 47 represent two very different mechanistic views of protein supercharging in native ESI. 
The current work examines the supercharging mechanism from a new perspective. 
Crown ethers can bind small cations, thereby enhancing the solubility of these charge carriers in 
nonaqueous solvents.62-63 We will test the following hypothesis: The charge trapping model58 
envisions that supercharging is caused by the low solubility of charge carriers in the SCA-
enriched droplet layers. Under such conditions, the capability of crown ethers to act as phase 
transfer catalysts62-63 should facilitate the shuttling of charge carriers to the droplet surface, 
thereby favoring charge ejection. We predict that these conditions will lower the extent of protein 
charging in the presence of SCAs. 18-crown-6 (18C6) is of particular interest due to its ability to 
accommodate ESI-relevant species (Na+, NH4
+ and H3O
+) in solution and in the gas phase.62, 64-67 
Previous studies explored 18C6 binding to Lys+ and N+-termini of gaseous peptides or 
proteins,68-72 but the consequences of crown ethers for the ESI process remain largely 
unexplored.39 The MD simulations of this work, as well as experiments on proteins and 
dendrimers, support the proposed hypothesis. We report for the first time that 18C6 acts as a 
powerful supercharging antidote. These findings support the view that native ESI supercharging 
is caused by charge trapping. 
4.2. Materials and Methods 
4.2.1. Proteins and Reagents  
Horse holo-myoglobin (17568 Da) bovine ubiquitin (8565 Da), 18C6 (264 Da) and 
polyamidoamine dendrimer (generation 5, PAMAM succinamic acid dendrimer with 1,4-
diaminobutane core, theoretical mass 41669 Da) were from Sigma (St. Louis, MO). Neutral 
solutions were prepared at a protein concentration of 5 μM, with 1 mM ammonium acetate or 1 
mM NaCl. Dendrimers were electrosprayed in water containing 100 mM ammonium acetate. As 
needed, the samples were supplemented with 1% (v/v) sulfolane and/or 1 mM 18C6. 
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4.2.2. Mass Spectrometry  
Spectra were acquired on a Synapt ESI mass spectrometer (Waters, Milford, MA). 
Proteins were electrosprayed at 1.5 kV using gold-coated nanoESI emitters borosilicate glass 
emitters at a flow rate of ~40 nL min-1.73 Standard experiments were conducted under gentle 
conditions with cone voltage = 20 V, trap collision energy = 4 V, and source temperature = 80 
C. If required, collisional heating was applied by raising the cone voltage to 120 V, or by raising 
the trap collision energy (CE) to 40 V. Average charge states were calculated as zav = (zi Ii)/Ii, 
where Ii is the integrated signal intensity of charge state i. 
4.2.3. MD Simulations  
ESI droplet simulations followed a strategy similar to that described earlier,24, 58 using 
Gromacs 574 and the CHARMM36 force field.75 The TIP4P/2005 H2O model
76 was used because 
it closely mimics the experimental surface tension of water.77 18C6 parameters were obtained 
from the ParamChem Server78 and the ZINC database.79 Initial protein coordinates were taken 
from the crystal structure 1WLA, with default charges (NT+, Arg+, Lys+, His0, Asp-, Glu-, heme2-, 
CT-), for an intrinsic hMb charge of 2-. The initial droplet radius was r = 4 nm. The droplet 
compositions tested were (a) 8000 waters, (b) 7500 waters and 32 18C6, (c) 5300 waters and 460 
sulfolane, (d) 4800 waters, 460 sulfolane, and 32 18C6. The initial water:sulfolane ratio was 
chosen in accordance with our earlier supercharging simulations.58 32 18C6 molecules were 
included because these conditions generated hMb adducted with (10  1) 18C6 prior to the onset 
of forced evaporation in water/18C6 runs. This number is consistent with the experimental data 
of Figure 4.2b (gentle source conditions), where the most intense signal corresponded to hMb 
bound to 10 18C6. In all cases, 32 Na+ provided a net charge of 30+ which corresponds to the 
Rayleigh limit of a 4 nm aqueous droplet.11 Initially the protein was centered, and all other 
constituents had random positions within the droplet. After equilibration, production runs were 
conducted at 370 K for 75 ns, followed by 200 ns at 450 K. Starting at t = 150 ns, sulfolane and 
18C6 were subject to forced evaporation (see subsequent section).58 Runs were repeated five 
times with different initial positions and velocities.  
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Under experimental conditions ESI usually produces [M + zH]z+ ions.11 Modeling the 
formation of such species would require QM or DFT methods for properly describing proton 
transfer events. Unfortunately, the system size and time scale studied here exceed the capabilities 
of such high level methods.80 As in previous work, our simulations thus focused on droplets 
carrying Na+ as charge carriers, which produce [M + zNa]z+ ions instead of [M + zH]z+.11 In 
contrast to protons, ions such as Na+ are well described by classical force fields.75 The final 
simulated charge states reflect the sum of protein-bound Na+, minus the intrinsic 2- hMb charge. 
4.2.4. Accelerated MD with Forced Evaporation  
The ESI modeling strategy outlined in the main text readily produces free [M + zNa]z+ ions from 
aqueous droplets.24 Unfortunately the slow evaporation of sulfolane and 18C6 cause an 
unacceptable increase in wall clock time.58 This problem was overcome by subjecting sulfolane 
and 18C6 to forced evaporation58 after 150 ns of regular MD. i.e., after the droplet had shrunk to 
a fraction of its initial size due to complete water evaporation. Under this scheme, the sulfolane 
or 18C6 with the largest distance from the droplet center was removed at a rate of 4 ns-1 (or 0.17 
ns-1 for 18C6 after all other solvent molecules had left). This approach resembles biased MD 
techniques that are widely used for various applications.81-83 
18C6 forced evaporation causes a slight complication because some crown ethers 
existed as [18C6 + Na]+ complexes. It has to be decided if forced evaporation of these 18C6 
should include the bound Na+. Steered MD82 revealed that departing [18C6 + Na]+ lost their Na+ 
only if the Na+ was bound to a protein carboxylate (Figure 4.1). For reasons of simplicity, [18C6 
+ Na]+ forced evaporation was therefore always conducted by removing the crown ether along 
with its Na+, which represents the appropriate scenario for most of the [18C6 + Na]+ (those that 
were not protein-bound). The simulated average protein z values were corrected for instances that 
involved carboxylate-bound [18C6 + Na]+ (z = + 1.7 for water/18C6, and z = + 3.6 for 
water/sulfolane/18C6). The magnitude of these corrections is relatively small, and all of the 
arguments made in the main text remain valid regardless whether the correction is applied or not. 
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Figure 4.1. Illustrative results of COM (center of mass) pulling simulations for hMb-containing 
ESI droplets. The aim of these steered MD runs was to determine the proper forced evaporation 
strategy for [18C6 + Na]+. In other words, we determined whether [18C6 + Na]+ that leave the 
droplet depart with their Na+, or if the Na+ stays behind. Data were generated by adapting a 
literature method.82 An external force (indicated by black arrows) was applied to pull on the 
18C6 scaffold of [18C6 + Na]+, one crown ether at a time. This was achieved by placing the 
18C6 COM in a harmonic potential with k = 1000 kJ mol-1 nm-2, and by moving the potential 
minimum away from the droplet center at a velocity of 0.02 nm ps-1. Droplet displacement was 
eliminated by harmonically restraining all protein backbone atoms with k = 1000 kJ mol-1 nm-2. 
No external force was applied to Na+ or any other ion/molecule. The pulled 18C6 (orange/red) 
with their Na+ (blue) are shown in spacefill representation. All other solvent molecules are shown 
as sticks. The “initial” configurations in this figure represent MD-generated droplets at 
intermediate stages of the ESI process. The “final” configurations represent snapshots taken ~90 
ps later. (a) 18C6 pulling in the presence of water, culminating in departure of the entire [18C6 + 
Na]+ moiety. (b) 18C6 pulling in the presence sulfolane (green), culminating in departure of the 
entire [18C6 + Na]+ moiety. (c) 18C6 pulling out of sulfolane under conditions where the Na+ is 
bound to a side chain carboxylate. This causes departure of an empty 18C6, while the Na+ 
remains bound to the side chain. (d) 18C6 pulling for a largely desolvated protein that only 
retains a few crown ethers. The Na+ is bound to a side chain carboxylate. Pulling causes the 
departure of an empty 18C6, while the Na+ remains bound to the side chain. In total, 50 COM 
pulling simulations consistently revealed that departing [18C6 + Na]+ leave their Na+ behind only 
if the metal is bound to a protein carboxylate (protein-COO-Na+18C6 → protein-COO-Na+ 
+ 18C6). In all other cases the entire [18C6 + Na]+ complex departed from the droplet. 
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4.3. Results and Discussion 
4.3.1. Effects of 18C6 on ESI Charge States  
This work focused on holo-myoglobin (hMb), a heme-protein complex that served as model 
system for many earlier mechanistic studies.38, 45, 47, 53, 58 Native ESI in aqueous ammonium 
acetate solution generated hMb ions in the 8+ and 9+ charge states (Figure 4.2a), very similar to 
earlier data recorded on different instruments and with different ESI sources.40, 47, 58 Addition of 1 
mM 18C6 resulted in crown ether adduction,68 and a shift to slightly lower charge states (from 
8+/9+ to 6+/7+, Figure 4.2b). Collisional activation caused loss of the 18C6 adducts, while the 
charge state distribution remained virtually unchanged (Figure 4.2d). 
4.3.2. 18C6 Suppresses Supercharging  
Sulfolane is a typical SCA. As expected from earlier reports,30, 32, 38, 44-45, 47, 49-52, 54 high charge 
states (around 15+, Figure 4.2e) were observed when electrospraying hMb from sulfolane-
containing aqueous ammonium acetate. The supercharged protein ions largely retained their 
heme group,45 whereas denaturation in solution usually disrupts heme-protein interactions.40 
Remarkably, the addition of 1 mM 18C6 to the sulfolane-containing solution suppressed 
supercharging, i.e., the hMb charge state distribution shifted from around 15+ into the 6+ to 9+ 
range (Figure 4.2f). The experiments were repeated with collisional activation (cone 120 V). 
Similar to the sulfolane-free solutions (Figure 4.2b, d), these harsher conditions removed 18C6 
adducts without major changes of the charge state distribution (Figure 4.2f, h). It appears that the 
capability of 18C6 to act as supercharging antidote has not been reported before. 
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Figure 4.2.  Mass spectra acquired after electrospraying holo-myoglobin without (panels on left) 
and with 1 mM 18C6 (panels on right) in neutral aqueous solution containing 1 mM ammonium 
acetate. (a, b) Data recorded without sulfolane under gentle conditions, i.e., cone 20 V. Extensive 
adduct formation in (b) is due to noncovalent attachment of up to ~14 18C6. (c, d) Same as in (a) 
and (b), but with in-source activation (cone 100 V). (e, f) Spectra acquired after addition of 1% 
sulfolane under gentle conditions (cone 20 V). (g, h) Same as in (e) and (f), but with in-source 
activation (cone 120 V). h8+, a14+, etc. denote hMb and aMb charge states. * indicates free 
heme; # refers to an unidentified cluster. 
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4.3.3. 18C6 Effects in NaCl-Containing Solutions  
Native ESI-MS experiments on hMb were repeated in solutions containing NaCl instead of 
ammonium acetate, giving rise to the formation of [M + (z-n)H + nNa]z+ ions, all the way to fully 
sodiated [M + zNa]z+11. These conditions resemble those used for the subsequent MD 
simulations, where Na+ served as charge carrier. In addition to gentle ESI conditions, we tested 
the effects of source activation by raising the cone voltage. Alternatively, collisional activation 
was applied by raising the trap CE (Figure 4.3). All experiments were also repeated with 
ubiquitin, another common test protein (Figure 4.4). 
The data obtained for the NaCl-containing samples resemble those of Figure 4.2 and can 
be summarized as follows: Sulfolane causes supercharging. Addition of 1 mM 18C6 to the 
sulfolane-containing solution shifts the spectra back to low charge states. This supercharging 
suppression was observed even when lowering the 18C6 concentration from 1 mM to 0.1 mM or 
0.01 mM (Figure 4.5). Collisional activation removes 18C6 adducts without major charge states 
alterations. Thus, 18C6-induced shifts to lower charge states are not primarily caused by the loss 
of 18C6-bound charge carriers from the gaseous protein. This conclusion is consistent with 
previous work,71 where it was noted that collisional charge loss (such as protein-NH3
+18C6 → 
protein-NH2 + [18C6+H]
+) is enthalpically unfavorable, in agreement with the data of Figure 4.1. 
Therefore, the capability of 18C6 to act as supercharging antidote must have a different origin. 
We resorted to MD simulations for uncovering the basis of this phenomenon. 
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Figure 4.3. Mass spectra acquired after electrospraying holo-myoglobin without (panels on left) 
and with 18C6 (panels on right) in neutral aqueous solution containing 1% sulfolane and 1 mM 
NaCl. (a, b) Data recorded under gentle conditions. Protein ions in (b) show extensive sodium 
and 18C6 adduction. (c, d) Same as in (a) and (b), but with in-source activation (cone 100 V). (e, 
f) Same as in (a) and (b), but with quadrupole activation (trap collision energy 10 V). h15+, 
a16+, etc. denote hMb and aMb charge states. * indicates free heme, scaled by 1/3 in panel (c). 
The low m/z range in panels (b) and (f) is dominated by various NaCl/18C6 cluster ions. 
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Figure 4.4. Mass spectra acquired after electrospraying ubiquitin without (panels on left) and 
with 18C6 (panels on right) in neutral aqueous solution containing 1% sulfolane and 1 mM NaCl. 
(a, b) Data recorded under gentle conditions. Protein ions in (b) show extensive sodium and 18C6 
adduction. (c, d) Same as in (a) and (b), but with in-source activation (cone 100 V). Same as in 
(a) and (b), but with quadrupole activation (trap collision energy 10 V). The low m/z range in 
panels (b) and (f) is dominated by various NaCl/18C6 cluster ions. 
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Figure 4.5. Mass spectra acquired after electrospraying holo-myoglobin in neutral aqueous 
solution containing 1% sulfolane, 1 mM NaCl and (a) 0.01 mM 18C6, and (b) 0.1 mM 18C6. 
Cone 20 V, trap CE 10 V. Even these reduced 18C6 concentrations still suppress supercharging. 
 
4.3.4. Comparing MD and Experimental Results  
The ESI droplets modeled here (initial radius 4 nm) were significantly larger than in earlier 
studies,18-24 resembling the size regime encountered in experiments.11 Charge states predicted by 
MD simulations on four types of hMb-containing droplets are compiled in Figure 4.6, along with 
the corresponding experimental data. Gratifyingly, the MD data reproduced the experimental 
trends. Water droplets produced charge states around 8+/9+. Slightly lower charge states were 
seen for water/18C6. Supercharged proteins with z values around 14+/15+ were produced from 
water/sulfolane droplets. The addition of 18C6 to the water/sulfolane droplets dramatically 
reduced the extent of protein charging. The subsequent MD trajectory analyses reveal the 
physical reasons underlying the sulfolane and 18C6 effects on protein ESI charge states. 
The forced evaporation tool applied during the final stages of droplet shrinkage 
necessitated small corrections for MD charge states generated in the presence of 18C6 (see 
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Methods). Figure 4.6 includes results obtained with and without this correction. The MD data 
reproduced the experimental trends, regardless whether the correction was applied or not.  
 
 
Figure 4.6.  ESI charge states of hMb obtained experimentally and from MD simulations. 
Experimental values are averages of three measurements acquired under the conditions of Figure 
4.2 (cone 100 V, trap CE 4 V). MD data are based on five replicate runs for each condition. MD 
data for 18C6-containing droplets are shown with and without forced evaporation correction. 
Error bars represent standard deviations. 
 
4.3.5. Common Features of MD Trajectories  
Snapshots taken from representative MD runs for the four conditions are summarized in Figure 
4.7. All trajectories shared several features: The evaporating droplets retained an approximately 
spherical shape, with the protein in the interior. Multiply charged gaseous hMb was produced via 
solvent evaporation to dryness, as envisioned by the CRM.20-24, 58 Droplet shrinkage was 
accompanied by Na+ ejection from the droplet surface. None of these IEM events14, 18, 42 involved 
completely desolvated Na+, instead the departing charge carriers were bound to 18C6 and/or 
several water or sulfolane molecules. Examples of such IEM events are highlighted in Figure 4.7. 
Ejected 18C6-bound charge carriers can be observed experimentally. Aqueous ammonium 
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acetate/18C6 solution produced intense signals for [18C6 + NH4]
+ and [18C6 + Na]+ (Figure 
4.8), underscoring the role of Na+ as ubiquitous contaminant in analyte solutions,11 and giving 
credence to the use of Na+ in our simulations.24, 58 
 
Figure 4.7. Snapshots taken from MD trajectories that culminate in the production of desolvated 
hMb ions from ESI nanodroplets. Four solvent conditions were tested: (a) Water, (b) 
Water/18C6, (c) Water/sulfolane, (d) Water/sulfolane/18C6. Time points are indicated along the 
left hand side. Charge states of protein ions at the end of the simulation runs are shown (at t = 
275 ns). IEM ejection events of solvated and/or 18C6-complexed Na+ are highlighted. Coloring: 
Protein, pink; heme, black; Na+, blue; water oxygen, red; sulfolane, dark green; 18C6, 
orange/red. 
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Figure 4.8. (a) Mass spectrum obtained upon electrospraying 1 mM aqueous ammonium acetate 
containing 1 mM 18C6. Close-up views of the [18C6 + Na]+, [18C6 + NH4]
+, and [18C6 + H]+ 
signals are shown in panels (b) – (d). The intense [18C6 + Na]+ signal is consistent with the 
presence of Na+ ions as ubiquitous contaminants in ESI-MS analyte solutions,11 supporting the 
validity of our MD strategy that is based on nanodroplets charged with excess Na+. [18C6 + H]+ 
in panel (d) may be ejected from the droplet as protonated crown ether, or it could arise from loss 
of ammonia from [18C6 + NH4]
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4.3.6. Principles that Govern the ESI Charge States of Proteins  
Before proceeding, it is helpful to summarize the rules that govern the charge carrier behavior in 
native ESI.24, 58 (i) Charge carriers can experience only two fates, ejection from the droplet or 
binding to the protein. (ii) The ejection of bare charge carriers from desolvated proteins is not 
feasible, at least not for the charge state range considered here.84 (iii) Any charge carriers that are 
not ejected from the droplet will become part of the protein charge. (iv) Prerequisite for each 
charge ejection from the droplet is that the charge carrier can (at least transiently) reside close to 
the droplet surface; any factor that tends to exclude charge carriers from the surface will lower 
the charge ejection efficiency. From (i) - (iv) it follows that any factor that hinders charge carrier 
access to the droplet surface will increase the protein charge z. The repercussions of these 
considerations will become clear in the next section. 
4.3.7. MD Trajectories Reveal the Basis of Charging and Supercharging 
 In aqueous droplets water and Na+ shared the same radial distributions (Figure 4.9a), reflecting 
the favorable solvation of Na+ in H2O.
85 Under these conditions Na+ can roam the entire solvent-
occupied volume, including positions at the droplet surface from where charge ejection readily 
takes place (Figure 4.9b). As the final water molecules evaporated, charge ejection came to a halt 
(Figure 4.9b, c). The remaining Na+ underwent irreversible binding to hMb (Figure 4.7a, t  92 
ns) at protein carboxylates (Figure 4.10). 
For water/18C6 droplets (Figure 4.9b) all 18C6 were located close to the droplet 
surface, consistent with their amphiphilic nature.62-63, 86-88 Na+ exhibited a bimodal radial 
distribution, comprising water-solvated Na+ in the droplet interior and [18C6 + Na]+ at the 
droplet surface (Figure 4.9d). The positioning of [18C6 + Na]+ at the liquid/vapor interface 
facilitated ejection of these complexes from the droplet. Thus, the high surface affinity of [18C6 
+ Na]+ was responsible for the slightly lower protein charge states in water/18C6 compared to 
pure water (Figure 4.6). The behavior seen here for [18C6 + Na]+ mirrors the facile IEM ejection 
of other cationic solutes that carry nonpolar groups.12 Charge ejection ceased just prior to 
evaporation of the last water molecules (Figure 4.9e,f). At this point, residual Na+ and [18C6 + 
Na]+ underwent ion pairing with protein carboxylates, while non-sodiated 18C6 bound to Lys+ 
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(Figure 4.10).68-72 These MD-predicted 18C6 adducts were experimentally observable under 
gentle ESI conditions (Figure 4.2b). The number of MD-adducted 18C6 (10  1) was consistent 
with the experimental data of Figure 4.2b, where the most intense signal corresponded to hMb6+ 
attached to 10 crown ethers. 18C6 removal by MD forced evaporation (Figures 4.7b, 4.9e) or by 
collisional heating (Figure 4.2d) produced fully desolvated hMb. 
 
 
Figure 4.9.  MD data for four types of hMb-containing ESI droplets, as noted along the top. Top 
row: Spatial distribution of solutes, averaged over t = 25 to t = 32 ns in all repeat runs. For 18C6-
containing droplets two separate Na+ distributions are shown, reflecting the behavior of sodium 
in [18C6 + Na]+ vs. all other sodium ions (denoted as Na+free). Middle and bottom rows: Time-
dependent changes in droplet composition for four typical trajectories, reflecting the occurrence 
of solvent evaporation and charge ejection. Dashed vertical lines indicate the point where 200 
water molecules remain in the droplet; after this point only panel (k) shows Na+ ejection (as 
[18C6 + Na]+). Dotted blue lines indicate Na+ data after correction for [18C6 + Na]+ forced 
evaporation (see Methods). The coloring of droplet components matches that of Figure 4.7. 
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Figure 4.10. Protein interactions with Na+, 18C6, and [18C6 + Na]+, exemplified for a t = 205 ns 
MD frame taken from a water/sulfolane/18C6 run. Coloring is as in Figure 4.7. Large blue 
spheres represent Na+; small blue spheres represent N atoms of Lys+; hydrogens have been 
omitted. 
 
Water/sulfolane droplets (Figure 4.7c) showed sulfolane enrichment in the outermost 
layers. This nanoscale segregation is consistent with phenomena reported for other binary 
mixtures, such as methanol/water or ethanol/water, where the nonaqueous component undergoes 
surface enrichment despite being “fully miscible” in bulk solution.86-89 A key driving force for 
the sulfolane/water segregation seen here is the maximization of enthalpically favorable water-
water contacts in the droplet core.90 (Analogous arguments explain why 18C6 is driven to the 
surface of the water/18C6 droplets discussed in the preceding paragraph.86-90) For the ESI 
water/sulfolane droplets of Figure 4.7c these segregation phenomena produced a sulfolane-
enriched surface layer that surrounded the protein-containing aqueous core (Figure 4.9g). The 
ionophobic nature of sulfolane58, 61 (along with the high water affinity of Na+)85 largely confined 
the charge carriers to the droplet interior. The resulting Na+ depletion at the droplet surface 
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reduced the charge ejection probability. Because of this reduced IEM efficiency, a larger number 
of Na+ remained trapped within the droplet compared to the water or water/18C6 droplets 
(Figures 4.9h vs. 4.9b, 4.9e). Complete H2O loss from the water/sulfolane droplets subsequently 
generated sulfolane-encapsulated hMb, concomitant with irreversible binding of all remaining 
Na+ to protein carboxylates (Figure 4.7c, t = 92 ns). Further charge loss would require the 
occurrence of highly unfavorable events, i.e., dissociation of protein-COO-Na+ ion pairs, 
followed by Na+ diffusion through the ionophobic sulfolane environment. Hence, the protein 
attained its final “supercharged” z value after all water had left the droplet, but long before 
evaporation of the sulfolane shell had gone to completion.  
These data for water/sulfolane reflect the charge trapping model outlined in the 
Introduction.58 This mechanism causes supercharging via two interrelated factors, i.e., (i) 
formation of a SCA layer at the droplet surface that tends to confine charges to the aqueous 
interior, thereby impeding charge ejection. (ii) After complete water loss, the protein becomes 
surrounded by an SCA shell and the remaining charge carriers are forced to associate with 
protein carboxylates. Charge partitioning during droplet shrinkage is governed by the low affinity 
of charge carriers for the SCA, their greater affinity for protein carboxylates, and their high 
affinity for water.58, 85 For the three droplet types discussed so far (water, water/18C6, water 
sulfolane), only Na+ solvation by water prevented irreversible charge carrier binding to the 
protein. Charge ejection came to a halt once the number of H2O dropped below ~200 (vertical 
lines in Figure 4.9b, e, h), forcing freely diffusible Na+aq to transition into carboxylate-bound 
environments. 
As noted, a key element of the charge trapping model is that SCAs exhibit a low charge 
carrier affinity. This aspect is consistent with earlier work that focused on protein charging by 
H+, where it was noted that SCAs generally exhibit a low H+ affinity in solution (i.e., a weak 
Brønsted basicity).48, 91 These parallels support the view that the charge trapping model is not 
limited to droplets containing Na+, but that it also applies to H+ and other ESI-relevant charge 
carriers. 
In water/sulfolane/18C6 droplets the charge carriers exhibited a bimodal distribution, 
with H2O-solvated Na
+ in the interior and abundant sulfolane-solvated [18C6 + Na]+ in the 
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outermost droplet layers (Figure 4.9j). The latter reflect the capability of crown ethers to 
solubilize cations in unfavorable solvents.62-63 [18C6 + Na]+ enrichment at the droplet surface 
facilitated the ejection of these charged complexes. Numerous [18C6 + Na]+ remained at the 
surface of the droplet even after complete water evaporation, thereby ensuring continued charge 
ejection and suppression of charge carrier binding to the protein (Figure 4.7d at t = 92 ns, Figure 
4.9k, l).  
In summary, the MD data reveal that 18C6 nullifies the charge-enhancing effects of the 
SCA by eliminating charge trapping. Our results confirm the hypothesis stated in the 
Introduction, i.e., the proposal that 18C6 binds charge carriers (Na+, NH4
+, H3O
+)62, 64-67 and 
shuttles them through the SCA trapping layer. 
4.3.8. Relationship between Supercharging and Unfolding  
Our MD runs showed that hMb in water/sulfolane retained a compact structure until the droplet 
had almost completely dried out (Figure 4.7c), long after the final z value had been attained via 
Na+ binding. Coulombically driven unfolding of the supercharged protein started to take place 
during the final solvent evaporation steps (Figure 4.11). Hence, for the conditions examined here, 
unfolding is caused by supercharging and not vice versa. In other words, our data argue against 
the idea that native ESI supercharging is caused by protein unfolding within the droplet, with 
subsequent protein extrusion from the droplet surface.44, 47 Instead, our findings support the view 
that supercharging is caused by charge trapping. While supercharged hMb undergoes unfolding 
in the gas phase,47, 58 other supercharged proteins are more resilient and retain native-like 
properties. 30, 45, 55, 60 The experimental observation of such compact supercharged proteins30, 45, 55, 
60 would be difficult to reconcile with the unfolding model,44, 47 while our charge trapping model 
readily explains how such species can form. 
Notwithstanding the aforementioned conclusions, we do not rule out that unfolding may 
contribute to supercharging under some conditions, likely in combination with the SCA-mediated 
charge trapping outlined above. The latter scenario is supported by data on disulfide intact and 
reduced proteins.44 The possible occurrence of protein unfolding within the droplet will depend 
on various factors, including the droplet lifetime,92 confinement effects,93 and interactions with 
gas/liquid interfaces.94 
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Figure 4.11. Protein compactness during ESI, reported as radius of gyration (Rg) vs. MD 
simulation time, averaged over all runs. (a) Behavior of hMb in water, water/18C6, and 
water/sulfolane/18C6 droplets, all of which culminate in low charge states. In all three cases the 
protein retains a tightly folded conformation. (b) Rg of hMb in water/sulfolane droplets, which 
produce high charge states (supercharging). Vertical dashed lines in panel (b) indicate the 
behavior of water, sulfolane, and Na+ in the evaporating droplets. Coulombically driven 
unfolding starts to take place during the final stages of droplet evaporation. The protein reaches 
its final ESI charge state z long before unfolding commences (the last Na+ binding event is 
indicated in blue), implying that supercharging is not caused by unfolding. Instead, 
supercharging is the cause of unfolding. 
 
4.3.9. Dendrimer Supercharging 
Dendrimers are hyperbranched globular macromolecules that are incapable of large-scale 
unfolding.95-96 These analytes are well suited for further scrutinizing the competing 
supercharging models. The charge trapping model predicts that dendrimers will undergo 
supercharging, while according to the unfolding model dendrimers should be immune to SCAs.44, 
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47 For meaningful test experiments it is important to use dendrimers with ”protein-like” 
properties, i.e., with both acidic and basic sites, and with a MW similar to that of typical proteins. 
Earlier work 46 examined the behavior of DAB-16 (1687 Da) and DAB-64 dendrimers 
(7168 Da). The former did not undergo supercharging. For the latter, the presence of SCA in 
water caused a broadened charge state distribution that suggested supercharging for a sub-
population of the analytes. The implications of those data46 for proteins are inconclusive The 
absence of carboxylates in DAB dendrimers prevents analyte charging via R-COO- 
neutralization, unlike for proteins where carboxylates represent the main charge carrier binding 
sites.24 In addition, the small size of DAB-16 raises questions as to whether this species exhibits 
true CRM behavior.1 
Here we tested the behavior of G5 PAMAM succinamic acid dendrimer. Its theoretical 
MW (41669 Da) is comparable to proteins that have previously been subjected to native ESI 
supercharging.30, 45, 55, 59-60 This dendrimer possesses both basic sites (tertiary amines) and acidic 
moieties (succinamic acid groups). A slight complication is the fact that PAMAM dendrimers 
generally exhibit mass heterogeneity arising from defects in their branched structures, 
particularly for large species that are comparable in size to proteins.96 ESI mass spectra recorded 
in aqueous solution showed several broad maxima that can be attributed to the charge state range 
of 7+ to 12+ (Figure 4.12a). Upon addition of sulfolane the spectra underwent a dramatic shift 
towards lower m/z, corresponding to charge states around 15+ and higher (Figure 4.12b). Similar 
data were obtained when repeating the experiments in NaCl-containing solution (Figure 4.13). 
These spectra demonstrate the occurrence of sulfolane-induced supercharging for the PAMAM 
dendrimer, confirming the prediction of the charge trapping model. 
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Figure 4.12. ESI mass spectra of G5 PAMAM dendrimer in aqueous solution containing 
ammonium acetate (a) Without sulfolane, (b) With sulfolane. Mass heterogeneity obscures 
individual charge states. Red lines indicate expected peak positions for the calculated theoretical 
mass. 
 
 
 
 
 
 
 
Figure 4.13. ESI mass spectra of G5 PAMAM dendrimer in aqueous solution containing 
ammonium acetate (a) Without sulfolane, (b) With sulfolane. These data are analogous to those 
of Figure 4.12, but here the experiments were conducted in the presence of 1 mM NaCl to 
promote the formation of sodiated ions. Mass heterogeneity precludes the identification of 
individual charge states. Red lines indicate peak positions for the calculated theoretical mass of 
the analyte. Supercharging of the dendrimer in the presence of sulfolane is clearly apparent. 
m/z
2500 3500 4500 5500
(a)
(b)
12+
15+
N
o
rm
a
liz
e
d
 E
S
I-
M
S
 I
n
te
n
s
it
y
water
water/sulfolane
9+
8+
11+
10+ 7+
14+
13+
12+
11+
10+
13+
14+
16+
17+
18+
m/z
2500 3500 4500 5500
N
o
rm
a
liz
e
d
 E
S
I-
M
S
 I
n
te
n
s
it
y (a)
(b)
12+
15+
9+
11+
10+
13+
8+ 7+
11+ 10+
13+
water
water/sulfolane
12+
14+16+
17+
18+
131 
 
 
4.4. Conclusions 
The current work demonstrates that MD simulations represent a powerful tool for probing the 
behavior of ESI droplets containing multiple interacting components. We applied crown ethers as 
a mechanistic probe of the ESI process. The ability of 18C6 to act as phase transfer catalyst62-63 
alters the location of charge carriers inside ESI droplets, with dramatic consequences for protein 
charge states. Crown ethers may also influence protein structures in solution97-98 and in the gas 
phase,70 but our data do not support the view that such conformational factors are responsible for 
the charge state shifts reported here. The mechanistic insights obtained in the current work can be 
summarized in cartoon form (Figure 4.14), where blue “+” symbols indicate charge carriers. 
While the current work focused on Na+, Figures 4.2, 4.3, 4.4 suggest that similar considerations 
also apply to other ESI-relevant charge carriers such as H3O
+ and NH4
+ .11, 91 
Evaporating ESI nanodroplets experience internal Coulomb repulsion which tends to 
trigger charge ejection via the IEM.17 The efficiency of these events is modulated by the 
capability of charge carriers to migrate to the droplet surface (because only surface charges can 
undergo IEM ejection12, 14). In aqueous solution (Figure 4.14a) the favorable solvation 
characteristics afforded by water allow charge carriers to adopt positions throughout the droplet, 
including locations close to the surface from where they can be ejected. The relatively few 
remaining charge carriers in the vanishing droplet bind to the protein, producing low CRM 
charge states.11, 24-25 
The addition of SCA leads to supercharging via charge trapping (Figure 4.14b) 58. The 
SCA initially forms an ionophobic surface layer. As a result, charge carriers preferentially reside 
in the droplet interior such that their IEM efficiency is reduced; thus, a larger number of charge 
carriers remain in the droplet compared to the purely aqueous droplets. Once all the water has 
evaporated the SCA encapsulates the protein. Unfavorable interactions with the SCA force the 
remaining charge carriers to associate with the protein. All these (many) charge carriers remain 
bound until the SCA layer has evaporated – producing a desolvated supercharged protein ion. 
Depending on their structural resilience, supercharged proteins may undergo electrostatically 
driven unfolding (as in the case of hMb47, 58), or they can retain compact conformations (as 
demonstrated for several other proteins30, 45, 55, 59-60). Our MD simulations and dendrimer 
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supercharging data do not support the view that unfolding within the ESI droplet is the root cause 
of supercharging.44, 47  
Figure 4.14c illustrates how 18C6 acts as supercharging antidote. 18C6 solubilizes 
charge carriers in the SCA, allowing the charge carriers to reside at the droplet surface such that 
IEM ejection proceeds with high efficiency. Compared to the supercharging conditions of Figure 
4.14b the droplets lose more charge, such that the dried-out protein at the end of the process has a 
lower z. 
Experimental supercharging spectra exhibit wide charge state distributions (Figure 4.2e, 
g), whereas our simulations produced fairly well defined z values (Figure 4.6). The 
experimentally observed charge state range is attributed to the heterogeneous nature of 
evaporation/fission events in the ESI plume, which will yield nanodroplets with different SCA 
concentrations.11 Nanodroplets containing more SCA will produce higher z values.47, 58 Modeling 
this heterogeneity is difficult, as it would require knowledge of the exact ESI plume composition. 
Regardless of these nuances, it is remarkable how well the current MD data capture the 
experimental trends, i.e., a dramatic shift to higher charge states in the presence of sulfolane and 
the suppression of supercharging by 18C6 (Figure 4.6). 
Our use of 18C6 as a mechanistic ESI probe expands on previous studies, where this 
remarkable molecule was applied to examine protein structures in solution68 and in the gas phase. 
69-70 In future work we hope to apply strategies similar to those used here for uncovering the 
mechanistic basis of supercharging under denaturing conditions, where the charge states formed 
are even higher than under the native ESI conditions examined here.32, 44, 54 
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Figure 4.14. Cartoon summary of MD and experimental results. (a) Native ESI in aqueous 
solution, producing low charge states. A similar scenario is encountered for water/18C6 droplets 
(not shown). (b) Supercharging via the charge trapping. A highly charged protein is formed 
because charge ejection from the droplet is hindered. The supercharged protein may undergo gas 
phase unfolding. (c) 18C6 acts as supercharging antidote; it prevents charge trapping by 
promoting the ejection of charge carriers from the droplet surface. “X+” represents charge 
carriers such as Na+, H3O
+ or NH4
+. “IEM” indicates charge carrier ejection (field emission). 
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Chapter 5. Chain Ejection Model for Electrospray Ionization 
of Unfolded Proteins: Evidence from Atomistic Simulations 
and Ion Mobility Spectrometry  
5.1. Introduction 
Electrospray ionization (ESI) has revolutionized mass spectrometry (MS) by allowing the facile 
transfer of proteins and other analytes from solution into the gas phase.1 During ESI charged 
droplets emanate from a high voltage capillary. Solvent evaporation and jet fission decrease the 
droplet size to the nanometer range, while maintaining a charge close to the Rayleigh limit.2-7 
The mechanisms whereby analyte ions emerge from ESI nanodroplets remain controversial.4, 8-18 
Recent progress in this area has been fueled by molecular dynamics (MD) simulations. MD 
studies revealed that small ions such as Na+ undergo field emission from the droplet surface,15, 19-
21 consistent with the ion evaporation model (IEM).8, 22 Simulations on peptides,23 globular 
proteins,24 and nucleic acid duplexes25 indicated that these larger species are liberated by droplet 
evaporation to dryness, as envisioned by the charged residue model (CRM).3-4 
“Native” protein ESI experiments aim to preserve solution-like structures and 
interactions in the gas phase by employing non-denaturing aqueous solutions and gentle ion 
sampling conditions.26-29 Structural retention under these conditions is promoted by the low CRM 
charge states of protein ions, which are close to the Rayleigh charge of protein-sized water 
droplets.3-4 
Electrosprayed protein ions can be further interrogated by ion mobility spectrometry 
(IMS)30-35 and by various activation methods.36-38 Collision-induced dissociation (CID) of 
multisubunit complexes usually causes ejection of one highly charged chain.39 This behavior has 
been attributed to gradual unfolding of one subunit, H+ migration onto the unraveling chain, and 
subsequent separation of this chain from the complex (Figure 5.1a).38, 40-41 This CID model is 
consistent with IMS data,32, 37 the mobile nature of H+ in gaseous proteins,42-45 and the fact that 
H+ migration onto the unraveling chain will minimize electrostatic repulsion.46-47 
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While the CRM is widely accepted for globular proteins in native ESI,3-4, 11, 24, 48 the 
behavior of unfolded proteins is more controversial.12, 48-49 [M + zH]z+ ions formed from unfolded 
proteins exhibit wide charge state distributions centered at much higher z values than in native 
ESI. This effect is encountered after unfolding by acid,50-51 base,52 heat,53 disulfide cleavage,54 
mutations,55 and cofactor removal.51 The high charge states of unfolded proteins can boost mass 
analyzer performance56-57 and enhance top-down fragmentation.58-59 
 Various attempts have been made to explain the dramatic shift to higher charge states 
seen for unfolded proteins. Early work proposed that ESI charge states reflect the titration 
behavior in solution,60 but subsequent studies showed this not to be the case.52, 61-62 Other ideas 
focused on the accessibility of titratable sites,50, 54, 63 but even in native proteins most titratable 
sites are accessible at the surface.64 It has also been proposed that COO- groups may neutralize 
positive sites in folded gaseous proteins.12 Although such zwitterionic contacts are well 
documented,65 it is unclear if they can account for conformation-dependent charge state 
changes.48 Other studies pointed out that the gas-phase basicity of biomolecular ions could result 
in H+ transfer from the solvent vapor.12, 66 While all these ideas are interesting, they do not 
directly address the mechanism whereby unfolded proteins emerge from ESI nanodroplets. 
Unfolded proteins in solution adopt disordered conformations, similar to certain 
synthetic polymers such as polyethylene glycol (PEG).67 MD simulations of PEG-containing 
aqueous ESI droplets by Consta et al. revealed that PEG binds Na+ from the solvent, followed by 
polymer extrusion from the droplet surface.68 Our laboratory proposed that the ESI process for 
unfolded proteins follows similar avenues.15 According to this “chain ejection model” (CEM, 
Figure 5.1b), the protein is driven to the droplet surface by electrostatic and hydrophobic factors. 
The protein then undergoes gradual ejection via “tadpole-like” structures where the droplet 
carries an extended protein tail. This CEM scenario15 bears close parallels to the CID process of 
multi-subunit systems (Figure 5.1a). Specifically, a central aspect of the protein CEM is the 
migration of mobile H+ between the droplet and the protruding polypeptide tail. This H+ transfer 
causes the unfolded protein to depart as a highly charged ion, analogous to H+ transfer during 
CID which causes the departing subunit to be highly charged.15 H+ migration is absent for 
sodiated PEG,68 i.e., the CEM scenarios of unfolded proteins and PEG chains are not equivalent. 
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Several studies have endorsed the CEM.15, 26, 69-70 However, it is unsettling that protein 
CEM processes have never been verified by atomistic MD simulations. Instead, the idea relies on 
simple coarse-grained models, Monte-Carlo methods,15 and salt adduction studies.71 Atomistic 
ESI simulations on unfolded proteins face two challenges. (1) Mobile H+ are difficult to treat 
computationally. MD methods are available for H+ transfer in the gas phase,46-47 but H+ migration 
in water (and between water and protein, Figure 5.1b) requires ab initio tools. The computational 
cost of these tools makes them unsuitable for ESI droplets.72-74 (2) ESI droplets have to 
accommodate the analyte at the onset of the simulation. This is not a problem for native proteins, 
where a few thousand water molecules are sufficient for building a droplet that completely 
engulfs the analyte.24-25 In contrast, the increased dimensions of unfolded proteins67 require 
larger droplets, driving up computational cost which scales as N2 with the number of atoms.75 
The current work scrutinizes the viability of the CEM by conducting atomistic MD 
simulations on ESI droplets containing unfolded proteins. Myoglobin has been used in numerous 
earlier ESI mechanistic investigations,24, 30, 50-51, 63, 69, 71 and therefore it was chosen as model 
protein for our work as well. Difficulties associated with the treatment of mobile H+ were 
circumvented by focusing on carefully selected pH environments. Graphics processing unit 
(GPU)-accelerated algorithms76 allowed us to overcome challenges related to droplet size. MD 
simulations were complemented by ESI-MS/IMS experiments. Our results support the view that 
the ESI process of unfolded proteins in aqueous solution proceeds via the CEM. 
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Figure 5.1. Cartoon depiction of two analogous gas phase processes. (a) CID of a noncovalent 
protein complex. Subunits are depicted as spheres, excess H+ are represented by “+” signs. One 
subunit (red) undergoes unfolding, and the protruding tail accumulates charge due to H+ 
migration from the residual complex. The subunit leaves as a highly charged unfolded ion. (b) 
Proposed chain ejection model (CEM) for the release of an unfolded protein from an ESI droplet. 
As the protein gets gradually ejected, the protruding tail undergoes charge equilibration with the 
droplet via H+ migration. The protein leaves as a highly charged unfolded ion. Modified from 
ref.15 
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5.2. Materials and Methods 
5.2.1. Protein, Reagents and Mass Spectrometry   
Apo-myoglobin (aMb, Sigma, St. Louis, MO) was prepared by butanone extraction. The 
protein was dialyzed against 10 mM neutral aqueous ammonium acetate, followed by 
acidification with formic acid to pH 4 or pH 2. ESI-MS and IMS data were acquired on a Synapt 
G2 instrument (Waters, Milford, MA). Aqueous aMb (5 μM) was infused at 5 µL min-1 using a 
standard Z-spray ion source at +2.8 kV. The source and desolvation temperatures were kept low 
(25 C and 40 C) and the cone was set to 5 V to minimize the in-source activation. IMS 
calibration using a set of reference proteins yielded effective He collision cross sections ().77  
5.2.2. MD Simulations 
MD simulations were carried out using Gromacs 2016 with GPU acceleration,76 the 
Charmm36 force field,78 and TIP4P/2005 water79 in trajectory stitching mode.24 A temperature of 
370 K was chosen to mimic the presence of heating elements in typical ESI sources. Unfolded 
aMb starting conformations were produced by heating aMb (1WLA without heme) from 320 K 
to 450 K in vacuum using canonical charge states over 20 ns. Spherical water droplets with 5.5 
nm radius (~22,500 water molecules) were built around the protein, and the aMb charge was set 
to 22+, 27+, or 33+. All runs started with a droplet charge of 47+ which corresponds to the 
Rayleigh charge zR of a 5.5 nm aqueous droplet,
3-4, 24 calculated as zR = 8/e  (0  r3)1/2. To 
attain this regime, charges contributed by aMb were supplemented by Na+ ions in random 
positions. All runs were repeated three to five times with different initial aMb structures, Na+ 
positions, and starting velocities. The simulation time window was 75 ns. After release into the 
gas phase the desolvated protein was allowed to run for an additional 500 ns at 320 K; this lower 
temperature was chosen to reflect gentle ion sampling conditions.26-28, 80 He collision cross 
sections were calculated using the trajectory method in Collidoscope.81 These  values were 
determined by extracting MD structures from the 500 ns trajectories in 100 ns intervals. 
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5.3. Results and Discussion 
5.3.1. ESI-MS and IMS Experiments 
ESI mass spectra of aMb acquired at pH 4 showed a bimodal charge state distribution 
peaking at 9+ and 18+ (Figure 5.2a). The protein is known to be structurally heterogeneous in 
solution at pH 4, comprising compact conformers and disordered species.51, 82 This heterogeneity 
is reflected in the spectrum of Figure 5.2a, where compact conformers gave rise to lower charge 
states (around 9+), while the more unfolded chains formed charge states around 18+.51 
Acidification to pH 2 caused further unfolding,82 consistent with a shift to higher ESI charge 
states (around 20+, Figure 5.2b).51 The highest detectable charge state was 27+. 
 IMS data for charge states 22+ to 27+ are shown in Figure 5.2c (the complete dataset is 
shown in Figure 5.3). 22+ ions had collision cross sections of (3870  30) Å2, whereas higher 
charge states showed larger  values, e.g., (4190  100) Å2 for 27+. This trend reflects the 
internal Coulomb repulsion experienced by the gaseous ions.30-31 For the highly charged ions 
considered in Figure 5.2c, collision cross sections measured at pH 4 and pH 2 were virtually 
indistinguishable. 
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Figure 5.2. Experimental ESI mass spectra for aMb recorded in aqueous solution at pH 4 (a) and 
pH 2 (b). Selected charge states are indicated. Panel (c) shows IMS collision cross section () 
distributions for highly charged ions acquired at pH 4 (blue) and pH 2 (red). 
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5.3.2. ESI Modeling Strategy  
We already noted how difficult it is to model H+ migration in a droplet that carries a 
polypeptide tail (as envisioned within the CEM, Figure 5.1b).15 Such H+ transfer can cause the 
gas phase protein charge to be very different from that in solution.52, 61-62 However, the 
magnitude of this disparity depends on the conditions. The solution charge is dictated by the pKa 
values of titratable sites and by pH.64 Hence, a judicious choice of pH can result in a scenario 
where the protein solution charge resembles the charge state of the resulting gaseous ions. Figure 
5.4 shows that at pH ~4 the aMb solution charge is around 22+ (pH 4.25) to 27+ (pH 3.75). Gas 
phase ions with charge states 22+ to 27+ can be produced by electrospraying aMb at pH 4 
(Figure 5.2a). CEM-related H+ migration between droplet and protein will be minimal under 
these conditions because solution charge  gas phase charge. In this specific case it is reasonable 
to model the ESI process without mobile H+, thereby greatly simplifying the computational 
approach. 
Prior to applying the strategy outlined above, one has to consider that the droplet pH 
will likely deviate from that of the bulk solution. Solvent evaporation tends to increase the H+ 
concentration. On the other hand, formic acid in the in the aMb solutions used here has buffering 
capacity around pH 4  (pKa = 3.75). Therefore, the assumptions (1) solution pH  droplet pH and 
(2) [protein charge in solution]  [protein charge after ESI] provide a reasonable foundation for 
modeling the ESI behavior of unfolded aMb in the 22+ to 27+ charge states at pH 4. 
Another aspect that has to be addressed is the intramolecular H+ distribution. Most 
charge states can be implemented via a multitude of protonation patterns.12 To test whether the 
aMb behavior is sensitive to this aspect we performed simulations on various protonation 
patterns (Figure 5.5). Three 22+ patterns were tested, referred to as 22+[A] (all sites protonated, 
except His), 22+[B] (N-terminus and all Arg/His/Lys protonated, all Asp and some Glu 
deprotonated), 22+[C] (all sites protonated, except for some Lys). 27+ simulations were 
conducted where all sites were protonated, except for some Lys. Simulations on fully protonated 
aMb (33+) were included as well, although this value is beyond the range observed in our 
experiments. 
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To ensure that unfolded aMb chains were fully contained within the initial ESI droplet 
we employed a droplet radius of 5.5 nm. To the best of our knowledge, these are the largest 
protein-containing ESI droplets modeled to date. GPU-acceleration76 helped overcome the 
computational cost associated with this system size. TIP4P/2005 water79 was chosen because it 
reproduces the water surface tension, thus ensuring that the simulations yielded realistic data.24 
The droplets were initially charged to the Rayleigh limit2-4 by supplementing the aMb charge 
with Na+ ions, keeping in mind that Na+ represents a typical ESI charge carrier.3 Likely, other 
ions such as NH4
+ or H3O
+ would yield qualitatively similar results to those discussed below for 
Na+. 
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. 
Figure 5.4. Calculated aMb net charge in solution vs. pH (black). Also shown are the 
contributions of titratable sites (basic = blue; acidic = red), weighted by their abundance in the 
protein sequence. The number of sites and their pKa values
64 are: 1 N-terminus+ (7.4); 2 Arg+ 
(12.0); 19 Lys+ (10.8); 11 His+ (6.5); 8 Asp (4.0), 13 Glu (4.4), 1 C-terminus (3.9). Hatch marks 
highlight the range around pH 4, where the solution charge is between 22+ (pH 4.25) and 27+ 
(pH 3.75). CEM production of gaseous ions in these charge states from pH ~4 droplets will 
involve minimal H+ migration because gas phase charge  solution charge 
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Figure 5.5.  aMb charge patterns for MD simulations. Positive sites are indicated in blue, while 
negative charges are indicated in red. The proton distribution in 22+[A] reflects the view that Arg 
and Lys are key protonation sites in the gas phase,49 as well as the most basic residues in 
solution.64 22+[B] allows for negatively charged sites in [M + zH]z+ ions, i.e., zwitterionic and/or 
salt bridge motifs.12, 65 This pattern also reflects the partial deprotonation of Asp and Glu in 
solution at pH 4 (Figure 5.4). 22+[C] was chosen in accordance with the view that protons in the 
gas phase primarily reside on Arg/His/Lys46, 66, 83 Some Lys were left unprotonated because Lys 
has a lower gas phase basicity than His.84 
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5.3.3. MD Simulations Confirm CEM Behavior 
Aqueous ESI droplets containing unfolded aMb were subjected to MD simulations. Typical data 
for protonation patterns 22+[B] and 27+ are shown in Figure 5.6. Within a few ns the protein 
migrated from the droplet interior close to the surface (Figure 5.6a, 5 ns; Figure 5.6b, 2.5 ns). 
This was followed by partial aMb eruption as a hydrated bulge (Figure 5.6a, 7 ns). At this 
particular point Na+ and aMb22+ had partitioned into opposite regions of the droplet, highlighting 
the electrostatic forces within the system (see also Figure 5.7). Protein expulsion subsequently 
produced an electrostatically stretched tail that protruded into the vapor phase (Figure 5.6a, 10 
ns; Figure 5.6b, 12.5 ns). Further expulsion then caused aMb separation from the droplet. 
Nascent gaseous proteins retained some water which evaporated within 75 ns. Data very similar 
to those of Figure 5.6 were also seen for the other protonation patterns (22+[A], 22+[C], 33+, 
Figure 5.8), confirming that the behavior reported here is robust and reproducible. Figure 5.6 
embodies the central result of this work: for the first time atomistic MD simulations confirm the 
formation of gaseous ions from unfolded proteins via the CEM. 
The CEM trajectories showed slight variations. In some instances, aMb ejected with a 
small droplet attached to one terminus. These small droplets then evaporated without separating 
from the chain (Figure 5.9). Another variation involved ejection in a hairpin conformation. The 
hairpins either opened up as they departed from the droplet (22+[A], Figure 5.10a), or they 
retained looped conformations (22+[B], Figure 5.10b). In one instance aMb ejected without 
extensive stretching (22+[B], Figure 5.10c). All other (16 out of 17) runs showed the hallmark of 
the CEM, i.e., aMb ejection via droplets that carried an electrostatically stretched protein tail, 
consistent with the mechanism of Figure 5.1b.15 None of the unfolded aMb chains showed CRM 
behavior, i.e., protein release via droplet evaporation to dryness. 
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Figure 5.6. Typical snapshots from CEM simulation runs on Rayleigh-charged aqueous droplets 
containing unfolded aMb. The protein net charge was (a) 22+ (pattern 22+[B]) and (b) 27+. Na+ 
is blue, the protein backbone is magenta, positive/negative charges on the protein are highlighted 
as cyan/red spheres, respectively. Water oxygen is shown in red. The zoom level decreases from 
top to bottom. “IEM” in (a) highlights the field emission of a Na+ ion. 
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Figure 5.7. Snapshots taken from a CEM simulation run on aMb in protonation pattern 22+[B] 
(same data set as in Figure 5.6). Water was omitted to more clearly reveal the behavior of the 
protein (magenta) and Na+ ions (blue). Positive/negative charges on the protein are highlighted as 
cyan/red spheres, respectively. Black lines indicate the approximate outline of the droplets. 
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Figure 5.8. CEM ejection aMb from aqueous ESI droplets at the Rayleigh limit. The protonation 
patterns used for these simulations were (a) 22+[A], (b) 22+[C], and (c) 33+. Na+ is indicated in 
blue, positive/negative charges on the protein are highlighted as cyan/red spheres, respectively. 
Water oxygen is shown in red. 
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Figure 5.9. CEM ejection of aMb in charge states (a) 27+ and (b) 33+ from the ESI droplet. For 
these two runs the nascent aMb ions retained a small progeny droplet at one terminus which 
subsequently evaporated without detaching from the protein. 
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Figure 5.10. Snapshots from simulation runs on three protonation patterns. In contrast to Figure 
5.6 , these data illustrate less common scenarios, highlighting the variability of the ESI process. 
 
5.3.4. Charge Loss at the Rayleigh Limit  
Our simulations started with a droplet charge zD close to the Rayleigh limit zR.
2-4 Droplet 
shrinkage due to water evaporation (Figure 5.11a) had a tendency to increase the electrostatic 
repulsion further, forcing the droplets to shed charge. Three competing charge loss processes 
were encountered. The first was the IEM ejection of Na+ (Figure 5.6a). The second was CEM 
ejection of the protein. Multiple Na+ ejections occurred early during each run, followed by long 
plateaus where Na+ loss had come to a halt (Figure 5.11b). These plateaus represent the regime 
where formation of a protruding protein tail had decreased the electrostatic repulsion within the 
droplet to such an extent that Na+ ejection became kinetically unfavorable. 
The third charge loss process was the formation of Na+-containing progeny droplets via 
jet fission, a phenomenon well known from imaging studies on larger ESI droplets.5-6 Fission 
events reminiscent of those experimental data,5-6 involving water filaments, took place in several 
[
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MD runs and generated progeny droplets comprising ~50 water molecules and one or two Na+ 
(Figure 5.12). Similar to IEM ejection of Na+, jet fission was limited to time points prior to 
formation of a protein tail. Plots of zD / zR confirmed that the droplets stayed close to the 
Rayleigh limit during these early stages (Figure 5.11c). We limited the time frame of Figure 
5.11c to the initial ~4 ns during which protein ejection had not started yet in most runs, keeping 
in mind that the zR expression used here
2-4 applies only to spherical systems. 
All three of the aforementioned charge loss processes were kinetically viable, but 
ultimately protein ejection was the main avenue by which the droplets relieved electrostatic 
stress. In addition to its electrostatic driving force, the CEM behavior is favored by the fact that 
unfolded proteins possess many solvent-exposed hydrophobic side chains. The tendency of 
hydrophobic moieties to migrate to the liquid/vapor interface, rather than stay in the droplet 
interior, is well established.15, 18 The case is completely different for folded proteins, where most 
hydrophobic sites are buried, and where water interacts favorably with solvent-exposed 
hydrophilic/charged residues.64 The latter conditions cause folded proteins to remain within the 
ESI droplets until evaporation to dryness, resulting in CRM behavior.15 Solvent evaporation to 
dryness causes CRM-produced protein ions to carry adducts arising from nonvolatile solutes, 
including Na+ and other charge carriers.3, 15 In contrast, the CEM simulations of the current work 
did not reveal a single instance of Na+ adduction to aMb. This behavior is in line with the 
experimental finding that acid-unfolded proteins are much less prone to adduction than their 
natively folded counterparts.71 
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Figure 5.11. MD simulation data for typical CEM runs on aMb protonation patterns 22+[A] 
(green), 22+[B] (black), 22+[C] (orange), 27+ (blue), and 33+ (red). (a) Number of water 
molecules and (b) number of Na+ in the droplet vs. time. The end of each profile marks the point 
where the protein chain separates from the droplet. (c) Droplet charge zD relative to the Rayleigh 
charge zR, focusing on the initial regime where protein ejection had not started yet. 
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Figure 5.12. Formation of small progeny droplets via jet fission in two ESI simulation runs. 
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5.3.5. Protein Conformations after CEM Ejection 
For each ESI simulation the behavior of desolvated aMb after ejection from the droplet was 
explored in 500 ns MD runs. Representative structures from these vacuum simulations were 
extracted, and their  values were compared with experimental IMS data (Figure 5.13). 
Averaging the results of all aMb 22+ simulations yielded  = (3790  300) Å2, in good 
agreement with the experimental result of (3870  30) Å2. Simulated 27+ ions had  = (4190  
100) Å2, close to the measured value of (4050  30) Å2. The MD structures that most closely 
matched the experiments are shown along the right-hand side of Figure 5.13. These 
electrostatically stretched proteins had a stick-like appearance, with local -helices, and some 
coil formation at the termini. Electrostatic repulsion caused 27+ aMb to be slightly longer 
(overall length ~ 350 Å) than the 22+ ions (~ 310 Å).  
Overall, the results of MD runs on protonation patterns 22+[A], 22+[C], and 27+ agreed 
well with the experimental data (Figure 5.13). The zwitterionic pattern 22+[B] deserves a closer 
look. Two 22+[B] runs produced relatively compact structures that were incompatible with 
experiments (Figure 5.13b, left). Non-local salt bridges in these runs limited the extent of 
electrostatic stretching. A third 22+[B] run did yield a stretched structure that matched the 
measured  value (Figure 5.13b). Salt bridges in this third run only involved sites in close 
sequence proximity. Our data thus do not exclude the existence of local zwitterionic motifs in 
unfolded gaseous proteins, but non-local salt bridges are unlikely. We note that previous 
evidence for zwitterionic motifs in the gas phase was obtained primarily for tightly folded 
proteins,12, 65 rather than unfolded species. 
The gas phase conformations generated in our 500 ns vacuum simulations were 
governed by the morphology of the protein during ejection. Proteins that left the droplet as 
stretched chains retained extended conformations (Figures 5.3, 5.4a); proteins that ejected in 
more compact structures (Figure 5.10b, c) gave rise to less extended ions (Figure 5.13b, left). 
The near-absence of conformational changes in the 500 ns runs suggests that this conformational 
memory persists for time periods much longer than the simulation window explored here 
(overlays in Figure 5.13). The agreement between experimental data and MD-derived  values 
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in Figure 5.13 thus supports the fidelity of our MD data, and it bolsters the view that the 
observed ions are CEM products. 
 
 
Figure 5.13. Experimental IMS data measured at pH 4 (blue) and pH 2 (red) for charge states 
22+ (a-c) and 27+ (d). Vertical black lines represent average  values from individual MD runs, 
standard deviations are indicated as horizontal bars. The four panels represent data for different 
protonation patterns, as indicated. Shown on the right are MD structures of those trajectories that 
best matched the experimental data (pink asterisks, overlays of five structures between 100 ns 
and 500 ns, all at the same zoom level, N-termini pointing to the left). Also included in (b) are 
MD structures from two runs that yielded more compact structures than those observed 
experimentally. Positive/negative charges on aMb are shown as cyan/red spheres, respectively. 
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5.4. Conclusions 
This work marks the first time that the production of gaseous ions from unfolded proteins via the 
CEM has been verified in MD simulations using an atomistic force field for protein and solvent. 
The MD data are supported by IMS experiments, bolstering the view that unfolded proteins are 
ejected from ESI droplets as electrostatically stretched chains (Figure 5.1b).15 This CEM 
behavior can be contrasted to the CRM, which is operational in native ESI where protein are 
folded.24 
Computational challenges precluded the inclusion of H+ migration between droplet and 
protein (Figure 5.1b) in our simulations. Depending on the titration behavior of the protein, H+ 
migration may increase or decrease the protein net charge during ejection. Here we focused on 
aMb around pH 4, where z  solution charge, such that H+ migration could be neglected. How 
likely is it that more advanced modeling strategies involving mobile H+ would overthrow the 
viability of the CEM? Our IMS experiments demonstrated that the gas phase conformations of 
aMb 22+ to 27+ produced at pH 4 were indistinguishable from those generated at pH 2. This is 
despite the fact CEM-related H+ migration at pH 4 is negligible (z  solution charge), whereas 
pH 2 will be associated with significant H+ transfer (z < solution charge). Hence, H+ migration 
does not seem to affect the properties of these ions. In addition, our MD simulations consistently 
produced CEM behavior for various protonation patterns and charge states, all the way to 
aMb33+. It thus appears that CEM behavior is a robust property of acid-unfolded proteins. It is 
unlikely that this conclusion would change when applying computational strategies that allow for 
H+ migration. 
Notwithstanding the aforementioned comments, it is hoped that future studies on the 
ESI behavior of unfolded proteins will employ more sophisticated models that include H+ 
migration. Such strategies will be required for quantitatively explaining the wide range of ESI 
charge states seen for unfolded proteins (Figure 5.2). We hypothesize15 that this charge 
heterogeneity can be attributed to protein ejection from differently sized droplets, in conjunction 
with the fact that denatured proteins comprise various conformers that may accumulate different 
numbers of H+ during ejection.12, 51 It is possible that the CEM is not the only mechanism that is 
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operative during ESI of denatured protein. Only the highly charged ions in the spectra were 
attributed to the CEM, while less abundant ions in low charge states (such as 9+/10+, Figure 
5.2b) may represent CRM products. We hope that the current work will stimulate additional 
studies aimed at deciphering all these intricacies associated with the ESI process, as well as the 
possible involvement of the CEM in “supercharging” experiments.69 
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Chapter 6:  Conclusions and Future Work 
6.1 Conclusions 
Despite the many advances in ESI-MS in various research areas, many fundamental aspects of 
ESI remain intractable. The photographs of the droplet jet fission and progeny droplet formation 
by Gomez and Tang1 have inspired quite a number of researchers to develop techniques that give 
an atomistic view of the ESI process. In order to achieve a reliable and robust ESI analysis, it is 
essential to understand the underlying mechanisms, in the words of Richard Cole, we don’t want 
to be ‘blind men’.2 MD simulations are one of the tools that can provide a detailed information 
regarding the ESI process.3-6 There is a general consensus that small ions are ejected from the 
droplet via the IEM, while globular analytes follow the CRM.7-9 In this thesis, we have applied 
MD simulations as a complementary method along with experimental investigations.  Our work 
has broken new ground in terms of applying MD simulations to IEM, CRM and CEM events, 
and we have significantly contributed to understanding the mechanism of protein supercharging.  
The main goal behind the work in Chapter 2 was to investigate the role played by 
cations during protein charging in the positive ion mode. Analytes that have basic groups can be 
charged by cation binding which enhances their ionization and detection. Generally, the presence 
of non-volatile salts or buffers can be beneficial as most biological samples require the existence 
of cations such as Na+ and K+ to preserve native structure and non-covalent complexes. 
However, these non-volatile salts can be incompatible with the ESI-MS source. In literature, 
these salts can cause interferences and degrade the protein ion signal. The mechanistic 
understanding of salt interferences is yet to be explained. Instead of depending on experimental 
work only, we employed all-atom molecular dynamics simulation to gain a more detailed image 
of the behavior of nanodroplets in the presence of cations such as Na+ and NBu4
+.  Our findings 
showed that salts such as NaCl will cause a major adduction, while not strongly affecting the 
protein ion signal. Conversely, NBu4Cl completely degrades the protein ion formation. The main 
factor behind their differential response is their free energy of hydration or their surface activity. 
The surface accessibility of cation was described by the charge competition model, where species 
like NBu4
+ can be lost via facile ejection from the surface of the parent droplet. Species like Na+ 
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cannot be described by the charge competition model; rather it is a simple spread of ion count 
over a wide m/z range via adduction.   
Supercharging is a relatively new method that represents an addition to the field of 
tandem MS. The efficiency of fragmentation in techniques such as electron capture dissociation 
(ECD) and CID depends on the extent of charging.  To properly apply these dissociation 
techniques, it will be beneficial to understand the mechanism behind protein supercharging. By 
using experiments alone, it is impossible to obtain detailed insights into the temporal evolution of 
the protein/droplet system during supercharging. The mechanism of supercharging has been 
always controversial. In Chapter 3 we used a combination of MD simulations and ESI-MS/IMS 
to examine the supercharging mechanism of sulfolane and m-NBA. Our data showed that native 
supercharging takes place due to charge trapping; where supercharging agent (SCA) segregation 
lead to an aqueous core that contains the protein and Na+/H+ as a charge carrier with an outer 
shell of SCA. This layering will allow Na+/H+ to eject from the droplet via IEM with water. Once 
water completely evaporates, the outer shell decreases the chances of IEM and the remaining 
charges will irreversibly bind to the protein. The protein will be released via CRM and may 
undergo gas phase unfolding due to charge repulsion. In Chapter 4, we tested this proposal by 
using 18C6. As discussed above, based on our charge trapping hypothesis the solvation 
characteristics of  SCA determine the fate of charge carriers. 18C6 selectively binds Na+, thereby 
enhancing the solubility of charge carriers in the SCA layer and reversing the supercharging 
effects. Both MD simulations and experiments show agreement which reflects the utility of MD 
simulations in interrogating the behavior of ESI-droplets during supercharging. 
In Chapter 5, we studied the ESI mechanism for unfolded proteins. Several years ago, 
our laboratory proposed that the CEM can explain the release of proteins under non-native 
conditions. There has been a long gap between those earlier proposals and the actual MD 
simulations of the current work due to difficulties associated with H+ migration and droplet size.  
In the CEM, unfolded proteins migrates to the surface of the droplet due to electrostatic and 
hydrophobic factors and get ejected via formation of intermediates where the droplets carry 
extended protein tails. Our MD simulations along with ESI-MS/IMS have provided a clear 
evidence that unfolded proteins are released via the CEM. To our knowledge, this is the first 
study that shows the release of unfolded proteins from the droplet in an atomistic fashion.   
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6.2 Future Directions 
6.2.1 Studying the Effects of Anions on Protein Ion Signals in Negative Ion 
Polarity 
Chapter 2 explored the behavior of cations under positive polarity conditions. Even though 
positive ion mode is the widely used for protein analysis, negative ion mode is important for 
studying DNA and RNA duplexes.10 It will be exciting to explore the effects of anions such as 
acetate, formate, chloride, and phosphate in proteins, protein complexes, and DNA in negative 
ESI. Using MD simulations and ESI-MS/IMS can give more insights into the behavior of all the 
previously mentioned anions especially acetate anion. As ammonium acetate is commonly used 
as a “buffer” in direct infusion studies, many experiments have shown that the buffering capacity 
of ammonium acetate is not as effective as other buffers, besides some protein-ligand interactions 
are unstable in ammonium acetate.11-12  
6.2.2 Investigating the Effects of Salts on Protein Supercharging  
Chapters 3 and 4 shed light on the mechanism of supercharging. Exploring the effects of salts on 
supercharging is important as metal ions such as (K+, Li+) are ligands for some proteins or 
protein complexes. MD simulations for those cations in SCAs-containing droplets along with 
observing the changes in charge state distributions in ESI-MS can be used to interrogate the 
effects of cation size. This can be informative in designing experiments employing 
supercharging. 
6.2.3 Additional Supercharging Agents 
We focused on the most commonly used SCAs sulfolane and m-NBA but studies for additional 
SCAs can facilitate a better understanding of protein supercharging. 13-14 
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6.2.4 Examining the Effects of Supercharging Agents in Negative Ion Mode 
There is a lot of discussion about whether SCAs increase the charge in the negative ion polarity. 
Some reports suggest that m-NBA can efficiently increase charging in the negative ion mode15 
while sulfolane fails to boost charges in the negative polarity.16 An expansion of the work 
presented will be to investigate different SCAs in negative ion mode using ESI-MS/IMS along 
with the MD protocols of Chapters 3 and 4. In negative ion mode, proteins are charged by proton 
stripping so MD simulations using mobile proton algorithms have to be applied that can provide 
more details about supercharging in the negative ion mode by investigating how H+ is 
transferred.17 
6.2.5 Uncovering the Mechanism of Supercharging Under Denaturing 
Conditions 
Unfolded proteins have unique features as they show high charge state distributions. Addition of 
SCAs shift the ions to even lower m/z.18-19 Using our MD techniques of Chapter 3 which involve 
‘forced evaporation’ of SCAs along with placing the unfolded protein in a big droplet and 
judicious choice of pH as in Chapter 5 may be helpful in deciphering the behavior of unfolded 
proteins during supercharging. 
6.2.6 Can the Chain Ejection Model (CEM) be applied to Intrinsically 
Disordered Proteins (IDPs)? 
Generally, functional protein should have a compact conformation. IDPs are unique class of 
proteins, characterized by loose structures at physiological pH. Despite lacking any stable 
structures, they are vital to many cellular processes. This class of proteins is also known to be 
associated with human diseases like cancer and Parkinson’s.20-21 Employing our modeling 
strategy and ESI-MS/IMS in Chapter 5 will be able to uncover how these proteins are released 
from the droplet to improve their characterization using ESI-MS. 
 
172 
 
 
6.3 References 
1. Gomez, A., Tang K, Physics of Fluids 1994, 6, 404-414. 
2. B., C. R., Journal of Mass Spectrometry 2000, 35, 763-772. 
3. Konermann, L.; Ahadi, E.; Rodriguez, A. D.; Vahidi, S., Analytical Chemistry 2013, 85, 
2-9. 
4. Kim, D.; Wagner, N.; Wooding, K.; Clemmer, D. E.; Russell, D. H., Journal of the 
American Chemical Society 2017, 139, 2981-2988. 
5. Consta, S.; Oh, M. I.; Malevanets, A., Chemical Physics Letters 2016, 663, 1-12. 
6. Consta, S.; Malevanets, A., Physical Review Letters 2012, 109 , 148301. 
7. Kebarle, P.; Tang, L., Analytical Chemistry 1993, 65, 972A-986A. 
8. Cech, N. B.; Enke, C. G., Mass Spectrometry Reviews 2001, 20, 362-387. 
9. Meyer, T.; Gabelica, V.; Grubmüller, H.; Orozco, M., Wiley Interdisciplinary Reviews: 
Computational Molecular Science 2013, 3, 408-425. 
10. Porrini, M.; Rosu, F.; Rabin, C.; Darré, L.; Gómez, H.; Orozco, M.; Gabelica, V., ACS 
Central Science 2017, 3, 454-461. 
11. Konermann, L., Journal of The American Society for Mass Spectrometry 2017, 28, 1827-
1835. 
12. Gavriilidou, A. F. M.; Gülbakan, B.; Zenobi, R., Analytical Chemistry 2015, 87, 10378-
10384. 
13. Zenaidee, M. A.; Donald, W. A., Analyst 2015, 140, 1894-1905. 
14. Wang, H.; Yong, G.; Brown, S. L.; Lee, H. E.; Zenaidee, M. A.; Supuran, C. T.; Donald, 
W. A., Analytica Chimica Acta 2018, 1003, 1-9. 
15. Ogorzalek Loo, R. R.; Lakshmanan, R.; Loo, J. A., Journal of The American Society for 
Mass Spectrometry 2014, 25, 1675-1693. 
16. Douglass, K. A.; Venter, A. R., Journal of The American Society for Mass Spectrometry 
2012, 23, 489-497. 
17. Konermann, L., The Journal of Physical Chemistry B 2017, 121, 8102-8112. 
18. Donor, M. T.; Ewing, S. A.; Zenaidee, M. A.; Donald, W. A.; Prell, J. S., Analytical 
Chemistry 2017, 89, 5107-5114. 
19. Teo, C. A.; Donald, W. A., Analytical Chemistry 2014, 86, 4455-4462. 
173 
 
 
20. Beveridge, R.; Phillips, A. S.; Denbigh, L.; Saleem, H. M.; MacPhee, C. E.; Barran, P. E., 
Proteomics 2015, 15, 2872-2883. 
21. Natalello, A.; Santambrogio, C.; Grandori, R., Journal of The American Society for Mass 
Spectrometry 2016, 28, 21-28. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
174 
 
 
Appendix I-Permissions 
 
 
 
 
 
    
 
 
 
 
Title: Exploring the Mechanism of 
Salt-Induced Signal Suppression 
in Protein Electrospray Mass 
Spectrometry Using Experiments 
and Molecular Dynamics 
Simulations 
Author: Haidy Metwally, Robert G. 
McAllister, Lars Konermann 
Publication: Analytical Chemistry 
Publisher: American Chemical Society 
Date: Feb 1, 2015 
Copyright © 2015, American Chemical Society 
 
 
 
LOGIN  
If you're a copyright.com 
user, you can login to 
RightsLink using your 
copyright.com credentials. 
Already a RightsLink user or 
want to learn more? 
 
 
PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE 
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because 
no fee is being charged for your order. Please note the following: 
▪ Permission is granted for your request in both print and electronic formats, and 
translations.  
▪ If figures and/or tables were requested, they may be adapted or used in part.  
▪ Please print this page for your records and send a copy of it to your publisher/graduate 
school.  
▪ Appropriate credit for the requested material should be given as follows: "Reprinted 
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright 
(YEAR) American Chemical Society." Insert appropriate information in place of the 
capitalized words.  
▪ One-time permission is granted only for the use specified in your request. No additional 
uses are granted (such as derivative works or other editions). For any other uses, please 
submit a new request. 
  
    
 
   
Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.  
Comments? We would like to hear from you. E-mail us at customercare@copyright.com  
 
175 
 
 
    
 
 
 
 
Title: Mechanism of Protein 
Supercharging by Sulfolane and 
m-Nitrobenzyl Alcohol: 
Molecular Dynamics Simulations 
of the Electrospray Process 
Author: Haidy Metwally, Robert G. 
McAllister, Vlad Popa, et al 
Publication: Analytical Chemistry 
Publisher: American Chemical Society 
Date: May 1, 2016 
Copyright © 2016, American Chemical Society 
 
 
 
LOGIN  
If you're a copyright.com 
user, you can login to 
RightsLink using your 
copyright.com credentials. 
Already a RightsLink user or 
want to learn more? 
 
 
PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE 
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because 
no fee is being charged for your order. Please note the following: 
▪ Permission is granted for your request in both print and electronic formats, and 
translations.  
▪ If figures and/or tables were requested, they may be adapted or used in part.  
▪ Please print this page for your records and send a copy of it to your publisher/graduate 
school.  
▪ Appropriate credit for the requested material should be given as follows: "Reprinted 
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright 
(YEAR) American Chemical Society." Insert appropriate information in place of the 
capitalized words.  
▪ One-time permission is granted only for the use specified in your request. No additional 
uses are granted (such as derivative works or other editions). For any other uses, please 
submit a new request. 
  
    
 
   
Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.  
Comments? We would like to hear from you. E-mail us at customercare@copyright.com  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
176 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
Title: Crown Ether Effects on the 
Location of Charge Carriers in 
Electrospray Droplets: 
Implications for the Mechanism 
of Protein Charging and 
Supercharging 
Author: Haidy Metwally, Lars Konermann 
Publication: Analytical Chemistry 
Publisher: American Chemical Society 
Date: Mar 1, 2018 
Copyright © 2018, American Chemical Society 
 
 
 
LOGIN  
If you're a copyright.com 
user, you can login to 
RightsLink using your 
copyright.com credentials. 
Already a RightsLink user or 
want to learn more? 
 
 
PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE 
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because 
no fee is being charged for your order. Please note the following: 
▪ Permission is granted for your request in both print and electronic formats, and 
translations.  
▪ If figures and/or tables were requested, they may be adapted or used in part.  
▪ Please print this page for your records and send a copy of it to your publisher/graduate 
school.  
▪ Appropriate credit for the requested material should be given as follows: "Reprinted 
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright 
(YEAR) American Chemical Society." Insert appropriate information in place of the 
capitalized words.  
▪ One-time permission is granted only for the use specified in your request. No additional 
uses are granted (such as derivative works or other editions). For any other uses, please 
submit a new request. 
  
    
 
   
Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.  
Comments? We would like to hear from you. E-mail us at customercare@copyright.com  
 
 
177 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
     
 
 
 
Title: Chain Ejection Model for 
Electrospray Ionization of 
Unfolded Proteins: Evidence 
from Atomistic Simulations and 
Ion Mobility Spectrometry 
Author: Haidy Metwally, Quentin Duez, 
Lars Konermann 
Publication: Analytical Chemistry 
Publisher: American Chemical Society 
Date: Jul 1, 2018 
Copyright © 2018, American Chemical Society 
 
 
 
LOGIN  
If you're a copyright.com 
user, you can login to 
RightsLink using your 
copyright.com credentials. 
Already a RightsLink user or 
want to learn more? 
 
 
PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE 
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because 
no fee is being charged for your order. Please note the following: 
▪ Permission is granted for your request in both print and electronic formats, and 
translations.  
▪ If figures and/or tables were requested, they may be adapted or used in part.  
▪ Please print this page for your records and send a copy of it to your publisher/graduate 
school.  
▪ Appropriate credit for the requested material should be given as follows: "Reprinted 
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright 
(YEAR) American Chemical Society." Insert appropriate information in place of the 
capitalized words.  
▪ One-time permission is granted only for the use specified in your request. No additional 
uses are granted (such as derivative works or other editions). For any other uses, please 
submit a new request. 
  
    
 
   
Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.  
Comments? We would like to hear from you. E-mail us at customercare@copyright.com  
 
 
178 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
Title: Unraveling the Mechanism of 
Electrospray Ionization 
Author: Lars Konermann, Elias Ahadi, 
Antony D. Rodriguez, et al 
Publication: Analytical Chemistry 
Publisher: American Chemical Society 
Date: Jan 1, 2013 
Copyright © 2013, American Chemical Society 
 
 
 
LOGIN  
If you're a copyright.com 
user, you can login to 
RightsLink using your 
copyright.com credentials. 
Already a RightsLink user or 
want to learn more? 
 
 
PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE 
This type of permission/license, instead of the standard Terms & Conditions, is sent to you because 
no fee is being charged for your order. Please note the following: 
▪ Permission is granted for your request in both print and electronic formats, and 
translations.  
▪ If figures and/or tables were requested, they may be adapted or used in part.  
▪ Please print this page for your records and send a copy of it to your publisher/graduate 
school.  
▪ Appropriate credit for the requested material should be given as follows: "Reprinted 
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright 
(YEAR) American Chemical Society." Insert appropriate information in place of the 
capitalized words.  
▪ One-time permission is granted only for the use specified in your request. No additional 
uses are granted (such as derivative works or other editions). For any other uses, please 
submit a new request. 
 
If credit is given to another source for the material you requested, permission must be obtained 
from that source. 
  
    
 
   
Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.  
Comments? We would like to hear from you. E-mail us at customercare@copyright.com  
 
179 
 
 
Curriculum Vitae 
Haidy Metwally 
Department of Chemistry 
Western University 
 
 
Education 
-Western University- London-Ontario- Canada (September 2013- present) 
• Ph.D. Candidate in Physical and Analytical Chemistry 
      Principal advisor: Professor/ Lars Konermann. 
 -Ain Shams University-Faculty of Pharmacy –Cairo-Egypt (2007-2012) 
• M.Sc. Honors in Pharmaceutical Sciences-Pharmacognosy 
      Thesis: Phytochemical and Biological Studies of Some Artocarpus Species, Family 
Moraceae- Cultivated in Egypt.  
-Ain Shams University –Cairo-Egypt (2000-2005) 
• B.Sc.Honors Specialization in Pharmaceutical Sciences. 
  
Experience 
-Western University-London-Ontario-Canada (September 2013- present) 
• Teaching and Research Assistant.  
-National Organization of Drug Control and Research, Giza, Egypt, (2006-2012) 
• Quality Control Specialist.  
 
Honors and Awards 
-Canadian Society for Mass Spectrometry (CSMS) travel award (2016) 
• The 29th Tandem Mass Spectrometry Workshop. 
-Best Oral Presentation (2016)                                          
• Enabling Technology (ETP) Symposium in Ottawa. 
 
 
 
 
 
180 
 
 
Peer-Reviewed Publications 
• H. Metwally, Q. Duez, and L. Konermann “Chain Ejection Model for Electrospray 
Ionization of Unfolded Proteins: Evidence from Atomistic Simulations and Ion 
Mobility Spectrometry” Anal. Chem. 90, 10069 (2018). 
• Q. Duez, H. Metwally, and L. Konermann “Electrospray Ionization of Polypropylene 
Glycol: Rayleigh-Charged Droplets, Competing Pathways, and Charge State-
Dependent Conformations” Anal. Chem. 90, 9912 (2018). 
• L. Konermann, H. Metwally, R.G. McAllister, and V. Popa, “How to Run Molecular 
Dynamics Simulations on Electrospray Droplets and Gas Phase Proteins: Basic 
Guidelines and Selected Applications” Methods 144, 104 (2018). 
• H. Metwally and L. Konermann “Crown Ethers Modulate the Location of Charge 
Carriers in   Electrospray Droplets: Implications for the Mechanism of Charging and 
Supercharging” Anal. Chem. 90, 4126 (2018). 
• T. D. Schachel, H. Metwally, V. Popa, and L. Konermann “Collision-Induced 
Dissociation of Electrosprayed NaCl Clusters: Using Molecular Dynamics Simulations 
to Visualize Reaction Cascades in the Gas Phase” J. Am. Soc. Mass Spectrom. 27, 1846 
(2016). 
• C.E. Bartman, H. Metwally, and L. Konermann “Effects of Multidentate Metal 
Interactions on the Structure of Collisionally Activated Proteins: Insights from Ion 
Mobility and Molecular Dynamics Simulations” Anal. Chem.  28, 6905 (2016). 
• H. Metwally, R.G. McAllister, V. Popa, and L. Konermann “Mechanism of Protein 
Supercharging by Sulfolane and m-NBA: Molecular Dynamics Simulations of the 
Electrospray Process” Anal. Chem.  88, 5345 (2016). 
• R.G. McAllister, H. Metwally, Y. Sun, and L. Konermann “Release of Native-Like 
Gaseous Proteins from Electrospray Droplets via The Charged Residue model: Insights 
from Molecular Dynamics Simulations” J. Am. Chem. Soc. 137, 12667 (2015). 
• H. Metwally, R.G. McAllister, and L. Konermann “Exploring the Mechanism of Salt 
Induced Signal Suppression in Protein Electrospray Mass Spectrometry Using 
Experiments and Molecular Dynamics Simulations” Anal. Chem.  87, 2434 (2015). 
• L. Konermann, R.G. McAllister, and H. Metwally “Molecular Dynamics Simulations 
of The Electrospray Process: Formation of NaCl Clusters via the Charged residue 
Mechanism” J. Phy. chem. B.  118, 12025 (2014). 
 
 
181 
 
 
 
Presentations and Posters 
• H. Metwally, and L. Konermann “Crown Ethers Modulate the Location of Charge 
Carriers in Electrospray Droplets: Implications for the Mechanism of Protein Charging 
and Supercharging” 66th ASMS Conference on Mass Spectrometry and Allied Topics - 
San Diego- California-USA (2018). 
• H. Metwally, and L. Konermann “Crown Ethers Suppress Protein Supercharging in 
Native ESI-MS: Evidence for a Charge Trapping Mechanism” 30thLake Louise 
Workshop on Tandem Mass Spectrometry- Lake Louise-Alberta (2017). 
• H. Metwally, and L. Konermann “Molecular Dynamics Simulation of Electrospray 
Process: Why Do Crown Ethers Suppress Protein Supercharging?” 9thInternational 
Symposium on Enabling Technologies-Ottawa (2017).  
• H. Metwally, and L. Konermann “Mechanism of Protein Supercharging by Sulfolane 
and m-NBA” 29thLake Louise Workshop on Tandem Mass Spectrometry- Lake Louise-
Alberta (2016). 
• H. Metwally, and L. Konermann“ Mechanism of Protein Supercharging by Sulfolane 
and m-NBA: Molecular Dynamics Simulations of the Electrospray Process” 33rd 
Annual Trent Conference workshop on Mass Spectrometry- Toronto (2016). 
• H. Metwally and L. Konermann “Mechanism of Protein Supercharging by Sulfolane 
and m-NBA: Molecular Dynamics Simulations of the Electrospray Process” 21st 
International Mass Spectrometry Conference-Toronto (2016). 
• H. Metwally and L. Konermann “Exploring the Mechanism of Salt-Induced Signal 
Suppression in Protein Electrospray Mass Spectrometry Using Experiments and 
Molecular Dynamics Simulations” 98th Canadian Chemistry Conference and 
Exhibition-Ottawa (2015). 
• H. Metwally, and L. Konermann “Mechanism of Salt-Induced Signal Suppression in 
Protein ESI-MS” 31th Annual Trent Conference on Mass Spectrometry- Orillia (2014). 
 
